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Abstract 
Robust evaluation of public health interventions is required to ensure that interventions that lead to 
the greatest health benefit are adopted. However, traditional experimental evaluative designs are 
rarely possible for public health evaluation. - igns 
are underused, are seldom covered in detail in epidemiology courses and are excluded from many 
guidelines and reviews. As a result population level health interventions have suffered from an 
omised control trials are often either 
poorly evaluated or not evaluated at all.  
Interrupted time series (ITS) analysis is one of the most powerful quasi-experimental designs for 
evaluating the effectiveness of population level health interventions. It is increasingly being used to 
evaluate the effectiveness of interventions ranging from clinical guidelines to national public health 
legislation. The basic design involves comparing the outcome of interest before and after an 
intervention, whilst accounting for any underlying trend. Nevertheless, ITS studies, like other quasi-
experiments have more inherent threats to their internal validity than experimental designs, many of 
which have not been adequately addressed in the existing literature. Further guidance is needed on 
these threats and how they are best addressed in the design, application and appraisal of ITS studies. 
The overarching aims of this thesis are to improve the way that interrupted time series studies of 
public health interventions are designed in order to reduce the risk of bias and to make robust ITS 
designs more accessible to evaluators of public health interventions. This will be achieved through a 
range of methodological and applied studies using ITS designs. 
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 Background 
1.1 Introduction 
This thesis examines the use of interrupted time series (ITS) for the evaluation of public health 
interventions. ITS is one of a range of possible evaluative study designs and one that is particularly 
appropriate to public health interventions.(1)  In order to put the design in to context, in this 
background chapter I will introduce the broader topic of public health evaluation. I will begin by 
discussing what a public health intervention is and why robust evaluation is important. Next, I will 
discuss some of the features of public health interventions that make them complex to evaluate. I will 
then briefly introduce different types of evaluation, focussing on that to which ITS is most commonly 
applied: quantitative outcome evaluations. 
The remainder of the chapter will be focussed on the design of outcome evaluation studies. This will 
include, a discussion on counterfactuals and how they may be approximated in order to provide a 
comparator for estimating the effect of the intervention.  The way the counterfactual is defined 
determines the internal validity of an evaluation study and the extent to which causal inferences can 
be made. I will discuss internal validity and the possible threats to validity in the context of evaluation 
design. The evaluative study design with the strongest internal validity is the randomised control trial 
(RCT), or, more commonly in public health evaluation, the cluster randomised control trial (CRCT), 
therefore this is considered the gold standard. However, I will explain why RCTs and CRCTs are not 
always possible when evaluating public health interventions and therefore, why other, quasi-
experimental, designs such as ITS must be considered. Finally, I will discuss the features of quasi-
experimental designs, the broad group into which ITS fits and will introduce a number of other quasi-
experimental designs to which I will be drawing comparisons later on in the thesis. 
 Public health evaluation 
A wide range of programmes are described as public health interventions from infection prevention 
and control initiatives, to community development programmes, physical activity programmes to 
government legislation. Furthermore, many non-health interventions (for example those with 
educational, economic or environmental objectives) and even unplanned events may affect aspects 
of public health. Robust evaluation of such interventions is important for all stakeholders. Most 
notably, it is in the interest of the beneficiary population that interventions that they receive are 
effective in improving their health, and that such interventions do not cause them harm. This is of 
2 
 
course, also of interest to public health practitioners and policymakers who develop and implement 
these interventions, furthermore evaluations of previous initiatives will also be of interest to public 
health practitioners to inform the development of any new programmes or policies. Lastly, robust 
evaluation is important for the funders of health interventions be it taxpayers, private organisations 
or third sector organisations, each has scarce resources and it is important that these are allocated 
efficiently to fund the most effective interventions and not to those that lead to little or no 
improvement in health outcomes.(2, 3) 
In clinical practice, evidence based medicine has now become well established. Multiple randomised 
controlled trials (RCTs) to evaluate the effectiveness of each intervention are common and the 
establishment of organisations such as the Cochrane Collaboration facilitate the synthesis of this 
gs 
behind its clinical counterpart.(4) The gold standard RCT is not always possible, or even appropriate 
for public health interventions, yet alternative designs have not become well established and are 
excluded from many guidelines and reviews that aim to provide evidence based recommendations. 
recommendations are biased towards those interventions that are easier to evaluate but that may not 
necessarily be the most effective.(5) This may mean that resources are not allocated efficiently and 
the interventions leading to the greatest health benefits are not always chosen.(4-8) 
 Features of public health interventions 
Public health interventions differ from clinical interventions in a number of ways and have several 
commonly occurring features which can complicate their evaluation: 
Population level 
Most obviously, by their nature, public health interventions target a population rather than an 
individual. In clinical medicine an individual patient presents with a health problem, an intervention 
(be it medication, surgery, lifestyle changes or a wide range of other interventions) is then targeted at 
that individual with the desired outcome being an improvement in the health of that individual. In 
public health, the health problem is detected at a population level, this could range from a small 
community to a regional, national or even multinational population, the intervention is targeted at 
the population, with the aim of improving health outcomes (for example rates of a disease) within the 
population as a whole. 
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Complex 
(9) Public health interventions are often complex, for example, the 
Healthy Towns programme in England involved hundreds of different individual component 
activity initiatives) in nine different towns implemented at different points in time.(6) 
Multiple outcomes 
Public health interventions may affect a range of health outcomes. Furthermore, interventions may 
also seek to target non-health outcomes, for example a workplace health programme may seek to 
improve various health outcomes in employees but also to save an organisation money by reducing 
absence, street lighting interventions may seek to reduce road traffic accidents but also to reduce 
crime, the introduction of cycle lanes may seek to increase rates of physical activity but also to reduce 
carbon dioxide emissions.(5, 9) 
Long-term impacts 
Many public health interventions target outcomes that would occur months, years or even decades 
into the future. For example programmes targeting pregnant women and young children such as the 
(10) 
 Types of evaluation 
Evaluation science is a long-standing discipline and a range of theories and frameworks have been 
developed to explain the purpose and process of evaluation.(11-13) Perhaps the most common 
distinction is between outcome evaluation and process evaluation. There have been numerous 
definitions of these two types of evaluation; broadly speaking, outcome evaluation assesses whether 
an intervention works (its efficacy or effectiveness), whereas process evaluation assesses how and 
why it works.(14, 15) Outcomes may be intermediate, for example changes in behaviours such as 
smoking or physical activity, or they may be final, for example changes in disease rates or mortality. 
Process evaluation may examine how an intervention is implemented or received, why it is or is not 
effective and whether it could be implemented in other settings.(16) 
A further distinction that is often made in the evaluation literature is whether the evidence that is 
used for the evaluation is quantitative or qualitative. A wide range of data can be used for each of 
these, for example surveys or routine data in quantitative evaluations and semi-structured interviews 
or focus groups in qualitative evaluations. Outcome evaluation tends to have more of a quantitative 
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focus and process evaluation may have more of a qualitative focus, however both methods are used 
in each type of evaluation.(16, 17) 
The focus of this thesis will be on quantitative outcome evaluation. 
 Counterfactuals 
As described above, the aim of outcome evaluation is to assess whether an intervention works, that 
is, whether it achieves what it purports to achieve. In order to know whether an intervention has 
caused an outcome, a comparison needs to be made between what actually happened and the 
counterfactual, that is, what would have happened if the intervention had not taken place. Evaluation 
of the intervention requires the simulat
observed. Of course, it is not possible to observe the intervention both being implemented and not 
being implemented in the exact same population at the same time, therefore the true counterfactual 
is never known. Evaluation design is therefore centred on creating the best approximation of the true 
counterfactual and then comparing what actually happened to the approximated counterfactual.(18) 
 Causal inference and validity 
No method for approximating the counterfactual is perfect, therefore it is never possible to infer with 
certainty that an association found between an intervention and an outcome is causal. Evaluative 
study designs must reduce the possibility of other factors explaining any observed association. The 
internal validity of a study, in this case the evaluation of an intervention, refers to the extent to which 
an observed association between the intervention and the outcome (when compared to the 
approximated counterfactual) reflects a causal effect. Campbell and Stanley identified eight threats to 
internal validity which have since been expanded upon by Shadish et al (with the addition of 
ambiguous temporal precedence) (Table 1):(18-20) 
Table 1: Threats to internal validity(18-20) 
Threat to validity Description Epidemiological 
terminology 
Ambiguous 
temporal 
precedence 
When examining associations between an exposure and an 
outcome, it may not be clear whether the exposure 
preceded the outcome. In some cases it may be possible 
that the outcome caused the exposure, a phenomenon 
known as reverse causality. This is generally more of a 
Reverse causality 
5 
 
problem in aetiological studies than evaluative studies as 
the timing of an intervention is normally known. 
Nevertheless, if the timing of the intervention or even under 
study is unclear, it may not be obvious whether it preceded 
the outcome which could affect the study validity.  
Selection Selection bias occurs when those receiving the intervention 
differ from a comparison group by some factor or factors 
that could influence the outcome. Apparent differences in 
the outcome could therefore simply be due to differences 
in the groups being compared rather than due to the 
intervention. 
Selection bias and 
confounding due to 
population differences 
History History bias refers to any other events that occur at the 
same time as the intervention and that could affect the 
outcome. These events could thus provide an alternative 
explanation for the observed effect. 
Confounding  note that 
history bias is a more 
specific term than 
confounding and refers to 
confounding by other 
contemporaneous 
interventions or events 
that may be associated 
with the outcome. 
Maturation Maturation changes are those natural changes among 
participants whether or not an intervention is implemented, 
such as individuals growing older or more tired and secular 
changes within a population (such as changes to the 
economy). 
Time-varying 
confounding  maturation 
is a general term for 
confounding variables 
that may change over time 
from any pre-intervention 
observation(s) to any 
post-intervention 
observation(s) 
Regression Regression to the mean occurs when an intervention is 
introduced because of recent extremes in some measure. 
For example a smoking intervention may be introduced 
following the recent detection of higher than average 
smoking rates. In this situation there is a tendency for the 
measure to be less extreme on subsequent testing even 
without any intervention because part of the explanation for 
Regression to the mean 
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the initial extreme measure may have been due to random 
variation. 
Attrition Attrition is the loss of participants from the evaluation so 
that not all participants are measured in each observation. 
If there are differences in the kind of people lost in different 
comparison groups then this may explain differences in 
observed outcomes in the two groups. 
Loss to follow-up 
Testing Being tested (or observed) before an intervention may 
influence the observation on subsequent testing, simply 
due to being tested rather than due to the intervention. For 
example, asking somebody details about their smoking 
status may influence them to reduce or stop smoking. 
Research participation 
effect or Hawthorne effect 
Instrumentation Instrumentation occurs when the way in which an outcome 
is measured changes during the evaluation. For example in 
the evaluation of a workplace health intervention looking 
at the effect on sickness absences, if the way that sickness 
absences are recorded changes as part of the intervention, 
this could explain an observed effect on absence rates. 
Information bias or 
measurement bias 
Interaction between 
different threats to 
validity 
Different threats to validity can occur within the same 
evaluation and sometimes there can be an interaction effect 
between the two so that their combined effect is greater. 
For example a selection-maturation interaction may occur 
if comparison groups come from different communities 
and then there are different secular economic changes in 
each of these communities. 
 
 
These threats are drawn from the social science literature and the terminology may not always be 
familiar to epidemiologists. A third column has therefore been added to the table in order to translate 
Campbell and Stanley
 in epidemiology, is divided into three different terms in Campbell and 
 1) Selection incorporates confounding arising from differences between a control and 
intervention group according to other covariates (in addition to the typical epidemiological definition 
of selection bias: differential exclusion of participants from each group); 2) History  specifically 
describes confounding due to the effects of other interventions or events that are concurrent to the 
intervention under study; 3) Maturation  describes changes to a population due to time-varying 
confounding factors which can affect before-after comparisons.(18-21) 
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While strong internal validity of an evaluation is important in order that more accurate conclusions 
can be made about the effect of an intervention within the population and setting being studied, an 
evaluation can be even more useful if those conclusions can be extended to other populations and 
settings so that they can inform the choice of interventions elsewhere. The external validity of an 
evaluation refers to the extent to which its findings can be extended to other settings and populations. 
Evaluations conducted on varied populations in a range of settings may facilitate the study of 
subgroups, if similar effects are found in different subgroups this increases the likelihood that results 
are generalisable. However, if an evaluation has very stringent inclusion criteria or is conducted in a 
very specific setting, it is more difficult to draw conclusions about what effect might be expected if 
the intervention were implemented elsewhere.(18, 19, 22) 
 Evaluation of subgroups and effect modification 
Interventions may affect different groups in different ways. For example, males may be more affected 
than females or effects may differ by age. By only looking at the overall effect of an intervention in 
the whole study population, this can mask effects in certain subgroups. Conversely, observing an 
effect in the total study population, does not necessarily mean that all subgroups within the 
population would have been affected or affected equally. Differential effects of the intervention on 
the outcome according to some third variable (such as sex or age) is known as effect modification.(23, 
24) Where differential effects are considered plausible, evaluations should include subgroup analyses 
to explore effect modification. Formal tests for interaction are also available to test the strength of 
evidence for such differential effects and whether they may be due to chance.(23) For example, 
Matthews et al 2016 examined the impact of negative media coverage on statin prescriptions and 
found that older age groups and those who had been taking statins the longest were most likely to 
stop taking statins.(25) It is important that such differential effects are examined as this can help to 
identify groups that should be targeted with future interventions. 
 
 Experimental study designs 
Experimental designs involve the random assignment of individuals (randomised control trials [RCTs]) 
or groups (cluster randomised control trials [CRCTs]) to either an intervention or a control group. 
Because public health interventions are generally applied at the population level, CRCTs are generally 
more appropriate in this context.(26, 27) The outcome in the control group provides an approximation 
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of the counterfactual to which the outcome in the intervention group can be compared in order to 
estimate the effect of the intervention. RCTs and CRCTs are regarded as the gold standard
design due to their ability to ensure that the intervention and control groups are, on average, the 
same with regards to all variables (both known and unknown) other than their exposure to an 
intervention. Both groups would thus be expected to have similar outcomes given the same 
conditions. Therefore, the control group provides a valid approximation of what would have happened 
in the intervention group had they not received the intervention.(7, 28) CRCTs have strong internal 
validity, the randomisation process controls for selection bias, and, because the two groups are on 
average the same, history, maturation and regression should not affect either group differentially, nor 
should testing or instrumentation assuming that both groups are treated in the same way throughout 
the study.(28) 
Despite their strong internal validity, RCTs and CRCTs have a number of issues which can limit their 
applicability in public health evaluation. First, true equipoise may not exist, therefore it would be 
unethical to exclude some participants from the intervention.(7, 29) This happens, for example when 
introducing interventions that have already been shown to be effective in other populations or when 
evaluating secondary outcomes of an intervention in which there is already strong evidence of the 
effectiveness on primary outcomes.(5, 30, 31) Second, public health practitioners or policy makers 
introducing the intervention may require certain groups to receive an intervention for other reasons, 
for example those with the most need. Similarly, it may be necessary that the intervention is delivered 
to everyone in the population simultaneously, either for legal reasons or because an inherent feature 
of the intervention is its unanimous adoption, for example new laws, changes to social benefits or 
reforms of national systems.(7) Third, individuals or groups may have preferences regarding an 
intervention and disagree with randomisation. Preference trials are a possible solution to this, 
whereby only those with no preference for or against the intervention are randomised. Nevertheless, 
this limits generalisability and many public health interventions rely on active participation, therefore 
those who are indifferent may respond differently to others who take more of an interest in the 
intervention.(7, 32, 33) Fourth, researchers are often interested in evaluating the effects of 
interventions that have already been implemented or the health impacts of unplanned events such as 
natural disasters or political and economic events.(34, 35) In this situation designs that make use of 
pre-existing observational data will be necessary.(7) Fifth, for evaluations of interventions that target 
rare outcomes, the numbers needed to detect an effect are often far too large for a trial to be 
feasible.(32, 36) Finally, RCTs often have low external validity due to stringent inclusion critieria, 
participants behaving differently because of the knowledge that they are under investigation, and 
because settings and populations that tend to be involved in trials (for example research conscious 
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policy makers and participants, and settings with well established relationships universities) may not 
be representative of the wider population.(32, 37, 38) 
Given that experimental designs are often not possible in the context of public health evaluation, 
- should be considered. 
 Quasi-experimental designs 
Where a true experiment is not possible, other methods are needed for simulating the counterfactual. 
Shadish et al define quasi-exp
conditions but that otherwise have similar purposes and structural attributes to randomized 
(18) Whereas in experimental designs, the participants or populations are actively 
assigned to either the intervention group or the control group, quasi-experimental methods often 
take advantage of exogenous sources assignment to the intervention.(39) Where such exogenous 
sources of assignment exist, this is also termed a .(5) A whole range of quasi-
experimental designs exist, these can broadly be categorised into: designs that use a pre-post 
comparison, designs that use a control and designs that incorporate trends in the outcome, though 
designs may fall into more than one category.  
 Designs that use a control 
Where randomisation is not possible, alternative controls may be used to approximate the 
counterfactual (a cross-sectional non-randomised control design). Here, individuals may be actively 
assigned to an intervention or control group, or more typically, the intervention has been targeted at 
one particular population and an unexposed population is selected as the control group in a natural 
experiment. Selection bias is the main limitation of non-randomised control designs.(18) A number of 
methods have been developed to minimise selection bias, including adjusting for covariates, matching 
and propensity score matching can account for known characteristics that differ between the two 
groups, but cannot control for unmeasured confounders.(7, 29, 32) Furthermore, given that there are 
no pre-intervention observations, it is not possible to tell whether the two groups already differed 
with respect to the outcome, even prior to the intervention.(18) 
 Designs that use a pre-post comparison 
An alternative approach to approximating the counterfactual is to use pre-intervention observations 
within the same population. Here, it is assumed that the outcome of interest would remain the same 
in the absence of an intervention. The simple before-after design (also known as a one-group pretest-
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posttest design) compares observations at a time point prior to the intervention to those at a time 
point after the intervention. If there is a change in the outcome following the intervention, this may 
be as a result of the intervention. Nevertheless, this design has significant threats to its validity as 
there are numerous other potential explanations for a change in the outcome, including: random 
fluctuations, a pre-existing increasing or decreasing trend in the outcome of interest (maturation), an 
abnormally high or low observation during the pre-intervention period that simply returns to normal 
(regression to the mean), or a change due to another simultaneous event (history bias). Interrupted 
time series designs, also use a pre-post comparison but avoid many of these limitations, as will be 
discussed in the next chapter. 
 Designs that use a control and a pre-post comparison 
Controlled before and after (CBA) studies (also known as difference in difference designs) combine 
pre- and post-intervention observations with one or more non-equivalent control groups. The change 
in outcome in the intervention group is then compared to the change in outcome in the control group 
(Figure 1). While this design takes into account pre-intervention differences between the intervention 
and the control groups, it makes the assumption that in the absence of the intervention, observations 
in the two groups would have followed parallel trends. In order to strengthen the validity of the design 
it is important to ensure that control groups are as similar as possible to the intervention group. Where 
differences do exist a range of methods have been developed in order to match groups on individual 
level and group level variables as well as potential unobserved confounders.(18, 28, 40, 41) 
 
 
Figure 1: Controlled before and after design 
Treatment effect = d2-d1 
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Another design that uses both a control and a pre-post comparison, but does not make the assumption 
of parallel trends, is the controlled interrupted time series. This is discussed further in Chapters 2 and 
6. 
 Designs that incorporate trends in the outcome 
Sometimes interventions are assigned to individuals or populations based on reaching a cut-off 
threshold in some continuous variable, such as age or income (known as the assignment variable). 
One approach to analysing the effect of the intervention in this situation would be to compare those 
below the threshold, for example a group below the threshold age, to a group above the threshold 
age. This is effectively a non-randomised control design.  A regression discontinuity design (RDD) uses 
a more sophisticated approach incorporating trends in the outcome according to the assignment 
variable.(39) For example, Shoag et al looked at the impact of prostate biopsy on prostate cancer 
mortality by looking at prostate specific antigen (PSA) screening.(42) All those above a certain PSA 
score would be offered a biopsy, whereas those below this threshold would not. RDD involves 
regression of the outcome among the controls against the assignment variable, by extrapolating this 
regression line to scores in the assignment variable beyond the threshold a counterfactual can be 
created for those that received the intervention (Figure 2). The regression line in the intervention 
group can then be compared to this counterfactual, if the intervention causes an effect there will be 
a discontinuity in the regression line (either a step change or a slope change). Any threat to the internal 
validity of RDD would have to cause a discontinuity in the regression line that coincides exactly with 
the threshold in the assignment variable. There are often few circumstances in which this would be 
plausible. 
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Figure 2: Regression discontinuity design 
 
Interrupted time series can be considered a type of RDD study whereby the assignment variable is 
time (i.e. before a certain time the participants did not receive the intervention and after that time 
they did). 
 
The most powerful quasi-experimental designs are able to provide strong evidence on the 
effectiveness of an intervention, particularly if design adaptations, described in more detail elsewhere, 
are used to address potential threats to their validity.(18, 19, 43, 44) One or more of the designs can 
often be used in situations where an RCT is not possible. In particular, quasi-experimental designs can 
often be applied in natural experiments.(5) Despite their strengths, the potential for bias and 
confounding is greater in quasi-experimental studies. It is therefore important that researchers have 
a clear understanding of the threats to validity of such evaluations. Further methodological work on 
identifying and minimising the threats to validity of quasi-experimental studies is needed, as is further 
guidance on the transparent reporting of such studies. 
 Evaluation guidelines 
A range of quality criteria have been developed for reporting and appraising RCTs and the CONSORT 
statement has now been widely adopted.(45, 46) In recent years the importance of providing guidance 
on other evaluation designs has become more prominent. The UK Medical Research Council (MRC) 
has issued guidance 
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.(5, 9, 47) The Cochrane Collaboration has 
also developed criteria -Randomized  in systematic reviews.(48)  
Some reporting recommendations have also been developed for certain quasi-experimental designs. 
The most widely adopted of these is the 
nterventions by the USA 
Centers for Disease Control.(8)  This may go some way towards supporting the inclusion of non-
randomised studies in systematic reviews and evidence based guidelines on the choice of 
interventions, and thus reduce the bias towards only including interventions that are amenable to 
RCTs.(8) However, such guidance is lacking for other designs such as ITS and RDD. 
While further enhancement of existing guidance may be needed, it is encouraging that improving the 
evaluation of public health interventions is a key focus for applied researchers, systematic reviewers 
and funding agencies. Such interest should help to minimise the evaluative bias that exists with public 
health interventions and improve decision making to ensure that the most effective interventions are 
implemented. 
 Summary 
Public health interventions are frequently complex and have a number of features which can make 
them difficult to evaluate. Avoiding the evaluation of interventions where conventional methods such 
as RCTs are not possible results in evaluative bias and a lack of evidence on the effectiveness of many 
interventions. This creates difficulties for public health practitioners and policy makers wishing to 
tackle health problems. In this chapter I have described the features of alternative quasi-experimental 
designs which may be considered for the evaluation of public health interventions. Nevertheless, 
further methodological research is needed on identifying the potential threats to the validity of these 
designs and approaches to dealing with these threats. Further development of reporting criteria for 
quasi-experimental designs is also required in order to ensure that they are presented transparently 
and can be easily appraised for inclusion in systematic reviews and guidelines. 
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 Interrupted time series design 
 Introduction 
The last chapter introduced quasi-experimental designs. I have chosen to focus this thesis on 
interrupted time series (ITS), one of the more powerful quasi-experimental designs and one that has 
wide applicability in the evaluation of public health interventions.(1, 2) In this chapter I will provide an 
overview of the ITS design. I will begin by describing the main features in the context of quasi-
experimental design characteristics that were introduced in Chapter 1 and I will explain how the 
counterfactual is approximated in ITS studies. I will also explain the main analytical approach for ITS 
and the range of applications. Next, I will consider the main strengths of ITS and summarise the 
existing empirical evidence on its validity. ITS also has a number of weaknesses and I will discuss how 
these can threaten the internal validity as well as possible design adaptations that may be used in 
order to minimise these threats. Finally, I will discuss existing quality criteria that have been used to 
critically appraise ITS studies. 
Throughout the chapter, I will highlight areas where further methodological work is needed. This will 
be used to inform the aims of the thesis which will be presented in Chapter 3. 
 Features of the interrupted time series design 
The interrupted time series (ITS) design (also known as the time series experiment) has been described 
in the social sciences literature since the 1960s, (3, 4) An ITS study involves a set of observations on 
an object, an individual subject or, as is most commonly the case in public health and social sciences, 
a population, taken repeatedly over time before and after an intervention. The counterfactual is 
modelled by extrapolating the pre-intervention trend in the outcome of interest into the post-
intervention period (Figure 1). The impact of the intervention is then assessed by examining any 
change in the trend of the post-intervention observations.(3, 5)  
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Figure 1: the interrupted time series design 
Solid line = modelled trend; dashed line = counterfactual; vertical line = intervention implementation. 
 
ITS is therefore effectively a pre-post comparison. However, the analysis of trends is what 
differentiates ITS from simple before and after studies where either a single observation before the 
intervention is compared to a single observation after the intervention or the average of several 
observations before the intervention is compared to the average of several observations after the 
intervention. In a before-after design, the trend is assumed to be flat, any change in the outcome after 
the intervention is therefore considered an effect of the intervention. If this assumption is violated, 
for example, if there is a pre-existing decreasing trend in the outcome, an effect would be detected 
whether or not an intervention is introduced (figures  2a and 2b). ITS is able to differentiate an effect 
of an intervention from that of the underlying trend ( figures 2c and 2d). 
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Figure 2 Difference between simple before and after study and interrupted time series 
(a) Simple before and after assuming no intervention takes place (shows an effect) 
(b) Simple before and after with intervention (shows an effect) 
(c) ITS with no intervention (shows no effect) [observations from simple before and after are overlaid] 
(d) ITS with an intervention (shows an effect) [observations from simple before and after are overlaid] 
 
 
 Analytical approach 
Data requirements 
There are two basic requirements for undertaking an ITS study. First, a time series of the outcome 
data is required spanning the pre- and post-intervention period. That is: there must be multiple 
sequential measures of the outcome over time both before and after the intervention. Typically, this 
involves using routine data sources that are not necessarily collected specifically for the purpose of 
the evaluation study. Second, the timing of the intervention must be clear in order to separate the pre 
and post-intervention periods. (1, 5) The Cochrane Effective Practice and Organisation of Care group 
guidelines suggest a minimum of three data points are included before and three after the 
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intervention.(6) However, others suggest that the number of data points should be sufficient to 
evaluate seasonal patterns (discussed below), for example a minimum of 12 data points before and 
after for monthly data.(1) 
Describing the effect of the intervention 
The impact of an intervention is most commonly described in terms of a change in level (or intercept), 
a change in slope (or trend), or a change in both of these parameters (Figure 3).(1, 5) Other changes 
can, however, also be examined, such as changes in variability of the data or changes in cyclical 
patterns, for example, the UK Winter Fuel Payment might be expected to reduce the seasonal increase 
in mortality among the elderly that occurs in the winter.(5, 7, 8) Shadish et al describe these 
parameters (level, slope, variance and cyclicity) as the form of the effect, they also discuss two other 
dimensions by which the effect of an intervention should be described: its permanence and its 
immediacy. Permanence refers to whether the effect persists over time (a continuous effect) or 
whether it is temporary and then returns to the preintervention trend (a discontinuous effect). The 
immediacy describes whether an effect occurs straight after the intervention is introduced (an 
immediate effect) or whether there is a lag between the intervention being introduced and any impact 
(a delayed effect).(5) 
 
 
Figure 3 Types of effects in an interrupted time series study 
(a) Change in level 
(b) Change in slope 
(c) Change in level and slope 
 
There is extensive literature on statistical methods for modelling the pre-intervention trend and for 
quantifying a level or slope change, (9-11). However, there is a lack of guidance on how to decide on 
the form of effect that should be modelled, whether a lag should be allowed for, and if so, how long 
the lag should be. Methods often seem to rely on using the data to specify the impact model that fits 
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best, however, this could increase the likelihood of an effect being detected due to random 
fluctuations or chance.(12) Further guidance is needed on how researchers can select the most 
appropriate ITS model a priori. 
Methods of analysis 
The statistical approach to analysis of ITS studies is known as segmented regression. In a basic ITS 
study with one pre-intervention and one post-intervention period, segmented regression fits a 
separate least squares linear regression line to each period. The post intervention model can be 
allowed to change in level, slope or both.(1)  
A central assumption to linear regression is that the data are independent, however, this is often not 
the case in time-series data for two reasons: firstly, consecutive observations tend to be more similar 
to one another than those that are further apart, a phenomenon known as autocorrelation; secondly, 
there are frequently seasonal patterns whereby observations in one month are similar to observations 
in the same month a year previously, in particular when studying health and disease, for example, 
levels of influenza may be higher in winter, and levels of physical activity higher in summer.(1, 13) A 
range of techniques exist to test for and adjust for autocorrelation and seasonality.(1, 14-16) In 
addition to seasonal effects, other time varying confounders can be adjusted for within the segmented 
regression model. (17, 18) 
While some specific aspects of the analytical approach to ITS have been described in detail, for 
example the use of autoregressive integrated moving average (ARIMA) models to correct for 
autocorrelation and approaches to deal with seasonality.(11, 19) There is a lack of introductory 
guidance on ITS analysis, including how to structure the data, how to undertake a segmented 
regression analysis and the common factors that need to be adjusted for. This may act as a barrier to 
its wider adoption in public health evaluation. Furthermore, more in depth guidance is needed on 
selection of the most appropriate impact model and factors that can impact on how the counterfactual 
is defined. 
 Applications of interrupted time series 
Some of the earliest examples of ITS come from social policy research, including the impacts of policies 
on crime, economics and education.(4, 20-22) The design continues to be widely used in these fields 
but has expanded to evaluations of a broader range of interventions beyond policies such as 
manufacturing processes (23), war (24), education interventions (25), business practices (22).  
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ITS is now also being increasingly adopted for the evaluation of health interventions. It has been used 
for the evaluation of clinical interventions,(26) it has also been used extensively in single subject 
studies in clinical psychology.(27) However, they are most commonly used for public health 
interventions that are applied at a population level.(28-30) Part of the reason for this is that ITS designs 
are well suited to looking at population level outcomes, for which routine data with long time series 
are commonly available, for example: rates of health service use, disease incidence, mortality rates, 
smoking prevalence.(31) When examining population level outcomes, ITS studies can be considered 
an ecological design. 
inferences are made at the individual level based on findings at the population level.(32) However, 
when evaluating the impact of interventions that are applied at a population level, such as smoking 
legislation, we are primarily interested in outcomes at the population level, such as smoking 
prevalence, therefore an ecological design is often more appropriate. 
Fields of public health for which ITS studies have been used include: a wide variety of health promotion 
interventions, ranging from national legislation to local community level programmes;(2, 31, 33) 
communicable disease control, such as new vaccines or antimicrobial stewardship programmes;(28, 
34); and health service interventions including the introduction of new services, financial incentives, 
new guidelines and screening programmes.(30, 35-37) ITS has also been used to evaluate the health 
impacts of non-health interventions, road changes and mass gathering events.(38, 39) Furthermore, 
it can also be used to evaluate the impact of unplanned events such as natural disasters and economic 
events.(40, 41) 
 Strengths 
Wagner et -experimental designs to estimate 
intervention effects in non- (1) ITS is rarely subject to many of the threats to 
internal validity that affect 
the internal validity of a study design (Chapter 1: Table 1), only history is identified as a major threat 
to ITS designs.(3, 5) Having a series of observations before the intervention takes place enables 
maturation and regression effects to be detected, if routine data is used then respondents will not be 
aware that they are part of an experiment so testing effects are not plausible, even without routine 
data testing effects are unlikely in a long time series. Instrumentation can be a threat but only if the 
method of data collection changes over the same period as the intervention. Selection and attrition 
are only a threat if the composition of the study population changes after the intervention.(3-5, 42) 
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The use of longitudinal data in ITS designs also enables researchers to examine the impact of an 
intervention in much more detail than would be the case with cross sectional data, for example, 
establishing the permanence and immediacy of any effect.(42) Furthermore, longitudinal designs such 
as ITS, allow possible reverse causality to be examined, whereby the outcome leads to exposure (or in 
this case the intervention). For example, a change in a health outcome could lead to an intervention 
being implemented rather than vice-versa, examination of a time-series will enable the researcher to 
see which came first. 
In common with other observational studies, ITS designs, also have strong external validity given that 
they are normally undertaken in real world settings, using observational data. Generalisability to other 
populations or settings will be dependent on the particular intervention, outcome of interest, study 
population and study setting, however, subgroup analyses may help to establish whether effects are 
similar in different populations and thus support or reject the likelihood that findings are 
generalisable.(5) 
While designing an ITS study can be complex, another important advantage of ITS studies is that 
presentation of results in graphical format, and their subsequent interpretation, is simple and can 
easily be understood by lay readers.(1) This is clearly important in public health evaluations in order 
to facilitate decision making by public health professionals and policy makers as well as understanding 
of these decisions by members of the public. 
 Limitations 
The major threat to the validity of ITS studies is history bias, that is, other events occurring at the same 
time as the intervention which could explain the effect.(1, 3-5) The likelihood of other events 
impacting on the intervention increases if there is a greater time period between observations (e.g. 
yearly rather than monthly data) and the greater the lag between intervention and effect.(5) 
Coinciding events with a potential impact on the outcome should be investigated and controlled for 
where possible. Other threats to internal validity that occur in some circumstances include 
instrumentation, selection and experimental mortality. Instrumentation might occur if there is a 
change to the way the outcome data is collected over the study period, particularly if this coincides 
with or is as a result of the intervention.(3-5) Selection and experimental mortality could occur if the 
intervention leads to a change in the composition of the study population, or the loss of study 
participants. In this case, where possible, restricting the analysis to participants in all study phases can 
help.(5, 42) 
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While a benefit of ITS is that there are a whole range of possible impact models that can be used, 
selecting the most appropriate model can be challenging. Deciding, for example, the specific timing of 
the intervention, the form of effect, its permanence and whether there is any lag is complex and 
requires an in depth understanding of the intervention. An intervention, such as a policy change, could 
have an impact before it is implemented (due to publicity about the policy), at the point at which it is 
introduced, or sometime later (if the policy takes time to be implemented or communicated).(43) 
Similarly, researchers need to decide on the length of the time series to be included in the analysis. 
Visual inspection of the time-series data under investigation in order to identify the most suitable 
length of the series and the type of effect and then modelling this in the analysis is unlikely to be 
appropriate as this could result in any random changes that occur due to chance being interpreted as 
a significant treatment effect.(5) Evidence based theory or initial exploratory research of other data 
sources is needed in order to propose the most likely type of effect that the intervention will cause. 
Nevertheless, there is a lack of methodological literature on how ITS models should be specified. While 
testing a range of different models can help to deal with uncertainty in model selection it may also 
increase the risk of false positive effects being detected. 
Finally, interpretation of ITS studies can be simple where the impact of the intervention on the 
outcome occurs very soon after its implementation, however, one of the difficulties in the evaluation 
of public health interventions, is that often effects would be expected to take many years to 
materialise. Interventions addressing risk factors for chronic diseases such as diabetes and many 
cancers may only change disease outcomes decades after they are implemented. As discussed above, 
the greater the lag between intervention and effect, the greater the risk that history becomes a factor 
affecting the internal validity of the study, furthermore, the delay between intervention and effect is 
likely to vary from person to person so it is difficult to pre-specify a lag to model in the analysis.(5)  
 
 Approaches to strengthening the validity of ITS 
As discussed above, the principal threat to the validity of ITS is history bias. A number of design 
adaptations have been developed in order to mitigate history bias. The most common of these is to 
include a control series from a population that did not receive the intervention. If there is a change in 
the outcome in the intervention series, but not in a similar control series, this  eliminates concurrent 
events that would have affected both populations as a possible explanation for the change (Figure 
4).(5) For example, Dennis et al evaluated the impact of the introduction of helmet legislation in a 
number of Canadian provinces on cycling related head injuries by comparing outcomes in Canadian 
25 
 
provinces that did not implement helmet legislation.(44) The main limitation of non-randomised 
control groups in quasi-experimental designs is the possibility of selection bias and confounding due 
to differences between the groups. This is less of an issue in ITS studies as the pre-intervention trend 
among the intervention group serves as the primary control and this is derived from the same 
population as the post-intervention trend. Nevertheless, matching can be used to ensure that the 
control group is similar to the intervention group and various matching techniques exist to achieve 
this.(45) 
 
 
Figure 4: Graphical representation of a controlled ITS 
 
 
Including a control series can greatly increase the validity of an ITS study. However, in order to do so 
confounding events must affect both groups. Currently there is a lack of guidance on the different 
types of control series that can be used in ITS, which types of confounding events they can address 
and how to approach selecting the most appropriate control series. 
An extension of the controlled ITS design is the multiple baseline design. This involves introducing the 
same intervention to different populations at different points in time (Figure 5). For example, Biglan 
et al evaluated the impact of an intervention to reduce the sale of tobacco to young people in four 
communities, after a baseline period the intervention was first introduced in two of the communities 
and then in the other two communities at a later date.(46) One community acts as a control for the 
other depending on when it received the intervention. Furthermore any confounding event would 
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have to occur in two or more populations at two or more different time points. The design also 
strengthens external validity if findings are concordant in two different settings.(5) 
 
Figure 5: Graphical representation of a multiple baseline design 
 
  
Another approach to limiting history bias is to introduce the intervention and then withdraw it after a 
given period (Figure 6). If there is an effect on the outcome of interest when the treatment is in place 
and this effect disappears when the treatment is removed, this increases the likelihood of a causal 
link. This design limits the threat of history as a confounding event would have to both be introduced 
and withdrawn at the same time as the intervention.(2, 5, 47) The design, however, can only be used 
if, firstly, the intervention can ethically be removed and, secondly, the effects of the intervention do 
not continue beyond its withdrawal. In practice this may be useful with clinical interventions and single 
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subject designs, but often not possible with public health interventions that frequently have long term 
effects. 
 
 
Figure 6: Graphical representation of an ABA ITS design 
 
Finally, another technique to address some of the limitations of ITS studies is to conduct sensitivity 
analyses. This is primarily used when there is uncertainty about the type of effect that the intervention 
will have, in order to test different forms of effect (e.g. slope change instead of step change), different 
permanence (e.g. a discontinuous rather than a continuous effect) and different lags, as well as other 
model assumptions. No methodological literature was found addressing sensitivity analysis in ITS, 
however, the technique has been used in applied studies.(5, 16, 48) Whilst a continued effect under 
different assumptions may increase confidence that the intervention is indeed responsible for the 
effect, undertaking many hypothesis tests increases the chance of type 1 errors. In this instance there 
is a risk that researchers could pick the model which shows the greatest effect a posteriori. It seems, 
therefore, that developing an evidence based theory for the most likely model a priori still remains an 
important step. 
 Evidence of validity of the ITS design 
ITS has many theoretical strengths and has been endorsed as one of the strongest designs for 
evaluating the impact of an intervention where a randomised control trial (RCT) is not possible.(1, 5) 
Nevertheless, until recently, there was little empirical evidence of the ability of ITS to infer a causal 
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link between an intervention and an outcome. Three studies were found comparing ITS designs to a 
RCT:  
Fretheim et al compared a cluster RCT of an intervention to improve primary care prescribing of 
antihypertensives with a simple ITS of the treatment arm analysed using segmented regression.(49) 
Results were similar with the ITS result (11.5% change in prescribing[95% CI 9.5-13.5%]) within the 
95% confidence interval of the cluster RCT result (9.0% [95% CI 4.9-13.1%]). However, there were 
baseline differences between the intervention and control groups in the cluster RCT, therefore it is 
difficult to assess whether this was an appropriate comparator.  
Schneeweiss et al compared a cluster RCT with a form of controlled ITS in their evaluation of the 
impact of restriction of state funding of nebulised respiratory therapy on various outcome.(50) The 
control group in the ITS was the same population but in the two years prior to the intervention, when 
no restriction was implemented. Results initially differed between the two designs, but it was noted 
that there was a large amount of crossover from the control arm to the intervention arm in the RCT, 
after this was adjusted for results for the cluster RCT were concordant with those of the ITS. 
St. Clair et al used a comprehensive within study comparison design to compare a cluster RCT of a 
school based education intervention on academic achievement with a controlled ITS using both non-
matched and matched comparison groups.(51) The time-series was relatively short with 6 pre-
intervention observations and one post-intervention. Again, they found that the ITS results were 
concordant with those of the RCT. In addition, the precision of the controlled ITS was found to be 
higher than that of the RCT. They also compared using grouped pre-test means to an ITS design 
modelling the slope and found that the ITS design substantially improved the concordance with the 
RCT result and reduced bias. 
A further study by Somers et al examined the validity and precision of a controlled ITS compared to a 
regression discontinuity design evaluating the impact of a regional school based reading 
intervention.(52) Results were concordant between the two designs despite the short time series (4 
pre-intervention observations). This study may be limited by the fact that it does not use a RCT (the 
accepted gold standard) as a benchmark, although the authors provide strong arguments for the use 
of a regression discontinuity design as a valid comparator. 
Whilst each of the above studies has certain limitations, together they provide relatively compelling 
evidence of the validity of the ITS design, in particular when a control group is used. Nevertheless, it 
is important to be aware of the possibility of publication bias and further within-study comparisons 
are needed to test the generalisability of these results.  
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 Existing guidance on use of ITS 
Quality criteria and reporting guidelines exist for RCTs and observational studies such as cohort, cross-
sectional and case-control studies which both facilitate investigators in conducting high quality 
research and readers in critically appraising such studies.(53-55) No well-established reporting 
guidelines exist for ITS studies, nevertheless quality criteria have been used in systematic reviews that 
include ITS studies.
Perhaps the most widely quoted criteria for ITS designs are the Cochrane Effective Practice and 
Organisation of Care Review Group (EPOC) risk of bias criteria (Table 1).(6) These guidelines encourage 
authors to address the threat of history (criterion 1), instrumentation (criterion 3), testing (criterion 
4), as well as pre-specify effect models a priori (criterion 2), deal with missing data appropriately 
(criterion 5) and report all outcomes that were part of the original objectives (criterion 6). 
 
Table 1: Cochrane Effective Practice and Organisation of Care Review Group risk of bias criteria for ITS studies(6) 
1. Was the intervention 
independent of other changes? 
 
intervention occurred independently of other changes over time and 
the outcome was not influenced by other confounding 
variables/historic events during study period. If Events/variables 
identified, note w
intervention was not independent of other changes in time. 
2. Was the shape of the 
intervention effect pre-
specified? 
rational explanation for the shape of intervention effect was given by 
the author(s). Where appropriate, this should include an explanation 
 
3. Was the intervention unlikely to 
affect data collection? affect data collection (for example, sources and methods of data 
collection were the same before and after the intervention); Score 
(for example, any change in source or method of data collection 
reported). 
4. Was knowledge of the allocated 
interventions adequately 
prevented during the study? 
e authors state explicitly that the primary 
outcome variables were assessed blindly, or the outcomes are 
objective, e.g. length of hospital stay. Primary outcomes are those 
variables that correspond to the primary hypothesis or question as 
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defined by the a
 
5. Were incomplete outcome data 
adequately addressed? the results (e.g. the proportion of missing data was similar in the pre- 
and post-intervention periods or the proportion of missing data was 
less than the effect size i.e. unlikely to overturn the study result). Score 
 the results. Score 
up unless stated explicitly). 
6. Was the study free from 
selective outcome reporting? reported (e.g. all relevant outcomes in the methods section are 
 
7. Was the study free from other 
risks of bias? should consider if seasonality is an issue (i.e. if January to June 
comprises the pre-intervention period and July to December the post, 
sed a spurious effect). 
Reproduced from: Cochrane Effective Practice and Organisation of Care Review Group, Suggested risk of bias criteria for 
EPOC reviews - Risk of bias for interrupted time series (ITS) studies, in EPOC Resources for review authors. 2013, Norwegian 
Knowledge Centre for the Health Services: Oslo. 
 
Ramsay et al developed a separate set of quality criteria based on an earlier form of EPOC guidance 
Chapter 1: Table 1), which they used to 
appraise studies in two systematic reviews of behaviour change strategies (Table 2).(56) Criteria 1-3 
and 6 are very similar to EPOC criteria 1-4 (Table 1). The Ramsay et al criteria do not address missing 
data or selective outcome reporting but are more specific about the reliability of outcome measures 
(criterion 4), indicate that each data point should cover at least 80% of participants (criterion 5), that 
the reason for number and spacing of observations in the time series should be stated (criterion 7) 
and that ARIMA or time series regression should be used for analysis. Interestingly, in their systematic 
reviews of a total of 58 studies, Ramsay et al found that only 20 had ruled out other concurrent events 
and none had provided a rationale for the shape of the intervention effect model. 
 
31 
 
Table 2: Ramsay et al (2003) Quality Criteria for ITS Designs(56)
1. Intervention occurred 
independently of other 
changes over time 
DONE The intervention occurred independently of other changes over time 
NOT CLEAR Not specified (will be treated as NOT DONE if information 
cannot be obtained from the authors) 
NOT DONE Reported that intervention was not independent of other 
changes in time 
2. Intervention was unlikely to 
affect data collection 
DONE Reported that intervention itself was unlikely to affect data collection 
(for example, sources and methods of data collection were the same before 
and after the intervention 
NOT CLEAR Not specified (treated as NOT DONE if information cannot 
be obtained from the authors) 
NOT DONE Intervention itself was likely to affect data collection (for 
example, any change in source or method of data collection reported) 
3. The primary outcome was 
assessed blindly or was 
measured objectively 
DONE Stated explicitly that primary outcome variables were assessed 
blindly or outcome variables are objective e.g., length of hospital stay, drug 
levels assessed by a standardized test 
NOT CLEAR Not specified (treated as NOT DONE if information cannot 
be obtained from the authors) 
NOT DONE Outcomes were not assessed blindly 
4. The primary outcome was 
reliable or was measured 
objectively 
ome 
assessment is objective, e.g., length of hospital stay, drug levels assessed by 
a standardized test 
NOT CLEAR Reliability not reported for outcome measures obtained by 
chart extraction or collected by an Individual (will be treated as NOT DONE 
if information cannot be obtained from the authors) 
NOT DONE Two or more raters with agreement <90% or kappa <0.8 
5. The composition of the data 
set at each time point 
covered at least 80% of the 
total number of participants 
in the study 
DONE Data set covers 80 100% of total number of participants or episodes 
of care in the study 
NOT CLEAR Not specified (will be treated as NOT DONE if information 
cannot be obtained from the authors) 
NOT DONE Data set covers less than 80% of the total number of 
participants or episodes of care in the study 
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6. The shape of the 
intervention effect was 
prespecified 
DONE A rational explanation for the shape of intervention effect was given 
by the author(s) 
NOT CLEAR Not specified 
NOT DONE Any of the conditions above are not met 
7. A rationale for the number 
and spacing of data points 
was described 
DONE Rationale for the number of points stated (e.g., monthly data for 12 
months postintervention was used because the anticipated effect was 
expected to decay) or sample size calculation performed 
NOT CLEAR Not specified 
NOT DONE Any of the conditions above are not met 
8. The study was analyzed 
appropriately using time 
series techniques 
DONE ARIMA models were used or time series regression models were 
used to analyze the data and serial correlation was adjusted/tested for 
NOT CLEAR Not specified 
NOT DONE Any of the conditions above are not met 
Reproduced from: Ramsay CR, Matowe L, et al. Interrupted time series designs in health technology assessment: lessons 
from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care. 2003; 19(4): 613-23. 
 
These criteria provide useful guidance for those undertaking or appraising ITS studies, and their 
adoption would improve the validity of many ITS studies. Nevertheless, neither encompasses all 
sources of bias, and there is limited detail as to how each of the criteria could be addressed. Further 
advancement of these guidelines and wider adoption of an agreed set of more detailed formal 
reporting standards may improve the quality of evaluations conducted using an ITS design. 
 Summary 
Interrupted time series is a powerful quasi experimental design. It involves a pre-post comparison but 
avoids many of the threats of other pre-post designs by modelling the long term underlying trend in 
the outcome. It is being increasingly adopted for the evaluation of a broad range of public health 
interventions. While the design has many strengths, ITS, like other quasi-experiments has more 
inherent threats to their internal validity than experimental designs and it is important that these are 
recognised by evaluators and dealt with appropriately. There are a number of gaps in the 
methodological literature including a lack of guidance on the practicalities of the design and analysis 
of ITS studies, selecting the most appropriate model for defining the counterfactual and the impact of 
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an intervention, the use of controls to address history bias, and comprehensive reporting of ITS 
studies. Without further development of these areas, encouraging the wider adoption of this design 
and ensuring that it is used appropriately would be challenging. 
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 Aims, objectives and approach 
 Introduction 
The focus of this thesis is on improving the way that ITS is applied for the evaluation of public health 
interventions. The last chapter reviewed existing methodological work on ITS in order to identify areas 
in need of further development. In the remainder of this thesis I intend to build upon this work in 
order to develop methodological frameworks and guidance that will facilitate researchers in improving 
the validity of ITS studies. In this chapter I will summarise the gaps in the literature that were identified 
in the last chapter and use these to inform the aims and objectives of my thesis. I will then explain the 
methodological framework that I will be using for the thesis and how the thesis will be structured. 
 Key gaps in the literature 
Four clear gaps in the literature have been identified through the literature review. Firstly, while more 
traditional observational designs (such as cohort and case-control studies) as well as RCTs receive 
much attention in epidemiology courses and introductory texts, there is a lack of introductory 
guidance on the design and analysis of ITS studies. This is required so that the design can easily be 
adopted by those seeking to evaluate an intervention but with little experience of time series 
methods. Second, the ITS design is very flexible in terms of how it as applied to different interventions. 
Researchers need to decide what time series data to include, how to define the counterfactual and 
how to define the impact model. There is currently a lack of information on how these decisions should 
be made. There is a risk that if researchers base the decisions on apparent changes in the outcome of 
interest, detected effects could be due to type 1 errors. It is therefore important to develop guidance 
on model selection for ITS studies. Third, the potential for control series to strengthen the validity of 
ITS has been widely recognised, nevertheless traditional population based control groups are not 
always available or even appropriate. Other potential controls exist, nevertheless there is a lack of 
methodological literature on the different types of controls, their strengths and limitations and how 
they should be selected. Fourth, again unlike more widely used designs such as RCTs and cohort 
studies, there is a lack of formal criteria for reporting ITS studies. This is needed in order to help 
researchers think about and address the key threats to validity, and to facilitate critical appraisal of 
ITS studies in evidence syntheses. 
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 Aims and objectives 
The overarching aims of this thesis are to improve the way that interrupted time series studies of 
public health interventions are designed in order to reduce the risk of bias and to make robust ITS 
designs more accessible to evaluators of public health interventions. This will be achieved through the 
following objectives: 
1) To provide practical introductory guidance on the use of interrupted time series for the 
evaluation of public health interventions. 
2) To develop a methodological framework for defining the impact model of an intervention in 
order to strengthen the validity of interrupted time series. 
3) To develop a methodological framework for the selection of controls and analysis of 
controlled interrupted time series to limit the risk of history bias. 
4) To demonstrate the use of interrupted time series and controlled interrupted time series 
designs to evaluate complex interventions through their application in case studies. 
5) To develop guidance for transparent reporting of interrupted time series studies. 
 
Making ITS more accessible, will facilitate the choice of ITS over less robust designs, such as simple 
before and after evaluations or non-randomised controlled post-test only designs. Furthermore, 
improving understanding of the main threats to validity and methods to address these could lead to 
improvements in the evaluation of public health interventions using ITS designs, and thus 
improvements in the evidence base for adopting such interventions. Ultimately, stronger evidence for 
effective interventions will lead to improvements in the health of targeted populations. 
 Approach to thesis 
 Thesis style 
I present this thesis as a paper based PhD with most chapters centred around an individual paper 
prepared for publication.  
 
39 
 
 Type of studies 
Methodological studies 
A large proportion of the research contributing to this thesis consists of methodological studies. These 
consist of new approaches to modelling and adapting the ITS design in order to strengthen the validity 
of the results, including: an objective approach to defining the specific model to be used in the ITS 
analysis to ensure this is consistent the intervention and outcome under study and a framework 
adding an appropriate control series to an ITS study in order to limit history bias. Secondly, I also 
provide guidance for researchers undertaking ITS studies, including: a tutorial on the design and 
analysis of ITS, and recommendations for reporting ITS studies. Throughout, I demonstrate the 
strengths and limitations of different approaches by drawing on examples from the case studies 
described below and draw on existing methodological work both from ITS literature and wider study 
design literature. 
Case studies 
The case studies include my own original evaluations of complex interventions and events on health 
and health service outcomes using ITS designs. The first investigates the effect of the global financial 
crisis on suicides in Spain and the second evaluates the effect of National Health Service reforms in 
England on secondary care activity. The selected interventions and events are intentionally chosen 
because they cannot feasibly be evaluated using traditional study designs and in order to highlight 
specific methodological considerations. As well as these case studies, I also draw on other purposively 
selected existing studies which I reanalyse to illustrate different concepts. These include a study on 
the effect of the smoking ban in Italy on acute myocardial infarction and a study of the effect of 
changes to street lighting in the UK on road traffic crash casualties. All of these studies use large 
routine data sources for the outcome time-series. Finally, the penultimate chapter will include a 
restricted literature of recent empirical studies to examine how authors are reporting their methods 
in ITS studies. Specific methods used in the case studies are described within the respective papers. 
 Structure 
I begin by presenting the guidance paper on the practical application of ITS, followed by the new 
methodological frameworks on model selection for ITS analysis and the use of controls in ITS. I then 
present the two empirical studies that make up my case studies. Finally, I end by presenting the formal 
criteria that I have developed for the reporting of ITS studies. This does not always represent the order 
in which the work was done, therefore, in early chapters, I sometimes refer to work undertaken in 
later chapters. 
erall aims and objectives of the 
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thesis and how it links in with other chapters. Finally, the discussion chapter considers the overall 
lessons learned from the body of work undertaken, how the ITS methodology field has progressed 
over the duration of the thesis and areas for further development. 
 
 Terminology 
Some of the key terms used in this thesis are not used consistently across the existing literature. Below 
I define how I define some of the terms that are used throughout the thesis. Other terms that relate 
to more focussed topics are described in more detail within the relevant chapters. 
Public health interventions 
The UK Faculty of Public Health defines three domains of public health: health improvement (including 
health promotion and education activities targeting the wider determinants of health), health services 
(including interventions to improve health service effectiveness, efficiency, planning and equity), and 
health protection (including communicable disease control and response to chemical, radiological and 
environmental hazards).(1) In this thesis, I consider public health interventions to include those in all 
three of these domains that act at a population level, rather than individual level. I also include 
interventions or unplanned events that do not specifically target health but that nevertheless may 
affect public health outcomes. I do not include interventions acting at an individual level, such as the 
effect of a drug or a surgical procedure on patient prognosis. 
Interrupted time series 
Some authors have described pre-post designs which do not take into account underlying trends as 
interrupted time series.(2, 3) In common with most study design texts, I use the term interrupted time 
series exclusively for those studies which incorporate trends over time within the model.(4, 5) Studies 
with a single pre-intervention baseline observation and a single post-intervention observation or 
studies in which there are multiple pre- and post-intervention observations but where the time they 
were measured is not included in the model , in common with most authors, I regard as simple pre-
post or simple before-after designs.(4, 5) 
Controlled interrupted time series 
Similarly I differentiate controlled interrupted time series from difference in difference studies (or 
controlled before and after studies) in that the former accounts for the trend whereas the latter does 
not. I use the term controlled interrupted time series but this has also been referred to as comparative 
interrupted time series and interrupted time series with non-equivalent control elsewhere in the 
literature.(4, 6) I include all different types of control series within this definition, including control 
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outcomes (or non-equivalent dependant variables). Different types of controls are discussed in more 
detail chapter 7. 
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 Methodological paper 1: Interrupted time 
series regression tutorial 
 Research paper: Interrupted time series regression for the 
evaluation of public health interventions: a tutorial 
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 Summary of appendices for methodological paper 1 
All supplementary material for this paper is presented in the appendices (Chapter 11) 
11.1.1 Example dataset 
11.1.2 Stata code 
11.1.3 R code 
11.1.4 Further model specifications 
11.1.5 Contribution of the candidate to the paper 
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 Contribution of the paper 
Motivation for the paper 
The underlying motive for this thesis was to make robust evaluation of public health interventions 
more accessible to researchers and policy makers. Quasi-experimental designs, such as ITS, rarely 
feature in epidemiology and public health courses. Furthermore, weak before-after or cross-sectional 
designs are commonly used for evaluating public health interventions.(1, 2) This is particularly the 
case in service public health, despite frequent availability of routine data that would allow more 
powerful ITS designs to be used.(3) Unfortunately, the threats to the validity of these designs are such 
that effects can rarely be attributed to the intervention with confidence.(4) It was therefore important 
to me to introduce ITS in a way that would allow researchers to understand the principles of the design 
and the practicalities of a basic ITS analysis. The main purpose was to encourage wider adoption of ITS 
and to act as teaching material. 
Contribution to the thesis 
This paper directly addresses the first objective of the thesis 
guidance on the use of interrupted time series for the evaluation o  It also 
introduces some of the methodological concepts which will be expanded upon in Chapters 5 and 6, 
namely model selection and controlled interrupted time series analysis. Furthermore, the methods 
described here form the basis of those that were used in the two case studies in Chapters 7 and 8. By 
providing an easily reproducible guide to undertaking an ITS study, this paper goes a long way towards 
achieving one of the primary aims of the thesis  to make ITS accessible. Furthermore, the key threats 
to the validity of ITS are introduced in order to ensure that these are taken into account by researchers 
thereby making ITS evaluations more robust. 
Outputs and contributions to the literature 
The Stata and R code as well as example data layouts for different impact models (appendices 11.1.1-
11.1.4) are important outputs of the paper that should facilitate easy adoption of these techniques 
for researchers new to ITS analysis. The paper is currently the most read article of 2017 in the 
International Journal of Epidemiology, suggesting that it is encouraging wider adoption of the methods 
(22/09/2017).(5) Furthermore, this material, along with the stepwise approach to the paper, enable it 
to be easily adapted for use as teaching material. This is something that I have implemented for 
teaching of students and public health service professionals.(6-8) Feedback from readers suggests that 
it is being used in a similar way elsewhere. 
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Conclusion 
the first 
detailed guidance on how to conduct ITS studies .(9) It goes some way towards achieving the primary 
aims of the thesis and introduces those concepts that will be given further attention in later chapters. 
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interrupted time series 
 Research paper: Model selection in interrupted time series
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MODEL SELECTION IN INTERRUPTED TIME SERIES STUDIES 
 
J. Lopez Bernal,1,2 S. Soumerai,2 A. Gasparrini1 
1. Department of Social and Environmental Health Research, London School of Hygiene and 
Tropical Medicine, London, United Kingdom 
2. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care 
Institute, Boston, Massachusetts, United States of America 
 
 
ABSTRACT: 
Interrupted time series is a powerful and increasingly popular design for evaluating public health and 
health service interventions. The design involves analysing trends in the outcome of interest and 
estimating the change in trend following an intervention relative to the counterfactual (the expected 
ongoing trend if the intervention had not occurred). There are two key components to modelling this 
effect: first, defining the counterfactual; second, defining the type of effect that the intervention is 
expected to have on the outcome, known as the impact model. The counterfactual is defined by 
extrapolating the underlying trends observed before the intervention to the post-intervention period. 
In doing this, authors must consider the pre-intervention period that will be included, any time varying 
confounders, whether trends may vary within different subgroups of the population and whether 
trends are linear or non-linear. Defining the impact model involves specifying the parameters that 
model the intervention, including for instance whether to allow for an abrupt level change or a gradual 
slope change, whether to allow for a lag before any effect on the outcome, whether to allow a 
transition period during which the intervention is being implemented and whether a ceiling or floor 
effect might be expected. Inappropriate model specification can bias the results of an interrupted time 
series analysis and using flexible models or testing multiple models increases the risk of false positives 
being detected. It is important that authors use substantive knowledge to customise their interrupted 
time series model a priori to the intervention and outcome under study. Where there is uncertainty 
in model specification, authors should consider using separate data sources to define the intervention, 
running limited sensitivity analyses or undertaking initial exploratory studies. 
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What is new? 
 Interrupted time series is one of the strongest quasi-experimental designs for evaluating 
the effect of health interventions. However, this design requires careful specification of 
several modelling features, for which little guidance is offered in the literature 
 We demonstrate how incorrectly modelling either the trend or the type of impact model 
can generate misleading results and offer a methodological framework for making 
modelling choices in interrupted time series analyses. 
 Researchers must be transparent in providing a clear and objective justification for the 
choices they make in defining an interrupted time series model which is tailored to the 
specific intervention and outcome under study. 
 
 
INTRODUCTION: 
Interrupted time series (ITS) has become a core study design for the evaluation of public health 
interventions and health policies.(1) The design takes advantage of natural experiments whereby an 
intervention is introduced at a known point in time and a series of observations on the outcome of 
interest exist both before and after the intervention. The effect of the intervention is estimated by 
examining any change following the intervention c
the expected ongoing trend in the absence of the intervention (Figure 1).(2) ITS involves a pre-post 
comparison, controlling for the counterfactual baseline trend,  within the same population; therefore, 
it can be used in situations where no control population is available.(3, 4) This also has the advantage 
that selection bias and confounding due to group differences, which threaten the reliability of non-
randomised controlled designs, are rarely a problem in ITS studies.(2, 3) Furthermore, because ITS 
incorporates the underlying trend it controls for short term fluctuations, secular trends and regression 
to the mean.(3, 4)) The basic ITS design also has limitations; for example there is the potential for 
history bias whereby other events concurrent to the intervention may be responsible for an observed 
effect. Also, instrumentation effects can occur if there are changes in the way the outcome is 
measured over time.(3) Previous studies have described these strengths and limitations of ITS in more 
detail and have provided guidance on its application.(2, 4, 5) Furthermore, methodological 
publications have discussed effective approaches for limiting the risk of history bias, including 
controlled ITS designs and multiple baseline designs.(6-8)  
 
One area that has not been covered in detail in the existing literature is how researchers should 
approach specifying the ITS model used in the analysis. As discussed above, the ITS design involves 
making a comparison between the outcome observed following the intervention and the 
counterfactual. This comparison reduces to two key questions that define the estimated effect of the 
intervention.(2) First, how is the counterfactual defined? This involves modelling the pre-intervention 
trend. Second, how is the impact model of the intervention defined? That is, what type of effect do 
we hypothesise that the intervention will have on the outcome (such as whether the effect is gradual 
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or abrupt, immediate or lagged)? This involves parameterizing the effect of the intervention relative 
to the counterfactual. Multiple alternative approaches exist to defining the counterfactual and the 
intervention impact model and inappropriate model selection could bias results, yet ITS studies often 
fail to provide a clear justification for their choice of modelling approach.(9) 
In this paper we suggest approaches to ensure model specification is objective and appropriate to the 
intervention and outcome under investigation. The first section discusses the factors that contribute 
to defining the counterfactual and the second the factors that contribute to defining the impact 
model. For each of these sections we use illustrative examples from a recent ITS study of the impact 
of major reforms to the English National Health Service on hospital activity (described in Box 1)(10) to 
highlight the pitfalls of incorrect model specification and then provide a framework for a suggested 
approach to select the model. Finally, we also discuss sensitivity analysis and other approaches to 
dealing with uncertainty in model specification. 
 
 
 
Figure 1: the interrupted time series design 
Solid line = modelled trend; dashed line = counterfactual; vertical line = intervention implementation. This shows a step 
decrease and decrease in the slope following the intervention. 
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Box 1: Case study 
To illustrate the strengths and limitations of different approaches to model specification we use 
data from a recent study evaluating the impact of the of the 2012 Health and Social Care Act in 
England on hospital admissions and outpatient specialist visits.(10) This policy aimed to involve 
general  practitioners (GPs) in commissioning (planning and purchasing) secondary care through the 
establishment of GP-led Clinical Commissioning Groups. GP-led commissioning is expected to 
reduce healthcare costs by shifting care away from secondary care to primary and community 
settings.(11) We therefore hypothesized that the reforms would result in a relative reduction in 
secondary care activity (inpatient admissions and outpatient visits). The health and social care act 
was enacted in April 2012, there was then a 12 month period during which the Clinical 
Commissioning Groups worked alongside the existing healthcare administrative bodies before 
taking over fully independent commissioning in April 2013. We had quarterly data on all NHS 
hospital admissions and outpatient visits between the second quarter of 2007 and the final quarter 
of 2015. More details about the intervention and the data can be found in the original study.(10) 
 
 
DEFINING THE COUNTERFACTUAL 
A key step in ITS analysis is to predict how the outcome would have continued over time if no 
cenario. In practice this 
involves modelling the underlying trend in the outcome of interest. Since the effect of an intervention 
is a measure of its deviation from the counterfactual it is essential that the counterfactual is defined 
as accurately as possible. Incorrect definition of the counterfactual can lead to either overestimation 
consider both the data that will be included and the way the trend is modelled. 
 
The pre-intervention time period 
Routine data sources now often span many years; weekly or monthly time series with hundreds of 
data points are possible. For example, Swedish data on maternal mortality dates back to the mid 
eighteenth century.(12) Trends may change over time, therefore, how the counterfactual is predicted 
can vary depending on the range of data that is included. If the time period is too short, this increases 
uncertainty as there may be too little data to model the trend.(13) If a very long pre-intervention 
period is included, there is a risk that trends may have historically differed from current trends which 
raises doubts about the validity of the comparison. The minimum number of data points is a decision 
driven by the statistical requirements for the analysis and will depend on the variability of the data 
and the type of statistical model used. For example, to model a seasonal effect, a minimum of 12 data 
points will be required if using monthly data and complex autoregressive moving average (ARIMA) 
models often requires hundreds of data points.(2-4) The maximum amount of data to include is much 
more of a researcher driven decision and there are therefore risks that the data range can be 
manipulated to produce different outcomes. Researchers may choose to include the full dataset;  
nevertheless, the selection should focus on defining a valid counterfactual for the post-intervention 
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measurements. Therefore, periods characterised by external factors affecting the underlying trends, 
such as changes to data collection procedures or previous interventions targeting the outcome of 
interest, should be excluded, or the effects of these factors appropriately modelled. Researchers 
should adopt an objective approach a priori to selecting the data which is to be included in the study 
and any decision to restrict the range of data used in the analysis should be clearly justified and 
reported transparently.  
 
Time-varying confounders 
Under a simple linear ITS model it is assumed that population characteristics associated with the 
outcome either remain relatively constant throughout the study period, or that they change only 
slowly and are captured by the underlying linear trend. This may not be the case and irregular 
fluctuations in the baseline trend may be explained by changes over time in covariates associated with 
the outcome.(14) Epidemiologists are accustomed to identifying potential confounding variables a 
priori and using multivariate regression models to adjust for these potential confounders.(15) A similar 
approach can be adopted using segmented regression for ITS studies by including potential time-
varying confounders (explanatory variables that could affect the outcome and may change 
substantially and unpredictably over time).(2) Examples might include meteorological events,(16) 
population age distribution,(17) ethnicity or levels of deprivation.(18) Adjusting for time-varying 
confounders may result in irregular trends becoming linear thus conforming to this basic ITS 
assumption. Seasonality, can also be considered a time varying confounder and accounts for 
fluctuations in many health outcomes, such as infectious disease rates or hospital admissions.(2, 19) 
A range of methods exist for controlling for seasonality in time-series regression models which have 
been described in more detail elsewhere.(2, 20) 
 
Multiple groups 
ITS studies commonly use aggregate outcome data for the whole study population and define the 
underlying trend based on this aggregated data. This assumes that there is a uniform trend within the 
whole population. Nevertheless, different sub-groups or even different individuals within the study 
population may follow different trends that can result in irregular, non-linear trends when the data is 
aggregated together. More sophisticated ITS models can allow for these different trends and should 
be considered where sub-group or individual level data is available. For example, Steinbach et al 
evaluated the impact of changes to street lighting on casualties from road traffic collisions at night 
and used data on trends from individual road segments.(21) 
 
Linearity 
The above factors can be defined a priori by the researcher and may explain any non-linear trends. 
Nevertheless, the assumption of linearity should be checked both by visual inspection of the data and 
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residuals and through statistical goodness of fit tests such as the Pearson test.(14) If a linear trend 
exists, prediction of the counterfactual, and thus the isolation of an intervention is relatively 
straightforward. However, if the baseline trend is non-linear it can be harder to predict the 
counterfactual and difficult to disentangle intervention effects.(14) In particular, although flexible 
methods exist to describe non-linearities in regression models,(22) in the ITS framework it is often the 
case that the estimates are highly sensitive to the degree of smoothing, so that the intervention effect 
cannot be distinguished from underlying fluctuations, or is artifactually created by the extreme 
flexibility of the model.(23) Researchers should therefore be cautious about using ITS if the data 
follows a non-linear baseline trend which cannot be explained by other factors. Furthermore, it should 
be recognised that introducing non-linear terms post-hoc is a data driven approach and the underlying 
reason for these trends is unknown. It therefore must be assumed that the unknown underlying 
variables that explain this trend in the outcome follows the same pattern in both the pre-intervention 
and the post-intervention period. 
 
Illustrative example 
Figure 2 shows a time series from our case study (described in Box 1). Here we look at the impact of 
the policy on the number of outpatient specialist visits in England. Our full dataset had data on all 
outpatient visits between 2007 and 2015. To illustrate how changing the way that the pre-intervention 
trend is defined can affect the results of an ITS study we demonstrate different approaches to defining 
the trend. Each of the models allows for a change in the slope of the trend following the intervention. 
Figures 2a and 2b demonstrate the effects of choosing different pre-intervention time periods. In 
figure 2a the complete data series is used and there is no significant effect; in Figure 2b the data is 
restricted prior to April 2010 and there is a clear increase in the rate of specialist visits following the 
policy. Figures 2c and 2d show two different non-linear models, the second allowing a greater degree 
of smoothing in the data series. Again the results of the models differ with Figure 2c showing an 
increase in the outcome following the policy, whilst Figure 2d, which is a more flexible model, shows 
no change. The differing effects seen in these four models highlight the need for careful model 
selection in order to accurately estimate the effect of the intervention. In this example, in fact, a data 
quality issue was identified whereby a misclassification resulted in possible errors in outpatient 
numbers prior to 2010, therefore it was inappropriate to include data prior to this point.(24) Figure 
2b was therefore considered to be the most appropriate model a priori. 
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Figure 2: Four different approaches to modelling the trend  
Y-axis represents the quarterly total specialist visits in England per 1000. a: simple linear trend; b: excluding data prior to 
April 2010; c: non-linear allowing one inflection point; d: non-linear trend allowing two inflection points. Dots= data 
observations; solid line = fitted model; dashed line = counterfactual; vertical line = policy implementation. 
 
Framework for defining the trend 
Box 2 outlines a suggested approach to defining the trend in the outcome. 
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Box 2: Framework for defining the trend in the outcome 
1. Find out maximum time range of the dataset. 
2. Check with data provider and review data quality notes for changes to data collection and 
any data errors requiring the data to be truncated. 
3. Examine the literature for and seek expert advice on previous interventions or events that 
may have affected the outcome of interest. 
4. Consider whether the outcome is likely to have a seasonal pattern or other known cyclical 
patterns and adjust for these. 
5. Consider whether there are other measurable variables that could influence the outcome 
and may change substantially over time. If so include the variables within the model. 
6. Examine the pre-intervention data graphically for linearity and any obvious cyclical 
patterns or trend changes. 
7. Fit a model with linear trend on the pre-intervention data only and examine the fit. 
8. If a linear model is a poor fit, consider a non-linear model. Discuss reasons for any non-
linear trend and acknowledge in limitations if these are unknown or unmeasurable. 
9. Run relevant sensitivity analyses if there is any uncertainty over model selection 
68 
 
DEFINING THE IMPACT OF THE INTERVENTION 
As described above the effect estimate in an ITS study is a measure of the level and/or trend change 
in the outcome following an intervention. We have discussed how the trend is defined, the next step 
is to define how the intervention and its potential impacts are modelled. Different interventions can 
have different impacts on an outcome: for example, mandatory helmet legislation might be expected 
to have an abrupt effect on cycle head injuries, whereas an educational programme on cycle safety 
might be expected to have a more gradual effect.(25, 26) Likewise, different outcomes can be 
expected to respond differently to the same intervention, for example policies restricting alcohol 
availability may be expected to have a relatively rapid effect on alcohol related road traffic casualties 
but a longer lag before any effect on liver cirrhosis.(27) Different model parameters can be used to 
allow different effects to be expressed following the intervention. Flexible models can be used which 
allows a whole range of possible intervention effects to be detected. Nevertheless, this also increases 
the likelihood of false positive effects being detected due to other confounding events, data errors or 
chance resulting in type I errors.(2) It is therefore preferable that researchers select a more precise 
impact model for the intervention a priori, taking into account substantive knowledge on the nature 
of the intervention and how it was implemented, as well as the outcome of interest. There are a 
number of factors to consider in defining the impact model, including: whether the impact will be 
abrupt or gradual, whether any lag is expected, whether a ceiling or floor effect can be expected, and 
whether there was a transition period during which the intervention was implemented. These are 
discussed below. 
 
Abrupt or gradual effects 
The effect of the intervention may either be abrupt or gradual or both. An abrupt effect would result 
in an immediate or rapid change in the level of the outcome  observed as a step change in the time 
series (figure 3a(i)). A gradual effect would result in the level of the outcome changing slowly over 
time  observed as a change in the gradient of the trend (a slope change) (figure 3a(ii)). An intervention 
that is introduced at a precise point in time with an outcome that could respond rapidly would be 
expected to follow a step change model, for example the impact of restricting Medicaid funding for 
prescriptions on the number of prescriptions filled per month.(28) Conversely, interventions that 
results in a more gradual process of change with an outcome that could respond at a variable rate 
would be expected to follow a slope change model. This includes complex health policies that require 
large scale institutional changes such as the example in our case study (Box 1).(10) It is also important 
to consider the time interval of the time series when deciding whether to include a step change and/or 
a slope change model, a gradual slope change on a weekly time scale may appear as a step change on 
an annual time scale. It is important to underline that these two types of effects are not mutually 
exclusive, interventions may lead to an initial step change followed by a more gradual slope change in 
either direction.(4, 28) Nevertheless, modelling both can be problematic and prone to artefacts in the 
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absence of a strong signal in the data. This is particularly an issue where both exhibit a small effect in 
 
 
Immediate or lagged effects 
Following the intervention, the effect on the outcome, whether it is a step change or a slope change, 
or both, may occur immediately or may be delayed (figure 3b). This typically depends on the outcome 
and how rapidly it could respond to the intervention. Many public health interventions are ultimately 
targeting disease morbidity or mortality, but they often do so through behaviour changes. An 
intervention might have an immediate impact on the behaviour but a lagged effect on any health 
outcome. For example, tobacco control policies might be expected to have an immediate impact on 
maternal smoking levels but a lag of approximately nine months before any impact on small for 
gestational age births and a much longer lag before any impact on lung cancer.(29) 
 
Transition period 
Interventions may be introduced over a prolonged period of time or may result in a short period of 
adjustment before the lasting impact on the outcome is manifested.(10) Furthermore, effects can 
begin prior to the intervention as an anticipatory response to a new policy.(30) This can be accounted 
for by dividing the time series into three phases: a pre-intervention phase, a transition period (which 
may or may not be included in the analysis) and a post-intervention phase (figure 3c).(19, 31) For 
example, Landrigan et al evaluated the impact of a introducing a hospitalist system (employing 
physicians with a primary focus on caring for hospitalised inpatients) on length of stay in a paediatric 
hospital.(32) They allowed a transition from when the policy was first announced to when hospitalists 
fully took over patient care in order to allow for the effects of gradual system changes to prepare for 
the new policy. 
 
Floor and ceiling effects 
There is often a limit to how much an intervention could decrease or increase an outcome if the 
outcome is constrained by other factors, this can result in a floor or ceiling effect (figure 3d).(33) For 
example, vaccine uptake is limited to a level below 100% due to a small proportion of patients having 
allergies or other contraindications. Conversely, hospital length of stay could have a floor effect which 
will differ depending on the type of patient, disease or treatment being evaluated. The possibility of 
floor or ceiling effects should be anticipated a priori and incorporated into the ITS model, for example 
by allowing a second slope change at the floor or ceiling.(2) Furthermore, floor and ceiling effects 
should be considered as a potential reason for trend changes in the discussion. 
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Waning effects 
The effect of an intervention may change over time. In particular, there may be a more notable effect 
of the intervention when the intervention is first introduced but with the effect waning over time. This 
is often due to greater publicity of the intervention when it was first implemented, as was observed 
when examining the effect of widely publicised warnings about a possible increased risk of suicidality 
with antidepressant use on antidepressant use.(34) If the initial effect is expected to be abrupt, this 
could be modelled as a step change to model the effect and a slope change to model the waning of 
this effect. If a gradual effect is expected, a non-linear term may be included to model both the effect 
and the waning  (Figure 3d).(34) 
 
 
 
Figure 3: Interrupted time series impact models 
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X-axis represents time, y-axis represents the outcome. The vertical blue line is the time when the intervention was 
implemented; the red line is the ITS regression model. a(i) abrupt step change effect, a(ii) gradual slope change effect; b(i) 
immediate effect following the intervention, b(ii) lagged effect; c(i) intervention at a specific time point, c(ii) transition period 
(blue box) excluded from the model; d(i) ceiling effect d(ii) floor effect; d(i) waning effect following a step change, d(ii) gradual 
effect with gradual waning. 
 
 
Illustrative example 
Figure 3 is again taken from our case study evaluation of the GP commissioning policy. This time we 
look at the effect in Wales, a control population.(10) A control series can be added to an ITS study to 
help control for confounding events occurring around the time of the intervention.(8) Because the 
control population was not subject to the intervention, we do not expect to see an effect in the control 
series.(8) We demonstrate three approaches to modelling the impact of the intervention: In Figure 3a 
we use one of the most commonly used flexible impact models which allows for a step and slope 
change at the point of the intervention, here there is no significant change following the intervention. 
However, we have not taken into consideration either our knowledge of the intervention nor how we 
consider a priori that it would impact upon the outcome if effective. In Figure 3b, we instead select 
what we would consider a priori to be the most appropriate model. We know that the policy was 
enacted in April 2012 but that there was then a period of one year during which the new GP-led Clinical 
Commissioning Groups worked alongside the existing commissioners, we therefore allow a one year 
transition period. We also do not expect the policy to have an abrupt effect as existing secondary care 
contracts would only expire gradually and complex institutional changes would be required to 
establish new models of care, therefore a slope change model was selected. Again, there is no 
significant effect of the intervention. Finally, we select a model that provides the best fit to our data 
(using the Akaike Information Criterion),(35) here we find a significant reduction in both the level and 
the slope associated with the intervention. In this example, however, we know that the intervention 
did not cause the level and slope change as this was taken from a control population that did not 
receive the intervention. This highlights the danger that using a data driven approach to select the 
impact model can lead to spurious results due to factors other than the intervention .   
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Figure 4: Four different approaches to modelling the impact of the inter vention 
a) Step and slope change model; b) slope change only with a one year intervention phase; d) step and slope change with a 
one year intervention phase. 
 
 
 
Framework for defining the impact model 
Box 3 outlines a suggested approach to modelling the impact of the intervention. 
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DEALING WITH UNCERTAINTY IN MODEL SELECTION 
So far in this paper we have emphasised the need to carefully define the pre-intervention trend and 
the intervention impact model according to the specific intervention, outcome and data being used in 
the study. Often, however, the single best approach is difficult to define, in particular for novel 
interventions that have not previously been studied and when analysing the public health effects of 
unplanned events. Below we discuss some approaches to dealing with uncertainty in model selection: 
 
Modelling unplanned events 
While ITS is most commonly used for studies of pre-meditated health interventions or health policies, 
it can also be used to evaluate the health impacts of unplanned events.(36) If the timing of the event 
is clearly defined, for example: a natural disaster,(37) a chemical spill,(38) or a terrorist attack,(39)  
then the same modelling process can be used as for planned interventions. Nevertheless, the timing 
of many unplanned events is harder to define including: political or economic changes,(40, 41) 
war,(42) or interruptions in the supply of illicit drugs.(36) Under such circumstances an independent 
data source (unrelated to the outcome under investigation) should be used to establish the timing of 
(36) For example, Lopez Bernal et al used the widely acknowledged 
definition for recession of two successive quarters of contracting GDP to establish the timing of the 
late 2000s financial crisis in Spain in their evaluation of the effect of the financial crisis on suicides.(41) 
 
Box 3: Framework for defining the impact model of the intervention 
1. Consider whether the intervention was implemented gradually or abruptly. 
2. Consider whether the outcome would respond quickly or slowly if the intervention were 
effective. 
3. Consider whether the intervention would be expected to have an immediate or delayed 
impact on the outcome. 
4. Examine existing evidence on the duration of the lag with similar interventions or 
outcomes. 
5. Consider whether the intervention was introduced at a specific point in time or over a 
prolonged period. 
6. Check when the intervention was announced, marketed, implemented or removed  
consider whether each of these stages could have affected the outcome. 
7. Consider whether there could be a ceiling or floor effect on the outcome. 
8. Run relevant sensitivity analyses if there is any uncertainty over model selection 
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Sensitivity analysis 
It may be necessary to use sensitivity analyses to define a range of possible models or to test different 
assumptions.(2) For example, different ranges of outcome data or different lag periods may be 
selected.(41, 43) If the same effect is detected under different assumptions, this can increase 
confidence in the results. However, running multiple different models to test a wide range of 
assumptions increases the likelihood of false positive effects being detected. As with the primary 
model, it is therefore important to consider any sensitivity analyses a priori. Where there is a lot of 
uncertainty about the nature of potential effect of an intervention it may be necessary to run various 
exploratory sensitivity analyses in the first instance, rather than regarding the study as an explanatory 
evaluation. 
 
CONCLUSION 
Interrupted time series is one of the most rigorous quasi-experimental designs and avoids many of the 
sources of bias and confounding of other observational studies.(1, 3) Nevertheless, we have 
demonstrated the risk that incorrect modelling of either the underlying trend or the impact of the 
intervention has for generating misleading results. The threat to validity is greatest when more flexible 
or data driven models are chosen as this increases the likelihood of detecting false positive effects due 
to confounding events or random noise. Therefore, the most appropriate model for a given 
intervention and outcome should be carefully considered and we have outlined an objective approach 
for this. Where there is uncertainty over model choices, clearly defined sensitivity analyses can be 
added. If a flexible model is required, other design adaptations, such as controlled interrupted time 
series or multiple baseline designs,(44, 45) should be applied to help exclude alternative explanations 
for any effects.  
 
Given the range of possible model choices in ITS analysis, it is important that researchers are 
transparent in providing clear and objective justification for any modelling decisions when reporting 
ITS studies. The methods section should include a statement on the amount of data available, any data 
restrictions and the reasons for these. We would also suggest providing a scatter plot or table of the 
complete data series as a supplementary appendix so that readers and reviewers can scrutinise any 
data restrictions or model choices. The primary model for the baseline trend should be clearly justified, 
including the reasons for including or excluding any time varying confounders and the reasons for any 
non-linear trends. Similarly, authors should defend their chosen impact model, including a clear 
description of the nature of the intervention and the nature of its expected effect on the outcome. 
Finally, authors should acknowledge any uncertainty in model selection in the limitations and any 
sensitivity analyses should again be fully justified.  
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 Summary of appendices for methodological paper 2 
All supplementary material for this paper is presented in the appendices (Chapter 11) 
11.2.1 Contribution of the candidate to the paper 
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 Contribution of the paper 
Motivation for the paper 
While other limitations of ITS, such as history bias, have been well recognised, the issue of model 
misspecification has not previously been discussed in the literature. From the literature review, and 
from undertaking sensitivity analyses in the case studies, it was clear that different assumptions in the 
way the counterfactual and the impact model were defined could lead to very different results. As 
shown later in Chapter 9, the majority of ITS studies use a step and slope change model but do not 
explain why this was chosen and how it fits with the intervention. Neither do they explain the reason 
for the chosen time series data range. Given the potential impact of these assumptions on the results, 
it was therefore important for me to highlight the dangers of incorrect model selection and provide a 
methodological framework for selecting the most appropriate model. 
Contribution to the thesis 
This paper highlights some of the key underlying modelling decisions that are made, either explicitly 
To 
develop a methodological framework for defining the impact model of an intervention in order to 
strengthen the validity of interrupted time series. , modelling the impact of 
the intervention requires both the counterfactual and the impact model to be accurately and clearly 
defined and both of these areas are covered in detail. This paper expands on Chapter 4, where impact 
models were first introduced and draws on examples from the two case studies in Chapters 7 and 8. 
It will also feed into the reporting guidelines developed in Chapter 9. 
Outputs and contributions to the literature 
A key message of the paper is that researchers need to adapt the model based on knowledge of the 
intervention. It is therefore important that researchers have an in depth understanding of the 
intervention under study, including its timing, how it was rolled out and when it is anticipated to have 
an impact on the outcome. Modelling decisions should be made a priori and post-hoc changes based 
on the data should be avoided. Currently authors rarely make modelling choices explicit (see Chapter 
9). This can lead to allegations of bias and data manipulation. This paper provides a methodological 
framework to limit the risk of such bias. 
 
Conclusion 
Inappropriate model selection is a previously undescribed threat to the validity of ITS studies. By 
making model choices clear and explicit and basing these on a good understanding of the intervention 
and outcome under study, researchers can improve the robustness of ITS studies.
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 Methodological paper 3: The use of controls 
in ITS studies 
 Research paper: The use of controls in interrupted time series 
studies of public health interventions 
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THE USE OF CONTROLS IN INTERRUPTED TIME SERIES STUDIES OF PUBLIC 
HEALTH INTERVENTIONS 
James Lopez Bernal1* 
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1. Department of Social and Environmental Health Research, London School of Hygiene and 
Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH 
 
ABSTRACT 
Interrupted time series analysis differs from most other intervention study designs in that it involves 
a before-after comparison within a single population rather than a comparison with a control group. 
This has the advantage that selection bias and confounding due to between-group differences are 
limited. However, the basic interrupted time series design cannot exclude confounding due to co-
interventions or other events occurring around the time of the intervention. One approach to 
minimise potential confounding from such simultaneous events is to add a control series so that there 
is both a before-after comparison and an intervention-control group comparison. A range of different 
types of controls can be used with interrupted time series designs, each of which have associated 
strengths and limitations. Researchers undertaking controlled interrupted time series studies should 
carefully consider a priori what confounding events may exist and whether different controls can 
exclude these or if they could introduce new sources of bias to the study. A prudent approach to the 
design, analysis and interpretation of controlled interrupted time series studies is required to ensure 
that valid information on the effectiveness of health interventions can be ascertained. 
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KEY MESSAGES 
 History bias due to other interventions or events occurring around the time of the intervention 
is the primary threat to the validity of interrupted time series studies. 
 A wide range of different controls can be used in order to limit history bias and improve the 
validity of an ITS study.  
 Controls should be selected by considering, a priori, the possible sources of history bias and 
examining for differential changes in covariates between the study series and the control 
series throughout the study period. 
 Researchers should take care in interpreting the results of controlled interrupted time series 
studies, in particular when the results differ from those of simple (uncontrolled) analysis. 
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INTRODUCTION 
Evaluation of public health interventions normally relies on comparing the outcome of interest in a 
population exposed to an intervention to that in an external control group not subject to the same 
intervention.(1) Interrupted time series (ITS) is an increasingly popular design that adopts a different 
approach whereby comparisons are instead made across time within a single population.(2) This 
design is generally applied to natural experiments with an intervention introduced at a known point 
in time. By collecting data at regular intervals over time, a pre-post comparison can be made while 
accounting for underlying trends in the outcome.(2) Because the evaluation is based on observing a 
single population over time, the ITS design is free from problems due to between-group differences, 
such as selection bias or unmeasured confounders. Furthermore, by modelling the underlying trend, 
ITS also controls for within-group characteristics that tend to change only slowly over time.(3) 
Nevertheless, ITS studies cannot exclude time-varying confounders which do not form part of the 
underlying trend, for example other interventions or events occurring around the time of the 
intervention that may also affect the outcome.(4) 
 
One approach that limits the threat of these other confounding events is to include a control series, a 
design known as a controlled (or comparative) interrupted time series (CITS) analysis. A lack of effect 
in a well-chosen control can provide stronger evidence to support a causal relationship between the 
intervention and outcome. Conversely, the presence of an effect in the control series indicates that 
the change may be attributable to different factors. Indeed, a number of recent within study 
comparisons have provided empirical evidence of the validity of the CITS design by demonstrating 
comparable results to RCT benchmarks.(5-8) Nevertheless, while the basic ITS design has been 
described in detail elsewhere and reference is made to the inclusion of a control as a method of 
improving the validity of the design,(2, 9) there is little guidance available on what a control series can 
and cannot solve and how to select an appropriate control in CITS studies. The purpose of this paper 
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is to evaluate the use of controls in ITS studies and provide a framework for their selection, analytical 
approaches and the interpretation of results. We then provide an illustration of the application of this 
framework using an example from a recent study where alternative types of controls can be selected 
and compared. 
 
 
EVALUATIVE STUDY DESIGNS 
In order to know whether an intervention has caused an effect, a comparison needs to be made 
between the observed change in the outcome and the counterfactual, that is, what would have 
happened if the intervention had not taken place. Of course, it is not possible to observe the 
intervention both being implemented and not being implemented in the same population at the same 
time, therefore the true counterfactual is never known. Evaluation design is therefore centred on 
creating the best approximation of the true counterfactual and then comparing what happened in the 
intervention group to the approximated counterfactual.(3) There are two main approaches to 
approximating the counterfactual: controlled designs and before-and-after designs.(3) 
Controlled designs: 
Controlled designs normally compare the same outcome in the intervention group and an external 
control. Randomised controlled trials, cross sectional studies as well as other designs less commonly 
used for intervention evaluations (such as cohort and case control studies) all make comparisons 
between an intervention group and a control. The advantage of this approach is that both intervention 
and control groups are compared at the same point in time so other time sensitive factors that would 
affect both populations (such as other interventions or events that might impact on the outcome of 
interest) can be excluded. Nevertheless, selection bias and differences between the intervention and 
control population may mean that observed effects could be due to other confounding factors (which 
may be unknown or difficult to measure) rather than the intervention.(1) Randomisation addresses 
87 
 
this limitation in experimental studies, however this is often not desirable, feasible or practical in 
studies evaluating public health interventions.(1, 10, 11) Other approaches, such as adjusting for 
multiple variables in regression models or propensity score matching can account for known 
characteristics that differ between the two groups, but cannot control for unmeasured 
confounders.(1, 11, 12) 
Before-and-after designs: 
Before-after designs involve making a comparison between a period of time after the intervention has 
occurred and a period of time before the intervention within a single population. Here, the pre-
intervention period effectively acts as the control. Simple pre-post designs make before-after 
comparisons by estimating the change from a single pre-intervention time point to a single post-
intervention time point. However, these have poor internal validity as they cannot exclude underlying 
trends as a cause for any change. Conversely, interrupted time series use multiple pre-intervention 
and post-intervention observations, thereby allowing the underlying trend to be accounted for. These 
have the advantage that confounding is rarely a problem as population characteristics tend to only 
change gradually over time. (3, 13) Nevertheless, such before-after comparisons cannot exclude other 
events or co-interventions occurring around the same time as the intervention under investigation as 
the cause of any detected change in the outcome. This phenomenon is known as history bias in 
(4) 
 
CONTROLLED INTERRUPTED TIME SERIES 
Controlled (or comparative) interrupted time series (CITS) involves adding a control series, which was 
not exposed to the intervention, to the basic ITS design (Figure 1).(8) This results in the definition of a 
more complex counterfactual based on both  a before-and-after comparison and an intervention-
control comparison. The primary benefit of this approach is that it can help to control for history bias 
due to time-varying confounders, in particular co-interventions and other events concurrent to the 
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intervention.(3) In a CITS, if an effect is detected in the intervention group but not in a well-chosen 
control (Figure 1a) this suggests that the effect is more likely to be due to the intervention; conversely 
if an effect is detected in both the intervention and control series (Figure 1b), this suggests that it is 
due to some confounding event. 
 
 
Figure 1: Controlled interrupted time series 
Red line = intervention series, green line = control series. (a) Here there is an effect in the intervention series (step and slope 
decrease) but no effect in the control series which increases confidence that the effect is due to the intervention. (b) Here 
there is a step and slope decrease in both the intervention and control series suggesting the change is due to some other 
event or co-intervention that affected both groups. 
 
CITS is related to other study designs applied in evaluation analyses. For instance, the controlled 
before and after design (CBA) also involves a before-and-after and intervention-control comparison. 
Nevertheless, the CBA design involves a comparison of a single pre and a single post intervention, or 
a comparison of pre and post-intervention means. While both CITS and CBA designs involve a 
difference in difference calculation, CBA designs do not take into account baseline trends and 
therefore use the control group alone in order to approximate the counterfactual.(3, 14)  
An extension of the CITS design is the multiple baseline design. This is similar to a stepped wedge 
cluster randomised trial but typically does not involve randomisation. Here, following a baseline 
period, the intervention is first introduced in one group while one or more other groups act as a 
control.(15, 16) The intervention is subsequently introduced in other groups at different times, with a 
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different subset acting either as intervention or control groups at each time. In this design, the 
observation of an effect of similar strength and magnitude following the intervention in multiple 
different groups at multiple sequential time points, can provide strong evidence that the observed 
effect is due to the intervention rather than other potential confounding events.(15, 16) 
 
SELECTING A CONTROL 
With studies that rely on the control as the sole means of approximating the counterfactual (including 
RCTs, cross-sectional studies and CBA studies) the central prerequisite when selecting a control is that 
it is as similar as possible to the intervention group. The ideal control is the same in terms of all 
variables other than exposure to the intervention.(1, 3) RCTs accomplish this through randomisation. 
Where randomisation is not possible a range of methods have been developed to achieve covariate 
balance in cross-sectional and CBA designs including multivariable regression, propensity score 
matching and synthetic controls.(17-19) Nevertheless, none of these methods can account for 
systematic differences in unknown variables.(17, 20) 
 
As described above, ITS studies use the pre-intervention trend to predict the counterfactual. The 
purpose of the control in this case is to exclude time varying confounders, in particular co-
interventions or other events occurring around the time of the intervention, as these are generally 
unpredictable based on modelling pre-intervention trends.(2, 3) It follows that the key attribute of a 
control series for a CITS study should be its ability to control for known co-interventions or external 
events that may affect the outcome. Therefore, the control series should be exposed to any such co-
interventions or events that might also affect the intervention series, however, it should not be 
exposed to other interventions or events that could impact on the control series alone (and not the 
intervention series). The latter could result in artifactual effects being detected in the CITS which are 
in fact due to independent changes in the control series. Several different types of control series have 
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been used for CITS analyses; we have broadly classified some of the most commonly used controls as 
follows: location based control groups, characteristic based control groups, behaviour based control 
groups, historical cohort controls, control outcomes and control time periods. Table 1 describes these 
six types of controls, each of which may plausibly control for different sources of confounding events. 
 
Researchers should also consider whether the intervention under study could have an indirect effect 
on the control series, for example there may be a contamination effect in location based or 
characteristic based control groups, or a substitution effect with control outcomes.(21, 22) A 
contamination effect occurs when the effects of the intervention spreads beyond the target 
population, for example with behaviour change interventions, whereby members of the control 
population learn about the new behaviour and adopt it themselves.(21) An example of a substitution 
effect would be an evaluation of the effect of an intervention aimed  at reducing the prescription of a 
certain drug; in this scenario, prescriptions of a similar drug not targeted by the intervention may be 
considered as a control outcome, however, doctors may substitute the targeted drug with the similar 
drug so that it is indirectly affected by the intervention.(22) Control series that could be indirectly 
affected by the intervention should be excluded. 
 
Finally, while covariate balance between the intervention and control series in ITS is not required to 
predict the counterfactual, and is therefore not the fundamental prerequisite that it is in other 
controlled designs, it remains important for two reasons: firstly, certain subgroups may be more 
susceptible to either an intervention or a confounding event than others. If such a subgroup is more 
concentrated in the intervention group than the control, one would expect a greater effect in the 
intervention group simply due to the population distribution. Secondly, if certain characteristics are 
associated with the outcome and these characteristics change differentially over time in the 
intervention and control groups, the trend in the outcome may change in one group but not the other 
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simply due to differential changes in the populations under investigation. For example, there is 
evidence that rates of cycle head injuries are lower in females than in males.(23) In the cycle helmet 
legislation study by Dennis et al described in Table 1, if the intervention population had a higher 
proportion of females at baseline than the control population this would not necessarily be a 
problem.(24) Nevertheless, if the proportion of females increased more rapidly in the intervention 
group than in the control population following the intervention, this would be a source of confounding 
as there may be a decrease in head injuries in the intervention group simply due to the population 
change, rather than any effect of the intervention. Matching techniques, including propensity score 
matching can be used to ensure balance of known covariates at baseline which can help to limit the 
effects of differential susceptibility to the intervention by population subgroup.(18, 25) Nevertheless, 
whether matching at baseline or not, it is still important to check for covariate balance between the 
control and intervention group throughout the study period. If there are changes over time, variables 
associated with the outcome can be included in the interrupted time series regression model to adjust 
for confounding. However, none of these methods can control for unknown confounding and this 
should be recognised as a limitation of CITS studies in common with other non-randomised controlled 
designs 
Table 1: Types of controls  
Type of Control Description Examples Strengths Limitations 
Location based 
control 
The control series is 
selected from another 
location similar to the 
study location but that 
did not receive the 
intervention. The type 
of location depends on 
the scale of the 
intervention, for large 
scale interventions this 
may be a different 
geographical area (such 
as a country, district or 
city), whereas for 
smaller scale 
interventions this could 
be a different 
institution or a 
Dennis et al (2013) 
evaluated the impact of 
the introduction of 
helmet legislation in a 
number of Canadian 
provinces on cycling 
related head injuries by 
comparing outcomes in 
Canadian provinces that 
did not implement 
helmet legislation.(24)  
 
Lopez Bernal et al (2017) 
compared the change in 
hospital activity in 
England, following major 
health reforms, to those 
Help to control for 
confounding events 
that would affect 
both locations. 
Cannot exclude 
events that are 
unique to the 
intervention location. 
For example, in the 
study of helmet 
legislation, 
reductions in head 
injuries could be due 
to a protective effect 
of helmets 
(presumably the 
desired effect) or due 
to a reduction in the 
number of cyclists if 
the need to wear a 
helmet acts as a 
deterrent (which 
may not be a desired 
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different ward within a 
hospital. 
in Scotland where the 
reforms did not 
apply.(26)  
effect), comparing to 
provinces that did 
not implement the 
legislation would not 
help to distinguish 
these.(24) 
Characteristic 
based control 
Interventions are 
sometimes targeted 
according to certain 
characteristics, for 
example only males or 
only females, a certain 
age group, a specific 
ethnic minority group 
or patients with a 
certain diagnosis. 
Controls may be chosen 
from those groups that 
were not targeted.  
Feigl et al (2015) 
investigated the impact 
of a national ban on 
smoking in high schools 
and selected a control 
based on age by 
comparing trends in 
smoking prevalence 
among those aged 12-18 
years compared to those 
aged 19-24 years.(27)  
 
Kontopantelis et al (2015) 
examined the impact of a 
national primary care 
financial incentive 
scheme on trends in 
consultation rates among 
patients with severe 
mental illness compared 
to matched patient 
controls with no severe 
mental illness.(28) 
In cross sectional or 
similar designs, this 
type of control is not 
ideal as the 
characteristic that 
differentiates the 
two groups is a 
known confounder 
that cannot be 
controlled for, 
nevertheless in ITS 
studies, where the 
pre-intervention 
trend is the primary 
control, 
characteristic 
control groups can 
help to exclude 
concurrent events to 
the intervention that 
both groups would 
have been exposed 
to. 
Interventions may 
have been targeted 
at the intervention 
group because of a 
detected deviation in 
the trend, for 
example in the 
smoking ban study, 
high schools may 
have been targeted 
because of recent 
increases in smoking 
among adolescents 
therefore trends 
could differ 
substantially from 
the control 
group.(27) 
Behaviour 
based control 
Sometimes the 
intervention does not 
affect all of those 
within the population 
to whom it is targeted, 
this tends to occur 
when the intervention 
targets a behaviour 
that some individuals 
never performed 
(either prior to the 
intervention starting or 
since). Those 
individuals who never 
performed the 
behaviour can 
therefore be used as a 
control group. 
Ross-Degnan et al  (1993) 
evaluated the impact of 
the national withdrawal 
of a non-steroidal anti-
inflammatory drug 
(Zomepirac) on 
prescribing of other 
analgesics. They used 
physicians who never 
prescribed Zomepirac 
(and were thus 
unaffected by its 
withdrawal) as the 
control group.(22)  
 
Kiseley et al (2011) used a 
CITS to evaluate the 
impact of an increase in 
alcohol related harm by 
comparing the effect in 
young people aged 15-29 
to the effect in those 
aged 30-49. Alcopops 
tend to be favoured by 
young people so it was 
expected that older 
groups would be largely 
unaffected.(29) 
Controls can be very 
similar to the 
intervention group 
other than in the 
specific behaviour 
targeted by the 
intervention.  
It may be difficult to 
directly identify 
those who did not 
perform the 
behaviour, therefore, 
a proxy may have to 
be used  such as, 
age, in the alcopops 
study. This proxy 
may, however, 
introduce selection 
bias for example 
selecting based on  
age could bias the 
alcopops study 
because age could be 
independently 
associated with both 
the intervention 
(younger people may 
be lower earners and 
thus more affected 
by a tax increase) 
and the outcome (if 
rates of alcohol 
related harm vary 
with age).(29) 
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Historical 
cohort control 
Historical cohorts are 
commonly used in the 
evaluation of education 
interventions but have 
also been used for 
healthcare 
evaluations.(7) This is 
possible where a cohort 
periodically progresses 
to another level (for 
example moving from 
one school year to the 
next) and is replaced by 
another cohort. The 
intervention cohort can 
then be compared to a 
previous or subsequent 
cohort.(3) 
Schneeweiss et al (2004) 
evaluated the impact of a 
restriction of state 
funding of nebulised 
respiratory 
medication.(30) The 
intervention time series 
used monthly 
observations of nebulised 
drug expenditure, 
primary care visits and 
admissions to emergency 
department for a year (6 
months prior to the 
policy and 6 months after 
the policy). Control series 
were taken from the 
same population one 
year and two years 
before. 
Historical cohorts 
help to rule out 
seasonal effects 
(such as stockpiling 
of drugs in the 
Scheeweiss et al 
study) and events 
that occur on an 
annual basis.(30) 
They would not 
control for events 
that are unique to 
the year in which the 
intervention was 
implemented. 
Control 
outcome 
Where no control 
group is possible, 
another option is to 
compare the effect on 
the primary outcome to 
that in a related 
-equivalent 
within the same group. 
Such an outcome 
should not be affected 
by the intervention, but 
would be affected by 
confounding events. 
Walter et al (2011) 
conducted a study on the 
impact of helmet 
legislation on head 
injuries in Australia 
(similar to that by Dennis 
et al described 
above)(24). Rather than 
other locations, they 
used limb injuries as a 
control outcome to 
exclude other effects on 
cycling.(31)  
 
Lopez Bernal et al (2016) 
used accidental deaths as 
a control outcome in 
their ITS study of the 
impact of the financial 
crisis on suicides in Spain 
as both suicides and 
accidental deaths 
undergo similar judicial 
review and recording 
methods.(32) This 
enabled them to control 
for other events that 
could have impacted on 
these processes. 
Uses the same group 
as an intervention 
population therefore 
it is not sensitive to 
many of the 
between group 
differences that can 
affect other 
controls. 
Can often be used to 
control for potential 
confounders that 
would only affect 
the intervention 
group. For example 
by using limb 
injuries as a control 
outcome Walter et 
al were able to 
control for any 
changes in the 
number of cyclists 
where comparing to 
different states 
could not.(24, 31) 
Can only control for 
factors that would 
affect both the 
primary outcome and 
the control outcome. 
Control time 
period 
It may be possible to 
use the primary 
outcome as its own 
control for 
interventions that are 
only active at certain 
times (certain times of 
day or days of the 
week). In this case the 
outcome during times 
in which the 
Ross et al (1970) studied 
the impact of 1967 British 
Road Safety Act, which 
increased the use of 
breathalysers to reduce 
drink driving, on traffic 
casualties. They 
compared the effect on 
the weekend evenings 
when pubs are busiest 
and accidents are more 
Uses the same group 
as the intervention 
group therefore it is 
not sensitive to 
many of the 
between group 
differences that can 
affect other 
controls. 
Can only be used for 
short-term outcomes 
with rapid onset.  
The outcome must 
be recorded at a 
sufficiently high time 
resolution to allow 
identification of 
when the 
intervention is active 
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intervention is inactive 
act as the control. 
likely to be due to drink 
driving to that at 
commuting hours when 
pubs are closed and 
accidents are less likely to 
be due to drink 
driving.(33) 
and inactive. For 
example to the 
nearest hour if the 
intervention is only 
active at night 
time.(34) 
 
 
ANALYSIS AND INTERPRETATION OF CITS STUDIES 
There are a range of analyses that can be employed when undertaking CITS studies. These can broadly 
be divided into two: separate analysis of the intervention series and the control series; or a single 
model incorporating both series. Separate analysis is the simpler approach and may be suitable, 
particularly if there is no change in the control series. A single model can be developed by including 
indicator variables for the intervention or control series as interaction terms (web appendix 1) or by 
generating a new series of the ratio or difference between the intervention and control series at each 
time point.(5, 35) This approach provides a test of the differential effects of the intervention (level or 
slope change) across the groups. The benefit of this approach is that if there are trend changes in the 
control series which could be due to some confounding event, any additional effect of the intervention 
can still be calculated. 
Even if a single model combining the intervention and control series is selected, we would recommend 
starting with a simple (uncontrolled) ITS of the intervention group. Both the uncontrolled ITS and the 
CITS should always be planned a priori and the results reported with equal prominence. If the result 
of the simple ITS mirrors that of the CITS this provides a greater degree of confidence that any 
association between intervention and effect is likely to be causal. Results should be interpreted more 
cautiously if either the simple ITS shows an effect but the CITS shows no effect (or a smaller effect) or 
if the CITS shows an effect but the simple ITS does not. If the simple ITS shows an effect but the CITS 
does not, then there may have been a change in both the intervention and the control series  this 
suggests possible history bias due to some simultaneous event or co-intervention. If the CITS shows 
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an effect but the simple ITS does not, the change may be due (at least in part) to a change in the 
control series, as a result of some other event that affected the control population but not the 
intervention group. This framework for analysing and interpreting CITS studies is summarised in Figure 
2. 
 
 
Figure 2: Suggested steps for undertaking a controlled interrupted time series study  
*Both analyses should be undertaken and reported 
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SENSITIVITY ANALYSIS 
Different ITS model assumptions can be checked using sensitivity analyses. Specific to CITS designs, 
different types of controls may control for different sources of bias or confounding events. Therefore, 
where possible researchers should undertake sensitivity analyses using different types of controls to 
control for those potential sources of bias that have been identified a priori. Similar to the primary 
model, sensitivity analyses should be clearly pre-  
 
ILLUSTRATIVE EXAMPLE 
Steinbach et al (2015) recently used a CITS design to evaluate the impact of a range of changes to 
streetlights in various regions of the UK on road traffic crashes and crime at night.(34, 36) The purpose 
of the intervention was to save energy and costs. The intervention consisted of reductions in the 
brightness of streetlights, replacement of bulbs with lower energy consumption bulbs, reducing the 
hours during which streetlights were turned on at night (i.e. turning on later and turning off earlier) 
and reducing the ambient light threshold at which sensors would activate streetlights. The authors 
hypothesised that while the intervention may save costs, reduced street lighting may unintentionally 
increase road traffic crashes and crime at night. To illustrate the design and interpretation of CITS 
studies we used an extract of these data on minor roads in the Birmingham and Black Country region 
to analyse the impact of the intervention (introduced from 2010) on the number of casualties from 
road traffic crashes. Note that, for simplicity of this illustration, we make the assumption that the 
intervention was introduced simultaneously in 2010 throughout the region and that it would have a 
step change effect. A number of different controls can be considered for the analysis and we work 
through the process of selecting controls and analysing the CITS. 
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Data on road traffic crash casualties included variables on the region, the road type and the time of 
the road traffic crash. Therefore, three potential controls could be considered (1) another region as a 
location based control, (2) comparison of casualties from road traffic crashes on minor roads to those 
on major roads as a characteristic based control, (3) comparison of road traffic crash casualties at night 
to road traffic crash casualties during the day when street lights are not in use as a control time period.  
 
Our first step in selecting a control is to identify potential confounding events or co-interventions that 
would affect the study outcome.  In this study other changes to roads, such as changes to road layout 
or new road safety measures, were identified as a potential confounding event that could impact on 
road traffic crashes independently of the street lighting interventions. Another potential concern was 
instrumentation effects due to unidentified changes to data collection. Considering each of the 
controls in turn: the location based control would not be able to control for the identified confounding 
factors as road changes may have differed from one region to the next and data collection was 
separate in each region. The characteristic controls (different road types), would control for changes 
to data collection processes within a region but would not be able to control for road changes as these 
are likely to differ between minor and major roads. In this example, the control time period is the 
most appropriate as this uses the same roads and same data source and should therefore adequately 
control for all known potential confounders. No other interventions or events that would only affect 
day time road traffic crashes were identified and it was considered unlikely that the intervention 
would have any indirect effect on this control. Day time road traffic crashes were therefore selected 
as the control series. 
 
The next step was to check characteristics of the control and intervention series at baseline and 
throughout the study period for covariate balance. We know that the data comes from the same roads 
therefore this will not be different between night and day. However, no data on the characteristics of 
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the population of night time drivers compared to day time drivers were available. One could assume 
that there are fewer elderly drivers with visual impairments at night, however this is unlikely to change 
differentially between the intervention and control group over the study period independently of the 
intervention.  
 
Figure 3 shows the results of the analysis. First, an uncontrolled ITS analysis (Figure 3a) was 
undertaken. This shows a significant decrease in road traffic crash casualties following the 
intervention, contrary to the hypothesised increase. Nevertheless, when a CITS analysis using daytime 
road traffic crash casualties is run (Figure 3b), the decrease is also present in the controls series and 
there is no evidence of any additional effect in the intervention series. This suggests that the effect is 
due to a change occurring at the same time as the intervention and biasing the previously estimated 
association. 
 
To demonstrate the possible consequences of poor control selection, in figure 3c a location based 
control is used instead. We select the most closely matched region according to baseline 
characteristics (including number of roads in the region, population size, age distribution, sex 
distribution and level of unemployment). There is also no significant difference in baseline trends 
between the control and intervention group. In this case the results are very similar to the 
uncontrolled analysis, showing strong evidence of a decrease in road traffic crash casualties following 
the intervention. Nevertheless, this control group is clearly unable to account for changes to road 
layout or changes to data collection that are unique to the region, and could result in erroneous 
conclusions about the effect of the intervention. This highlights the potential pitfalls of selecting 
controls without first carefully considering potential confounding events or co-interventions specific 
to the study context, even when there is good covariate balance between the intervention and control 
group. 
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Figure 3: The effect of the Birmingham and Black Country street lighting intervention on road traffic crash casualties  
Red regression line is the intervention series (night time road traffic casualties on minor roads in Birmingham and the Black 
Country); blue regression line is the control series: (a) no control, (b) control time period: day time road traffic crash casualties 
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on minor roads in Hertfordshire (c) location based control: night time road traffic crash casualties on major roads in West 
Yorkshire.  The vertical red line is the intervention point. The incident rate ratio (IRR) is the step change in road traffic crash 
casualties following the intervention compared to before the intervention, in figures (b) and (c) the IRR is the step change in 
the intervention series over and above any step change in the control series. 
 
 
CONCLUSION 
In this paper we have highlighted how ITS studies differ from other evaluation designs by making 
within group rather than between group comparisons. While this has the advantage of limiting 
confounding by factors that change only slowly through time history bias can still threaten the validity 
of ITS studies. A wide range of different controls can be used in order to limit history bias and improve 
the validity of an ITS study. Nevertheless, it is important to systematically consider a priori the degree 
of risk of history bias associated with any particular study, what control series are available and 
whether these will adequately control for history bias. Finally, researchers should take care in 
interpreting the results of CITS studies, in particular when the results of CITS analysis differ from those 
of simple (uncontrolled) ITS analysis. If the results of the CITS and the ITS analysis are aligned, CITS 
studies can provide strong evidence on the effectiveness of public health interventions and when 
appropriate controls are selected the design ranks second only to randomised controlled designs in 
terms of their capacity to control for bias.(13) 
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 Summary of appendices for methodological paper 3 
Appendices for this paper are presented in Chapter 11: 
11.3.1 Web appendix 1: Segmented regression interaction model for a controlled interrupted time 
series  
11.3.2 Contribution of the candidate to the paper 
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 Contribution of the paper 
Motivation for the paper 
The topic of CITS was chosen as history bias has been clearly identified as the major threat to the 
validity of interrupted time series, however, there is a lack of methodological literature on approaches 
to addressing this limitation. Other approaches exist to address history bias, including multiple phase 
designs and multiple baseline designs.(1-3) Nevertheless, these approaches require relatively unique 
circumstances in order to be adopted. Conversely, CITS is more widely applicable and many ITS studies 
could be strengthened by the inclusion of a control series.  
Contribution to the thesis 
This paper directly address To develop a methodological 
framework for the selection of controls and analysis of controlled interrupted time series to limit the 
r 4 and informs the 
selection of controls in the two case studies in Chapters 7 and 8, in which two different types of 
controls are chosen. It will also contribute to the reporting guidelines developed in Chapter 9. 
Outputs and contribution to the literature 
To demonstrate the wide applicability of CITS, the paper, for the first time, identifies and classifies a 
broad range of controls that can be used and describes the different sources of history bias that these 
can address. The framework developed provides guidance on how to select controls and analyse CITS 
studies, but also suggests when controls may be inappropriate and when other designs such as 
uncontrolled ITS may need to be used. It is always important to consider whether a control will 
improve the validity of the study or if validity could be impaired by the introduction of new sources of 
bias. The decision on whether to include a control in an ITS study should be based both on an 
assessment of the risk of confounding events and the availability of appropriate controls. A well-
chosen control strengthens the validity of ITS study when there are concerns that the pre-intervention 
trend in the intervention population may not be able to accurately predict the counterfactual. This is 
normally because there is the possibility that confounding events or co-interventions could lead to a 
deviation in the trend independently of the intervention. It follows that a control series is most helpful 
when concurrent confounding events are more likely, for example: if there are known co-interventions 
that need to be excluded, if the intervention is introduced over a prolonged time period (allowing 
more time during which other confounding events could occur) or if the effect of the intervention on 
the outcome is lagged (again allowing more time during which other confounding events could have 
occurred).  
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There is a lower risk of history bias if there is a long, stable pre-intervention trend, there are no known 
co-interventions and the intervention is introduced over a short time period and has a rapid effect on 
the outcome. Under such circumstances there is a limited time during which other events could act 
and an uncontrolled ITS analysis remains a strong design. If researchers find that no suitable control 
is available after following the steps that are outlined in the framework. The use of an uncontrolled 
ITS design may be more appropriate (as indicated in Figure 2 of the paper). A control series can be 
detrimental to the validity of the study if it introduces selection bias and differs from the intervention 
series in the way it would respond to interventions or if it has been independently exposed to other 
interventions or events. Furthermore, using an uncontrolled ITS and stating that a key limitation is 
that it cannot control for simultaneous events or co-interventions that could impact on the outcome, 
may be preferable to (and more transparent than) using an inappropriate control that, at best, will 
not improve the validity of the analysis. 
The LANTERNS study provides an excellent example to demonstrate the selection of controls as there 
are various different types of controls that can be chosen for which data is available.(4) This provides 
a useful illustration to those considering using a CITS study on how to apply the proposed framework 
in order to select a control. 
Conclusions 
Where an appropriate control is available this can facilitate a very powerful quasi-experimental design. 
This paper encourages the use of CITS where such controls are available and should aid researchers in 
using this technique to strengthen evaluations of complex public health interventions. 
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 Summary of appendices for case study 1 
Appendices for this paper are presented in Chapter 11: 
11.4.1 Gross domestic product growth in Spain 
11.4.2 Unemployment in Spain 
11.4.3 Trend in monthly mortality rate from accidental falls (control) for all of Spain before and since 
the financial crisis 
11.4.4 Trend in monthly suicide rates before and since the financial crisis by area 
11.4.5 Trend in monthly suicide rates before and since the financial crisis by sex 
11.4.6 Trend in monthly suicide rates before and since the financial crisis by age group 
11.4.7 Time series plots of trends in monthly suicide rates for all of Spain based on the alternative 
models used in sensitivity analysis 
11.4.8 Unemployment rates during the first quarter of 2005 and the last quarter of 2010 
11.4.9 Contribution of the candidate to the paper 
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 Contribution of the paper 
Motivation for the paper 
This paper was chosen as a case study because it highlights how ITS can be used to evaluate a complex 
intervention. One of the major challenges to evaluating the effects of the financial crisis is that it was 
an unplanned event, which means both that experimental designs are not possible and that 
establishing the timing of the intervention is not straightforward. The potential effects of the financial 
crisis are multifaceted and not only affect individuals but also society as a whole. Furthermore, it had 
a broad international reach which means that there is no obvious control population that could 
definitively be assumed to have been unaffected by the crisis. I wanted to highlight how the 
complexity of the intervention does not preclude evaluation and demonstrate how I dealt with some 
of these issues. 
Contribution to the thesis 
This study addresses objective four of the thesis by demonstrating an application of ITS. It 
demonstrates how ITS can be used in real world settings with complex interventions where outcome 
evaluation using other robust study designs is unlikely to be possible. It also demonstrates the use of 
routine data sources in addressing important research questions. Furthermore, this study highlights 
some of the methodological challenges that link to other sections of this thesis, including how to deal 
with defining the timing of an unplanned event in evaluative studies which was discussed in more 
detail in Chapter 5, and the risk of history bias, in particular when the intervention is diffuse, and how 
to address this when typical controls are not available, this was discussed in more detail in Chapter 6. 
Outputs and contribution to the literature 
Prior to this study, most previous evaluations of the health effects of the financial crisis relied on 
simple pre-post designs that did not account for underlying trends or random fluctuations in the 
outcome and therefore had poor internal validity.(1, 2) I considered a population level ITS as the best 
design to evaluate the effects of the financial crisis. The lack of any available control group means that 
other strong evaluative designs are not possible. Furthermore, because the effects of the financial 
crisis act as much at a population or societal level as an individual level, an ecological study using 
population level data is more appropriate. 
This study provides strong evidence of an association between the financial crisis and suicides and 
should inform the provision intervention such as mental health and social welfare programmes to 
mitigate the effects of financial shocks.(3) 
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Conclusion 
This study demonstrates the practical application of ITS to evaluate a very complex intervention and 
answer an important question. It is difficult to see how other robust designs could be applied in this 
setting and this highlights the wide applicability of the design in public health evaluation. 
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 Summary of appendices for case study 2 
Appendices for this paper are presented in Chapter 11: 
11.5.1  S1 Table: Population characteristics: England and Scotland 2007-2014 [1] 
11.5.2  S2 Table: Trend changes in specialist visits and hospitalisations following the intervention  
11.5.3  S1 Figure: Time series of outpatient specialist visits in England and Wales 
11.5.4  S2 Figure: Time series of inpatient hospitalisations in England and Wales 
11.5.5  S3 Figure: NHS reference costs 
11.5.6  S1 Text: Controlled interrupted time series model 
11.5.7  S1 Checklist. REporting of studies Conducted using Observational Routinely-collected health 
Data (RECORD) statement. 
11.5.8  S1 Protocol 
11.5.9  S1 Data: English data 
11.5.10 S2 Data: Scottish data 
11.5.11 S3 Data: Algorithms used for extraction of English data. 
11.5.12 S4 Data: Algorithms used for extraction of Scottish data. 
11.5.13 Contribution of the candidate to the paper 
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 Contribution of the paper 
Motivation for the paper 
The second case study evaluates the impact of the 2012 Health and Social Care Act in England on 
inpatient hospitalisations and outpatient services. This was a major health policy that resulted in 
extensive changes to the way healthcare is purchased by giving GP led clinical commissioning groups 
control of secondary care budgets.(1) It has similarities to the previous case study in that they both 
evaluate large scale interventions and are undertaken using national population level routine data 
sources. However, it differs from the previous study in that this was a planned health service policy 
intervention with clear implementation dates. 
This case study was chosen as the evaluation presents several methodological challenges. In their 
paper entitled  Vittal 
Katikireddi et al summarise some of the main difficulties in evaluating this policy.(2) The four 
challenges they describe are: 1)   
Here, they discuss how some of the policies can be considered a continuation of previous initiatives, 
citing the Private Finance Initiative, the introduction of hospital Foundation Trusts and the Payment 
by Results system. 2)   Here, 
the authors raise a number of issues in defining the outcomes for evaluation, first that changes in 
outcomes may be confounded by pre-existing trends; second, data quality may vary as a consequence 
of the policy; third, baseline data may not be available for some outcomes prior to the reforms; fourth, 
they question the meaning of some outcomes such as avoidable admissions and mortality amenable 
to healthcare. 3)   Here, they highlight 
that the timing of the reforms is not completely clear some changes began before the reforms were 
fully implemented. Furthermore, they highlight that some outcomes may take a long time before 
becoming apparent. 4)  what would have happened if the reforms were 
 Finally, the authors argue that it is difficult to find a comparator in order to model a 
counterfactual, they suggest a pre-post design may not be suitable as a change may reflect trends in 
determinants of health rather than the health policy. They also propose comparing England with 
Scotland or Wales (where the reforms did not occur) as a potential solution and critique the 
Department of Health for excluding this type of analysis in their call for research on the policy. 
Contribution to the thesis 
As with the previous case study, this case study directly addresses objective four of the thesis by 
demonstrating the use of ITS to evaluate a complex public health intervention. In doing so it highlights 
some of the limitations of routine data in terms of data quality issues. The study also links into 
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objective three which relates to CITS analysis, the study uses a location based control and was 
undertaken alongside developing a framework for CITS analysis which is described Chapter 6. Finally, 
analysis from this study is used as the primary example in developing a framework for model selection 
in ITS (objective 3), this is illustrated in Chapter 5. The analytical model used here was designed to 
closely align with how the intervention was implemented and the nature of the expected effect on 
the outcome. Re-analysis using less appropriate models is demonstrated in Chapter 5 and I highlight 
the impact that this can have on the results. 
Outputs and contribution to the literature 
An ideal approach to evaluating this type of health policy would be to pilot it as a cluster randomised 
trial or to randomise the order in which it is implemented in different regions using a stepped wedge 
design.(3) This would have good internal validity and improve the ability of researchers to infer 
causality with any effects. Nevertheless, for practical and political reasons, implementing policies in 
this way is not always possible, furthermore, this would not address all of the issues outlined above, 
including defining the outcomes and lagged effects.(4) Given the way that the policy was 
implemented, possible evaluative designs that could be used include a simple pre-post design, a cross-
sectional non-randomised controlled study (with Scotland or Wales as the control), a controlled before 
and after design (difference in difference), or an interrupted time series (with or without a control 
series). Of these, a controlled ITS study (CITS) is the most powerful. The pre-post and cross-sectional 
controlled designs are inherently weak, neither takes into account trends, the former has no control 
and the latter has no baseline measurements.(5) The controlled before and after study is more 
powerful, nevertheless, it still does not take into account trends and with the limited controls available 
for this analysis accurately matching is not possible. Uncontrolled ITS does take into account 
underlying trends, nevertheless, because the policy was introduced over a relatively long time period 
(one year), there is a greater risk of history bias. Adding a control series helps to mitigate the risk of 
history bias and strengthens the design. 
The CITS design in itself addresses the fourth issue identified by Vittal et al (defining the 
counterfactual) by allowing the counterfactual to take into account underlying trends in the outcomes 
and by including a control which helps to exclude other changes occurring around the time of the 
policy. In this study I also attempted to address the other issues that were raised by Vittal et al: In 
defining the intervention I focussed on one of the major changes of the policy which was the 
introduction of GP-led commissioning groups, this was purported as a major change in that clinicians 
became the decision makers with regard to secondary care budgets.(4) This was a clear difference 
from previous policies, nevertheless there is evidence that clinicians felt less empowered than 
anticipated which may mean the change was not as radical as expected, I addressed this issue in the 
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discussion of the paper. Second, in defining the outcome I used a routine data series that was in place 
well before the policy was introduced and that has continued since the policy, I also reviewed data 
quality reports and where data quality issues could have impacted the data, I excluded this data from 
the analysis. Finally, I addressed the issue around the timing of the intervention by including a 
enacted and when Clinical Commissioning Groups took full responsibility for commissioning, and by 
using a slope change model which allowed for a gradual change in the outcome. Nevertheless, effects 
with a long lag will not be identifiable for some time and this is something that I highlighted in the 
discussion. 
Conclusion 
This study again demonstrates the flexible use of ITS for evaluating complex interventions. However, 
it contrasts from the previous study in the type of impact model used and the type of controls. The 
study both informs and was informed by the methodological work in the previous chapters and, as 
such shows a progressive improvement in the robustness of the design and analysis since the previous 
case study. Nevertheless, the publication was required to adopt established reporting criteria, of 
which none currently exist for ITS studies of public health interventions. The STROBE and RECORD 
criteria used do not align well to ITS and this highlights the need for reporting criteria specific to ITS 
as proposed in Chapter 9.(6, 7) 
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FRAMEWORK FOR ENHANCED REPORTING OF INTERRUPTED TIME SERIES 
(FERITS): REPORTING RECOMMENDATIONS FOR INTERRUPTED TIME SERIES 
EVALUATIONS OF PUBLIC HEALTH INTERVENTIONS AND REVIEW OF EXISTING 
PRACTICE 
 
ABSTRACT 
Background 
Interrupted time series (ITS) is an increasingly popular design for evaluation of public health 
interventions. It has a number of methodological features and potential sources of bias that are not 
addressed in existing quality criteria. We propose a new set of reporting recommendations for ITS 
studies. To assess the need for such recommendations, we also review recent reporting practice in 
the field of public health. 
Methods 
A Framework for Enhanced Reporting of Interrupted Time Series (FERITS) was developed by adapting 
the Transparent Reporting of Evaluations with Nonrandomised Designs (TREND) statement to 
include methodological features and potential sources of bias of ITS studies. 
The literature review examined the Medline database for ITS studies of public health interventions 
published in 2015. Data was extracted on interventions, outcomes, data source, and how methods 
and sources of bias were reported. 
Results 
104 studies were included in the analysis. Studies evaluated a broad range of interventions and 
outcomes, primarily using routine data. Authors were generally comprehensive in reporting 
characteristics of the data series (e.g. 100% clearly defined the timing of the intervention) and the 
model used (e.g. 98.1% reported whether a level or slope change model). However, they often failed 
to report sources of bias and how these were addressed including: checking for changes to data 
collection (20.2%), considering history bias (66.3%) and considering seasonality (47.1%). 
Conclusion 
There is a need for improved reporting of ITS studies in public health. Researchers are encouraged to 
use formal reporting criteria such as the proposed FERITS statement when reporting ITS studies. 
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INTRODUCTION 
Interrupted time series (ITS) is a powerful quasi-experimental study design for intervention 
evaluation.(1, 2) The design involves estimating the effect of an intervention by modelling the 
underlying trend in the outcome of interest and examining the change in the trend following the 
introduction of the intervention.(3, 4) It has a number of advantages: accounting for the underlying 
trend controls for secular trends, regression to the mean and confounding by variables that change 
relatively slowly in time. Furthermore, because the evaluation is based on a comparison within the 
same population, selection bias is rarely a problem and a control group is not an essential 
requirement.(2, 3) The use of ITS in health research has increased exponentially in recent years 
(Figure 1). It is particularly applicable to evaluations of public health interventions and for examining 
the public health impacts of non-health sector interventions as these are often not amenable to 
evaluation through traditional methods such as randomised controlled trials.(5, 6) Furthermore, the 
implementation of interventions as natural experiments mean that ITS is often a pragmatic study 
design in this context.(7) Examples of the use of ITS in public health include evaluations of health 
policies, health promotion programmes, infectious disease interventions and health service 
reforms.(8-12) 
 
 
FIGURE 1: NUMBER OF PUBMED ARTICLES WITH THE SEARCH TERM "INTERRUPTED TIME SERIES" BY YEAR 
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Alongside the increasing popularity of the design, there has been a proliferation of methodological 
research concerning the design, analysis and validity of ITS studies.(3, 6, 13-20) This research has 
identified factors that strengthen the validity of ITS and provided recommendations on approaches 
to undertaking ITS analysis. Because of their longitudinal nature and because the population acts as 
its own control there are a number of unique methodological considerations in ITS studies that differ 
from other evaluative designs.(3) For instance, some of the key unique methodological questions 
that authors need to address include: Have there been any changes to the way outcome data was 
collected or reported over time (leading to potential instrumentation bias)?(2, 20) How should the 
underlying trend be defined?(20) What is the nature of the hypothesised effect (i.e. the impact 
model) of the intervention on the outcome?(20) Was the intervention independent of other 
changes?(2, 19) Nevertheless, these questions are not always clearly addressed in published ITS 
studies and potential sources of bias appear to be poorly understood. Without such questions being 
explicitly answered, comprehensive quality assessment of studies using ITS is not possible. 
 
For other study designs there are now well established quality criteria, such as the CONSORT 
statement for randomised controlled trials and STROBE for observational studies.(21, 22) These 
provide guidance for researchers to ensure that the key sources of bias in each design are openly 
addressed. This facilitates critical appraisal of the quality of studies by reviewers and readers. A 
number of quality criteria have been developed for systematic reviews of ITS studies in specific fields 
of health research, including: professional practice and the organisation of health care,(23) health 
technology assessment,(24) and drug utilisation research.(25) However, these do not incorporate 
more recent methodological work nor are they focused on the field of public health evaluation. The 
aims of this paper are twofold: first, to propose a set of reporting recommendations for authors of 
ITS studies in order to enhance clarity and transparency in the reporting of such studies in the 
scientific literature. Second, to review current practice in reporting of ITS methods in the field of 
public health. The first section of the paper will present the proposed new reporting 
recommendations and explain their scope and how they were developed; the second section will 
present the methods and results of an illustrative literature review of the applications and methods 
of recent ITS studies in public health; finally, the discussion will bring these two sections together in 
order to highlight the major gaps in current reporting practice and how these may be addressed with 
the proposed reporting framework. 
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REPORTING RECOMMENDATIONS: FRAMEWORK FOR ENHANCED REPORTING OF 
INTERRUPTED TIME SERIES (FERITS) 
Development of FERITS statement 
We reviewed existing established reporting guidelines for observational and quasi-experimental 
study designs as well as methodological literature on ITS design. The most relevant reporting 
statement is the Transparent Reporting of Evaluations with Nonrandomised Designs (TREND) 
statement.(26) TREND has become the most well established set or reporting recommendations for 
quasi-experimental evaluative studies. As such, the TREND statement forms the basis for developing 
our reporting recommendations for ITS studies. Nevertheless, the focus of TREND is on non-
randomised controlled studies such as difference in difference designs. It does not cover many of the 
key methodological considerations of time series data. The Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) statement also has some items relevant to ITS, 
-
control or cross-sectional study designs.(22) As evaluative designs, ITS studies must have a clear 
description of the intervention under study, we therefore also build on recommendations from the 
Template for Intervention Description and Replication (TIDieR) checklist.(27) Finally, ITS studies of 
public health interventions typically use routine data sources and we therefore draw on items from 
the REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) 
statement.(28) However, these existing reporting statements do not cover some of the important 
methodological issues outlined earlier in the paper that are specific to ITS. We have identified a 
number of key areas that comprehensive reporting recommendations should cover, including: 
 Sources of bias: history bias and measurement bias have been identified as the primary 
sources of bias in ITS studies.(2-4) History bias arises when other changes occur around the 
time of the intervention and could have an effect on the outcome.(2, 19) Because ITS studies 
examine the change in the outcome before and after the intervention within a single 
population, it may be difficult to distinguish intervention effects from those of other 
changes. Measurement bias occurs when there are differences in the way outcomes are 
measured between groups or over time. As discussed above, ITS studies of public health 
interventions often rely on routine data sources and the way that routine data is collected or 
processed can change over time resulting in artefactual changes in the outcome.(2) In 
particular, instrumentation may occur whereby the intervention itself results in a change in 
the way outcome data is measured. 
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 Interrupted time series model specification: ITS analysis involves modelling the underlying 
trend in the outcome and estimating the intervention effect as the change in this trend 
following the intervention. Different intervention models can be used to model different 
effects (for example gradual or abrupt changes in the outcome).(3) The type of model used 
should be specified according to the data series used and the nature of the intervention and 
outcome and authors should justify their model selection a priori.(20) 
 Statistical considerations of time series data: There are a number of statistical considerations 
specific to time series data which authors should address including, linearity of the trend, 
whether there is any seasonal variation in the outcome, whether there are time-varying 
confounders that could influence the outcome and whether data are autocorrelated (a 
phenomenon whereby data points close together in time are more closely correlated than 
those that are further apart).(3, 29) 
 
Scope of FERITS statement 
The purpose of the proposed FERITS statement is to encourage comprehensive and transparent 
reporting by authors ITS studies in public health. Many of the items will also be relevant to clinical 
ITS studies and studies in other fields but there is a focus on studies that use routine data sources. 
The checklist should also facilitate appraisal of ITS studies for synthesising evidence in systematic 
reviews or guidelines development.  
We present the statement as a basis for further discussion of comprehensive reporting of ITS 
studies, therefore they should not be regarded as a definitive statement. We hope to receive input 
from researchers and publishers so that the statement can be improved and developed as a 
collaborative effort with formal guidance to be generated and adopted in the future. 
 
Items in the FERITS statement 
Table 1 presents the items in the FERITS statement. 
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TABLE 1: FRAMEWORK FOR ENHANCED REPORTING OF INTERRUPTED TIME SERIES STUDIES (FERITS) STATEMENT 
Title and Abstract 
Title and Abstract 1 Study design (interrupted time series) indicated in the title or the abstract 
Structured abstract recommended 
Information on target population or study sample 
Introduction 
Background 2 Scientific background and explanation of rationale 
Objectives 3 Specific objectives and hypotheses 
Methods 
Study Population 4 Eligibility criteria for participants, including criteria at different levels in recruitment/sampling plan (e.g., 
cities, clinics, subjects) 
Methods of study population selection (such as codes or algorithms used to identify subjects from 
routine datasets) 
Settings and locations where the data were collected 
Study time-period 5 Start and end dates of the data included in the study, including reasons for selecting this date range and 
whether this was the full dataset available or if data was restricted. (Presentation of the full time series 
as a web appendix recommended) 
Time intervals used (e.g. daily, monthly, annual) and the reason for selecting this interval 
Clear definition of the preintervention period, the intervention point (including any transition period) 
and the post-intervention period 
Intervention 6 Details of the intervention(s) and how and when they were actually administered, specifically including:* 
_ Why: Description of the rationale, theory, or goal of the elements essential to the intervention 
_ What: Description of what was done including details of any policy changes, procedures, activities and 
information provided to participants 
_ Who: Who developed, implemented and/or provided the intervention 
_ How: Description of the modes of delivery of the intervention and whether it was provided individually,  
in a group or to a whole population 
_ Where: Description of the type(s) of location(s) where the intervention occurred, including any 
necessary infrastructure or relevant features 
_ When: Description of when the intervention was first announced, marketed and delivered, the number 
of times it was delivered and the duration. Did all groups receive the intervention at the same time 
_ Tailoring and modifications: Description of any adaptations or modifications to the intervention during 
the course of the study 
_ Adherence: Report on whether the intervention was compulsory, whether adherence was assessed 
and any activities to increase compliance or adherence 
Outcomes 7 Clearly defined outcome measures 
Data source(s) 
Methods used to collect, process, record and extract data; any changes in data collection, processing or 
recording over time 
Information on validity and reliability of outcome measures 
Information on data quality, coverage and completeness over the duration of the study period; any 
changes in quality, coverage or completeness over time 
History bias 8 Identification of co-interventions or other concurrent events that might affect the outcome; if no such 
events exist, clear statement that the intervention was independent of other changes 
Description of design adaptations to mitigate the risk of history bias e.g: adding a control series, using 
multiple phases or a using a multiple baseline design 
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Unit of Analysis 9 Description of the smallest unit that is being analysed to assess intervention effects (e.g., individual, 
group, or community) 
Statistical Methods 10 Statistical methods used (e.g. segmented Poisson regression, ARIMA etc) 
Appropriateness of a linear model, including description of any tests for linearity and any non-linear 
terms included 
Detailed description of the a priori impact model and why this was chosen, including allowance for: step 
or slope change effects, lagged effects, transition phase, floor or ceiling effects. Describe why this model 
is appropriate for the intervention and outcome under study 
Adjustments for time varying confounders (including seasonality) 
Assessment of autocorrelation and how this was handled 
Description of any stratified or subgroup analyses 
Explanation of how missing data were addressed 
Discussion of uncertainty in the primary statistical model and description of any additional sensitivity 
analyses 
Statistical software or programs used 
Results 
Numbers analysed 11 Report on the number of participants (denominator) included in each analysis for each study condition 
throughout the study period, particularly when the denominators change for different outcomes. 
Population 
characteristics 
12 Description of the baseline demographic and clinical characteristics of the intervention group and any 
control groups at baseline and throughout the study period (a table is recommended) 
Report on study group equivalence at baseline and statistical methods used to control for baseline 
differences 
Identification of differential changes in population characteristics between study groups throughout the 
study period and description of statistical methods used to control for differential changes 
Outcomes and 
estimation 
13 For each primary and secondary outcome, a summary of results for each estimation study condition, and 
the estimated effect size and a confidence interval to indicate the precision 
Report on both relative and absolute changes in the study outcomes following the intervention 
Inclusion of null and negative findings 
Inclusion of results from testing pre-specified causal pathways through which the intervention was 
intended to operate, if any 
Graphical presentation of the time series for each outcome with the regression line, pre-intervention 
time period, intervention points and post-intervention period clearly indicated 
Ancillary analyses 14 Summary of other analyses performed, including subgroup or restricted analyses and sensitivity analyses, 
indicating which are pre-specified or exploratory 
Adverse events 15 Summary of all important adverse events or unintended effects in each study condition (including 
summary measures, effect size estimates, and confidence intervals) 
DISCUSSION 
Interpretation 16 Interpretation of the results, taking into account study hypotheses, sources of potential bias, imprecision 
of measures, multiplicative analyses, and other limitations or weaknesses of the study 
Discussion of results taking into account the mechanism by which the intervention was intended to work 
(causal pathways) or alternative mechanisms or explanations 
Discussion of the success of and barriers to implementing the intervention, fidelity of implementation 
Discussion of research, programmatic, or policy implications 
Generalizability 17 Generalizability (external validity) of the findings, taking into account the study population, the 
characteristics of the intervention, length of follow-up, incentives, compliance rates, specific 
sites/settings involved in the study, and other contextual issues 
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Overall Evidence 18 General interpretation of the results in the context of current evidence and current theory 
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LITERATURE REVIEW 
In order to provide an illustrative example of current reporting we undertook a literature review of 
ITS studies of public health interventions published in 2015. Here, we aim to provide a picture of the 
specific research areas where ITS is applied within public health and the type of data that is used. 
We then aim to look at how well the studies report the ITS specific methodological issues that feed 
into the FERITS framework.  
 
Methods 
The UK Faculty of Public Health defines three domains of public health: health improvement 
(including health promotion and education activities targeting the wider determinants of health), 
health services (including interventions to improve health service effectiveness, efficiency, planning 
and equity), and health protection (including communicable disease control and response to 
chemical, radiological and environmental hazards).(30) We include population level studies of 
interventions in any of these areas as well as studies evaluating the impact of non-health 
interventions on health outcomes. We exclude studies evaluating clinical interventions that act at an 
individual level. We searched Medline for all studies published in 2015 using Interrupted Time Series 
 
Studies were screened using the title and abstract and we excluded studies that were not original 
research papers, not ITS studies or did not evaluate public health interventions. Further exclusions 
on this basis were made when reviewing full papers. From eligible studies, we extracted information 
on the characteristics of the study and the methodological reporting of the study. A detailed 
description of the data extracted is provided in Appendix 1. For methodological reporting, we 
focussed on items of the FERITS checklist that are specific to ITS studies, including description and 
justification of the study time period (item 5), changes in outcome measurement over time (item 7), 
history bias (item 8), the impact model and statistical considerations of time-series data (item 10). 
 
 
Results 
Figure 2 shows the flow diagram of the literature search. The Medline search identified 304 unique 
articles. 80 of these were not original empirical research (49 review articles; 17 commentaries, 
letters or protocols; 14 methodological articles). 81 used other study designs (primarily traditional 
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time-
claimed to be ITS studies but did not 
adjust for trend and would therefore more commonly be regarded as a simple pre-post design. 32 of 
the remaining studies did not evaluate a public health intervention or outcome. Of the 105 eligible 
articles (Appendix 2) we were unable to access one and could not contact the author of this study. 
 
 
FIGURE 2: FLOW DIAGRAM OF LITERATURE SEARCH 
 
 
STUDY CHARACTERISTICS 
Table 2 shows the characteristics of the studies included in the analysis, including the interventions 
and outcomes studied and the data sources used. There were a broad range of interventions 
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evaluated. The most common application of ITS (63.5% of studies) was in health services research, 
especially health service financing (15.4%, including incentives and penalties for healthcare 
professionals and changes in user fees) and evaluations of pharmaceutical policies or guidance 
(15.4%). 16.3% of studies evaluated health protection interventions all of which related to 
communicable disease control, 10.6% were evaluations of interventions targeting the use of 
antimicrobials in order to limit antimicrobial resistance and/or infections such as Clostridium dificile. 
15.4% of studies evaluated health promotion interventions such as those targeting smoking, alcohol 
and illicit drug use as well as interventions promoting physical activity and road safety. Many of 
these evaluated national policies or legislation but there were also studies of smaller scale 
educational programmes.(31-35) 
In line with the propensity towards health service interventions, many of the outcomes were health 
service outcomes including service or treatment uptake (56.7%) and treatment outcomes or service 
quality measures (13.5%). Measures of health or disease were also common outcomes (24%), in 
particular disease incidence (17.3%). Other outcomes included mortality measures (4.8%), health 
behaviours (5.8%) and non-health outcomes of public health interventions (3.8%). 
Again, the range of data sources used was broad. Almost all studies used routine data sources, with 
just two studies using prospective data collection for their time series: one using pedometers,(34) 
and another collecting new surveillance data.(36) The most common sources of data were health 
service administrative data (23.1%), for example Hospital Episode Statistics from NHS hospitals in 
England),(37) electronic health records (18.3%), and health insurance claims data (17.3%). A number 
of studies used data sources not traditionally associated with health research including police data, 
transport data, a flight database and a child protection database. 
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TABLE 2: CHARACTERISTICS OF IDENTIFIED STUDIES (N=104) 
Intervention n %   Outcomes n %   Data source n % 
Health promotion 16 15.4%  Health/disease measures 25 24.0%  disease registry 2 1.9% 
Alcohol interventions 3 2.9%  disease incidence 18 17.3%  child protection database 1 1.0% 
Illicit drug use interventions 1 1.0%  disease prevalence 1 1.0%  electronic health records 19 18.3% 
Physical activity interventions 1 1.0%  health index 1 1.0%  flight database 1 1.0% 
Smoking interventions 8 7.7%  road traffic crash casualties 4 3.8%  health insurance claims data 18 17.3% 
Road safety interventions 3 2.9%  self harm 1 1.0%  health service admin data 24 23.1% 
        laboratory data 1 1.0% 
Health protection 17 16.3%  Mortality 5 4.8%  maternity records 1 1.0% 
Antimicrobial intervention 11 10.6%  suicides 2 1.9%  microbiology data 7 6.7% 
Infection control 5 4.8%  infant mortality 1 1.0%  mortality data 4 3.8% 
Vaccine introduction 1 1.0%  mortality 1 1.0%  pedometer 1 1.0% 
    drug related deaths 1 1.0%  pharmacy data 15 14.4% 
Health services 66 63.5%      police data 3 2.9% 
Health service financing 16 15.4%  Health behaviours 6 5.8%  population survey 3 2.9% 
New services/service 
withdrawal 7 6.7%  physical activity measure 1 1.0%  surveillance data 2 1.9% 
Pharmaceutical 
policy/guidance 16 15.4%  smoking prevalence 4 3.8%  transport data 2 1.9% 
Treatment guidelines 9 8.7%  drink driving 1 1.0%  worker health examinations 1 1.0% 
Screening 4 3.8%         
Other health service 
interventions 14 13.5%  Service/treatment uptake 59 56.7%     
    prescriptions 29 27.9%     
Non-health 
interventions/events 5 4.8%  screening uptake 5 4.8%     
Economic policy/event 2 1.9%  diagnostic test uptake 1 1.0%     
Mass gathering event 1 1.0%  caesarean sections 1 1.0%     
Road changes 1 1.0%  treatment uptake 5 4.8%     
TV programme 1 1.0%  hospital admissions 2 1.9%     
    ED presentations 2 1.9%     
    referrals 1 1.0%     
    service utilisation 13 12.5%     
           
    
Treatment outcomes/service 
quality 14 13.5%     
    
service performance/quality 
indicator 6 5.8%     
    treatment complications 1 1.0%     
    adverse drug reactions 1 1.0%     
    length of stay 1 1.0%     
    medication adherence 1 1.0%     
    readmissions 4 3.8%     
           
    Non health outcomes 4 3.8%     
    child protection referrals 1 1.0%     
        costs 3 2.9%         
NB: some studies looked at more than one primary outcome and used more than one data source. 
 
 
METHODS REPORTING 
Table 3 shows how methods were reported by the identified ITS studies. Almost all studies (99.0%) 
clearly stated the study period (the time range of the data series) and the time interval (97.1%) and 
all studies clearly defined the timing of the intervention. However, only 20.2% of studies reported 
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checking for changes to data collection or processing (including variations in data quality or 
completeness) over time and only 10.6% provided a clear justification for their choice of study 
period. 66.3% of studies reported considering potential confounding interventions or events as an 
alternative explanation for their findings (history bias). 35.6% of studies adapted the ITS design to 
mitigate the risk of history bias, normally by including a control series, a controlled (or comparative) 
ITS design (29.8% of studies). Other studies used multiple phase designs whereby the intervention 
was introduced and then withdrawn (1.9%), multiple baselines (whereby the intervention was 
introduced in different locations at different times) (1.0%), by including potential confounding 
interventions as dichotomous variables within their model (1.9%) or by triangulating with another 
study design (1.0%), in this case a regression discontinuity design. The controlled ITS studies used a 
range of different types of control series, the most common were location based controls (13.5% of 
all studies) and control outcomes (or non-equivalent dependent variables, 9.6%). 
 
All bar one study reported their method of analysis, 83.7% used segmented regression and 15.4% 
used autoregressive integrated moving average (ARIMA) models. The majority of studies (76.9%) 
allowed both a level and slope change impact model, 13.5% allowed a level change only and 7.7% 
allowed a slope change only. 8.7% of studies included a transition phase during which the 
intervention was being implemented,(20) and 1.9% allowed for a lagged effect. No studies modelled 
possible floor or ceiling effects. While the impact model used was generally described in detail, only 
2.9% of studies fully justified their choice of impact model a priori, with 4.8% justifying part of their 
impact model (the transition phase only) but not other parts such as why a level and/or slope 
change model was appropriate. The majority of studies (87.5%) used a linear model but only 14.4% 
reported checking the fit of a linear model. 47.1% of studies reported considering seasonality as a 
potential confounder with 39.4% adjusting for seasonality in their model. 39.4% of studies reported 
considering other possible time varying confounders with 33.7% adjusting for such confounders. 
66.3% of studies considered autocorrelation and 49.0% made adjustments to the model to account 
for autocorrelation. Finally, 27.9% of studies conducted sensitivity analyses and the majority of these 
(24 out of 29) were clearly justified a priori. 
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Table 3: Methods reporting by identified ITS studies (n=104) 
Methodological issue 
n % 
Data series   
 Study period clearly stated 103 99.0% 
 Time interval clearly stated 101 97.1% 
 Timing of intervention clearly defined 104 100.0% 
 Checked for changes to data collection/processing 21 20.2% 
 Data range fully justified 11 10.6% 
History bias   
 History bias considered 69 66.3% 
 Design adaptations to mitigate history bias 37 35.6% 
  Control series 31 29.8% 
  Multiple phase design 2 1.9% 
  Multiple baseline design 1 1.0% 
  Included other interventions in model 2 1.9% 
  Triangulated with other study design 1 1.0% 
 Type of control series used   
  Behaviour based control 1 1.0% 
  Characteristic based control 6 5.8% 
  Control outcome 10 9.6% 
  Control time period 1 1.0% 
  Historical control cohort 1 1.0% 
  Location based control 14 13.5% 
  Different health plan 1 1.0% 
  Cluster randomised control 1 1.0% 
Method of analysis   
 Segmented regression 87 83.7% 
 ARIMA 16 15.4% 
 Not stated 1 1.0% 
Impact model   
 Level or slope change model   
  level and slope change 80 76.9% 
  level change only 14 13.5% 
  slope change only 8 7.7% 
  Not stated 2 1.9% 
 Tranisition phase modelled 9 8.7% 
 Lagged effect modelled 2 1.9% 
 Floor/ceiling effect modelled 0 0.0% 
 Impact model justified a priori   
  yes 3 2.9% 
  no 96 92.3% 
  partly (transition phase only) 5 4.8% 
Linearity   
 linearity assessed 15 14.4% 
 linear model used 91 87.5% 
 non-linear model used 13 12.5% 
Seasonality   
 not applicable 5 4.8% 
 considered 49 47.1% 
 adjusted for 41 39.4% 
Time varying confounders   
 considered 41 39.4% 
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 adjusted for 35 33.7% 
Autocorrelation   
 considered 69 66.3% 
 adjusted for 51 49.0% 
Sensitivity analysis   
 Sensitivity analysis conducted 29 27.9% 
 Sensitivity analysis justified a priori 24 23.1% 
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DISCUSSION 
This literature review has illustrated the broad range of public health interventions and outcomes for 
which ITS is being applied in evaluative studies. Authors tend to clearly report the methods used 
such as the time periods covered, the method of analysis, the type of model and any adjustments. 
Nevertheless, they often fail to report how some of the key threats to validity in ITS studies were 
addressed such as measurement bias from changes to data collection or processing over time, 
history bias, confounding due to seasonality and time varying confounders, and autocorrelation. 
Furthermore, studies rarely justify their analytical choices, such as the data range or the impact 
model selected, a priori based on substantive knowledge. This highlights the need for guidance on 
the reporting of ITS studies. 
Whereas openly discussing potential sources of bias has become standard in traditional study 
designs, for example blinding and allocation concealment in randomised controlled trials or selection 
bias and recall bias in case-control studies, we found that discussion of the primary sources of bias in 
ITS studies is often missing. Because of the pre-post comparison in ITS studies, history bias, is widely 
regarded as the primary threat to the validity of ITS studies.(1, 2, 19) However, a third of papers in 
our review did not consider whether other changes could have occurred around the time of the 
intervention and may offer an alternative explanation for the results. While there may be 
circumstances where history bias is unlikely, for example if there is an immediate large level change 
effect, authors should always make clear why they believe other events are unlikely to have caused 
the effect. Nevertheless, it was encouraging to see that those authors that did address history bias 
used a wide range of different approaches to limit this threat to validity and a number of innovative 
control series were used. Measurement bias or instrumentation bias is also a particular concern with 
ITS studies that rely on routine data sources, however few studies reported checking whether there 
had been changes to the way data was collected over time, for example changes in data quality or 
completeness. Similarly, authors should consider whether there are time varying confounders that 
could influence the trend differently before or after the intervention. Confounders common in other 
study designs, such as socio-economic status or age and gender distribution, tend to change only 
relatively slowly and regularly over time and are therefore often not a concern in ITS studies, 
however, variables that may be associated with the outcome and where changes can be more 
irregular should be adjusted for, examples might include meteorological events or numbers of 
hospital admissions for specific diseases.(38, 39) One particular time varying confounder that often 
needs to be adjusted for is seasonality, an uneven distribution of months before and after the 
intervention can affect the results if the outcome is expressed more at different times of year.(3) 
162 
 
ITS studies require a number of analytical decisions to be made a priori including the range of data to 
be included in the analysis and the type of impact model to be tested.(20) Only 10% of studies fully 
justified the data range included in the study. The purpose of modelling the underlying trend in an 
ITS study is to predict the counterfactual, that is the expected outcome if the intervention had not 
been implemented. It is therefore important that the data range included in the pre-intervention 
period is still relevant to post intervention trends. If the data dates back a long time it may include 
trends that historically differed and thus may bias results. Furthermore, if trends have changed over 
time, there is a concern that the data range can be manipulated to produce different results. 
Authors should therefore clearly justify their chosen study period based on data availability but also, 
for example, on whether there have been historical interventions or events that could have changed 
trends.(20) Even fewer studies reported the reasons for their choice of impact model a priori. The 
type of impact model should be aligned to substantive knowledge of the intervention and outcome 
under study.(20) Inappropriate or data driven model selection increases the risk of false positives 
being detected.(20) For example, an immediate level change effect with an intervention that is 
implemented only gradually or for an outcome which would be expected to follow a lag, suggests 
that effect is due to some factor other than the intervention. 
Two previous studies have reviewed methodological reporting of ITS studies in other fields: Ramsay 
et al reviewed mass media campaigns and guidelines implementation, Jandoc et al reviewed drug 
utilisation studies.(24, 25) Though there are some differences in the aspects of the studies that were 
extracted there is also some overlap with our study. Ramsay et al found in 2003 that no studies gave 
a rationale for the number of data points included and no studies gave a rationale for the shape of 
the intervention effect (the impact model) similar to our low numbers of 10.9% and 2.9% 
respectively in these categories. They also found that only 39.7% of studies assessed whether the 
intervention was independent of other changes (i.e. the threat of history bias), it is encouraging to 
see that in our study this has increased to around two thirds of studies. Jandoc et al did not specify 
the number of studies that considered history bias but found that 35% of studies included a control 
series to mitigate this threat which is similar to our finding. Jandoc et al also found that 66.4% of 
studies considered autocorrelation (essentially the same as our finding of 66.3%), 30.9% of studies 
considered seasonality (compared to 47.1% in our study) and 20.5% included sensitivity analyses 
(compared to 27.9% in our study). In general our results are very similar to those of the two previous 
reviews but point to a slight improvement in reporting. This could be due to slightly better practice 
among public health researchers or to an improvement over time, given that our review focussed 
only on very recent ITS studies. 
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Our review has a number of limitations. This was not an in depth systematic review, only one 
database was searched and we only looked at a single year. The purpose of this review was to gain 
an illustrative overview of current practice rather than to obtain a detailed answer to an empirical 
research question, therefore we feel that our literature review is appropriate. Secondly, our findings 
are based on what authors have reported. It is likely that many more authors considered the 
methodological issues that we looked at but did not explicitly report doing so in their manuscript. 
This links into our proposal that formal reporting criteria are needed. 
The FERITS statement that we have proposed is intended to improve and standardise the reporting 
of methodological aspects of ITS evaluations of public health interventions. Previous quality criteria 
that have been developed for ITS studies have focussed on systematic reviews in relatively narrow 
research topics.(23-25) The most comprehensive of these was developed by Jandoc et al for ITS 
studies in drug utilisation research which is adapted from the STROBE statement.(25) The Jandoc 
recommendations are commendable and share a number of similarities to our recommendations for 
public health research. They encourage researchers to clearly report the statistical models used and 
to consider important adjustments such as autocorrelation and seasonality, as well as design 
adaptations such as including a control series. There are some areas where we believe these 
recommendations are deficient however, for example they do not encourage authors to justify the 
data range included in the time series nor the impact model selected, neither do they require 
authors to identify potential sources of history bias which is the primary limitation of the ITS design. 
We also believe authors need to provide more details on the way the intervention was implemented 
as this is required so that readers can judge whether an appropriate impact model has been applied. 
Furthermore, given that public health ITS studies commonly rely on routine data sources we 
encourage greater reporting of how outcome data was collected and processed and any changes 
over time. 
The results of our literature review highlight the need for improved reporting of ITS studies in public 
health and we hope that the FERITS statement will go some way towards achieving this. We 
reiterate that this should be regarded as a suggested approach and that we welcome input from 
other research groups and publishers in order to develop a collaborative set of recommendations. 
Better reporting of ITS studies in public health will improve the ability of researchers and 
policymakers to evaluate and synthesise evidence and ultimately improve the application of this 
evidence in selecting the most effective interventions to address public health challenges. 
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 Summary of appendices for methodological paper 4 
Appendices for this paper are presented in Chapter 11: 
11.6.1 Data extracted in the literature review 
11.6.2 Eligible studies 
11.6.3 Contribution of the candidate to the paper 
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 Contribution of the paper 
Motivation for the paper 
Like many quasi-experimental study designs, there are no well-established reporting criteria for ITS 
studies. The literature review conducted as part of this paper highlights the problems with current 
reporting of ITS studies. In many cases papers did not report on how they dealt with the primary 
sources of bias that typically affect ITS studies. This suggests that there is a clear need for recognised 
reporting criteria for ITS studies. 
Contribution to the thesis 
This final paper of the thesis brings together the methodological work from the previous chapters, 
along with the wider ITS methodological literature in order to propose a set of formal reporting 
recommendations for ITS studies. It addresses the final objective of the thesis: To develop guidance 
for transparent reporting of interrupted time series studies. The criteria that I have proposed include 
recommendations around detailed description of the intervention and the use of routine data 
necessary for typical ITS studies of complex public health interventions. The recommendations from 
Chapter 6 of the thesis, on analysis of ITS studies, feed into section 10 of the FERITS reporting criteria 
respectively; finally, the recommendations from Chapter 8, on ITS models, 
time-  
Outputs and contribution to the literature 
Quality criteria have previously been developed for ITS studies, however, these come from fields 
outside public health.(1-3) They also do not include a lot of the methodological issues that have been 
highlighted in the literature, including those covered in the earlier chapters of this thesis. The 
literature review included in this paper is the first to demonstrate the broad range of public health 
interventions and outcomes to which ITS is being applied. With the ever increasing use of ITS in public 
health, reporting criteria such as these are vital to ensuring that researchers produce robust 
evaluations that can be easily appraised and allows the inclusion of more information within evidence 
syntheses. 
Conclusion 
Improving the quality of reporting of ITS studies will facilitate the inclusion and appraisal of ITS studies 
in systematic reviews, as well as in evidence summaries and guidelines development used in service 
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public health. Ultimately this will help public health practitioners and policymakers to select the most 
effective interventions. 
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 Summary and conclusions 
The aim of this thesis was to improve the way that interrupted time series studies of public health 
interventions are designed in order to reduce bias and to make the design more accessible to 
researchers and public health professionals. This has included a combination of case-studies and 
methodological papers. My primary focus has been on study design rather than analysis and statistical 
approaches, in particular, because this is a topic that has not previously been covered in detail in the 
literature. This is in contrast to study design of well-established designs such as randomised controlled 
trials, cohort studies and case-control studies.(1-4) 
The overall aim was addressed through five objectives. The first objective was to provide introductory 
guidance on the use of ITS for the evaluation of public health interventions. There was a clear lack of 
guidance on ITS prior to starting this thesis and this objective was therefore key to my overall aim of 
making ITS more accessible to researchers and public health professionals. Chapter 4 provides 
guidance on the design and analysis of ITS studies in an easily accessible step by step approach with 
suggested models, data layouts and code. The second objective was to develop a methodological 
framework for defining the impact model of an intervention. This was addressed in Chapter 5 and 
drew on examples from the case study analyses in Chapters 7 and 8. Here I highlighted that defining 
the impact of an intervention requires a clear specification of the counterfactual and of the impact 
model, both of which need to be specified a priori. This should take into account the specific 
intervention and outcomes under study as well as the context in which they are being studied and the 
data available. The third objective was to develop a methodological framework for the selection of 
controls and analysis of controlled interrupted time series. This was addressed in Chapter 6, in which 
a range of innovative types of controls were identified and categorised, and a structured approach 
was proposed for selecting controls based on their ability to limit the risk of history bias. The two 
primary case studies provide examples of very complex interventions for which it has been recognised, 
for differing reasons, that evaluation is challenging.(5, 6) This illustrates how ITS can be applied in 
settings where evaluation is not amenable to other methods, and still provide a robust analysis of the 
impact of the intervention. Other applications of ITS were utilised to illustrate particular 
methodological problems or solutions, in particular to illustrate different types of controls in Chapter 
6 and issues with reporting in Chapter 9. The final objective was to develop guidance for transparent 
reporting of interrupted time series studies. This was, again, integral to my overall aims of reducing 
the risk of bias and making robust ITS more accessible. Chapter 9 proposes formal reporting criteria 
with a view to making the presentation of ITS studies more transparent and facilitating their appraisal 
in evidence syntheses. 
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In this final chapter, I will discuss some of the broad messages that have emerged from the thesis, put 
these advances into the context of other literature and discuss directions for future research. 
 Key messages 
discuss the main messages related to ITS from each paper. Nevertheless, there are some broader 
recurring themes throughout the thesis, many of which relate to the wider topic of evaluation study 
design. These are discussed below: 
 
1) Start with evaluation in mind 
An important message for public health professionals and policy makers who are responsible for 
introducing health interventions, is to begin with evaluation in mind. There is a clear gap in the 
application of evidence based public health when compared to evidence based medicine in clinical 
practice.(7) If decisions regarding public health interventions are to become more evidence based an 
expansion of robust evaluation of interventions is required. In order to facilitate this, interventions 
should be implemented with evaluation in mind from the start. First, a consideration of how the 
intervention is rolled out with, ideally, a pilot phase where the intervention is rolled out in certain 
groups but not others so that it can be used to conduct a cluster randomised controlled trial. Where 
this is not possible other robust designs can be considered at the implementation stage, including 
stepped wedge trials or multiple baseline ITS studies by introducing the intervention to different 
groups at different times. Second, ensure that the outcomes being targeted are explicit from the start 
and that there are measurable outcomes. A lack of clear primary outcome goals by the government 
was something that made the evaluation of the 2012 Health and Social Care Act in Chapter 5 
particularly challenging.(8) This is often the case in policies for which not achieving the desired 
outcomes can be politically damaging and may require more cross-party collaboration.(5, 9) Finally, 
public health professionals and policy makers should consider the availability of baseline data on the 
outcomes of interest. For pre-post designs such as ITS, baseline data is an essential requirement and 
even for controlled designs, baseline data greatly strengthens the robustness of the analysis.(10) This 
means either ensuring well-validated routine data exists for the outcomes of interest, or capturing 
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new data on the outcomes prior to implementation of the intervention, ideally for a sustained period 
so that pre-existing trends can be incorporated into the analysis. 
2) Plan the evaluation design and analysis a priori 
Regardless of whether the evaluation was considered by those implementing the intervention, a 
continually emerging theme across this thesis is the need for researchers to carefully design the 
evaluation study a priori. This is true of all evaluation study designs but for ITS in particular it includes 
highlighted the dangers of making these decision based on examination of the data or statistical fit. 
Instead, the methodological papers have consistently recommended that researchers make these 
decisions prior to looking at the data and based on an objective consideration of the intervention and 
outcomes under study. Where there is uncertainty over the most appropriate approach, separate 
exploratory analyses should be undertaken or sensitivity analyses may be used. 
 
3) Evaluation design is context dependent 
Related to the need to plan the design and analysis a priori, is an acknowledgement that there is no 
one size fits all approach to evaluation design.(11) While the analytical approach to ITS is relatively 
straightforward, customising the design to complex interventions or events with a potential public 
health impact is complex. In Chapter 7 I highlighted the broad range of possible controls and how 
selecting these depends on the specific sources of potential history bias and the availability of 
appropriate data. Similarly, Chapter 8 highlighted how the most appropriate impact model varies 
depending on the type of intervention, how it was implemented and over what period, and the 
purported causal pathway between intervention and outcome. Expanding this concept to evaluation 
more broadly, it is clear that choice of design is very much context dependent, for example where 
researchers have control over who receives the intervention and when: a randomised controlled trial 
may be best, if the intervention is allocated according to a predefined threshold (such as above or 
below a certain age group): a regression discontinuity design may be most appropriate, and when the 
intervention is implemented at a clear point in time or where there is a lack of traditional control 
groups: an ITS design may be considered. 
 
4) Make use of routine data 
Although the first message highlighted the need for public health professionals and policy makers to 
clearly spell out their targeted outcomes and ensure baseline data is available, the reality is that this 
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is often not done. Fortunately, the availability and quality of routine data has improved dramatically 
over the past decade. Both of the case studies used in this thesis, as well as most of the examples in 
the methodological papers used routine data sources. This highlights the potential for robust 
evaluations of complex interventions and unplanned events using routine data. This is the case for ITS, 
but also for other quasi-experimental designs such as regression discontinuity designs and controlled 
before and after studies. 
 
5) Use the strongest study design available 
It is widely recognised that randomised controlled trials are not always possible, especially when 
evaluating past interventions or unplanned events.(12, 13) However, too often, evaluation of PH 
interventions uses weaker pre-post or cross-sectional designs.(14-16) These are subject to multiple 
inherent biases and perpetuate the idea that robust evaluation of complex PH interventions is not 
feasible. However, more robust quasi-experimental designs such as ITS can often be applied in these 
situations. Both case studies are good examples of the types of interventions that are challenging to 
evaluate and where most other study designs would not be possible, but where it is not necessary to 
resort to weaker designs that provide poorer evidence on the effectiveness of the intervention. 
 
6) Think outside the box to strengthen design validity 
There are many ways in which the validity of quasi-experimental designs such as ITS can be 
strengthened. Introducing controls is discussed in detail in Chapter 6, other approaches such as 
multiple baseline designs and multiple phase designs are discussed in Chapters 4, 6 and 9. ITS is often 
used in situations where traditional location based controls are not possible, and this may be precisely 
the reason that ITS is selected. Nevertheless, a broad range of other innovative and unconventional 
controls, such as control outcomes or control time periods were highlighted. Thinking outside the box 
about such options can enable researchers to control for threats to validity such as history bias or 
instrumentation in situations where this may otherwise not have been possible. 
 
 Advances in the literature 
Over the course of the PhD there have been several advances in the ITS literature that it is important 
to put my findings into the context of. Perhaps most notable, has been the ongoing exponential 
increase in the use of ITS for evaluating public health interventions, as illustrated in Figure 1 of Chapter 
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9. This further justifies the need for methodological work to ensure that the strengths and limitations 
of ITS are well recognised and to ensure that ITS studies are designed robustly to minimise the risk of 
bias. Furthermore, the fact that more ITS evaluations are being published means that systematic 
reviewers will need to become familiar with how to appraise ITS studies in evidence syntheses. This 
emphasises the importance of reporting guidelines such as those proposed in Chapter 9.  
Another important development has been the publication of studies testing the validity of the ITS 
design. I had originally considered empirically assessing the validity of ITS through a formal within 
study comparison against a RCT benchmark as one of the objectives of this thesis. When this was first 
proposed, only one previous comparison of ITS with RCT existed and there were limitations to the 
benchmark RCT used.(17) Nevertheless, since then, a number of within study comparisons have been 
published, including one (Fretheim et al 2015) that compared ITS to RCT using data from 8 different 
cluster-RCTs.(18-22) While it is important to consider the possibility of publication bias, these studies 
have repeatedly found that ITS is able to produce findings that are consistent with those of the RCT in 
a broad range of settings. These findings underpin the importance of making ITS accessible to 
researchers and public health professionals through introductory methodological articles (such as 
Chapter 4 of this thesis) and guidance (such as Chapter 9 of this thesis). 
Significantly, given the emerging evidence on the strength of the validity of ITS, there have also been 
efforts to make robust evaluative design more accessible to public health professionals, policy makers 
and the public. In a pair of papers published through the US Centers for Disease Control and 
Prevention, Soumerai et al 2015 and Naci et al 2016 present the strengths and limitations of various 
evaluative study designs in an easily accessible format.(23, 24) They present a hierarchy of design in 
They also provide an in depth discussion on the issue of history bias which complements the more in 
depth paper on how to address this in Chapter 6. Similarly, Kontopantelis et al 2015, present a 
methods paper introducing ITS in which they argue that ITS is the next best approach for evaluation 
of interventions when randomisation is not possible. This paper discusses the advantages and 
disadvantages of different ITS models with examples.(25) Again, this paper complements some of the 
work of this thesis in which first the practicalities of design and analysis of ITS are presented in a 
stepwise fashion (Chapter 4) and, second, a methodological framework for selecting the most 
appropriate model is proposed (Chapter 5). 
Finally, as discussed in Chapter 9, Jandoc et al 2015, published a review of ITS studies in drug utilisation 
research along with proposed reporting recommendations for ITS studies in this field.(26) The fact 
that reporting guidelines have simultaneously been developed both in pharmacological research and 
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in public health underscores the increasing use of ITS and need for better reporting of the design in 
order to facilitate appraisal. My reporting guidelines differed in that they were based on the 
Transparent Reporting of Evaluations with Nonrandomised Designs (TREND) statement rather than 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. 
Furthermore, there is a greater emphasis on potential issues with routine data and the methodological 
work on controls and model selection from Chapters 5 and 6. 
 
 Directions for future research 
The field of ITS methodology has advanced substantially in recent years; nevertheless, there remain 
areas for further development. First, although I have presented an in depth analysis on the use of 
controls, there is limited discussion on other approaches to address history bias, such as multiple 
baseline designs, whereby the intervention is introduced to different groups at different times, and 
multiple phase designs, whereby the intervention is introduced and then removed.(27, 28) Further 
work on where these may be best applied and how they should be designed is needed. Secondly, 
another, area for development is the use of ITS studies that allow for differing trends in different 
subgroups. I discussed in Chapter 8 how this may explain non-linear trends and lead to better 
definition of the baseline trend and therefore improve the modelling of the counterfactual. Thirdly, in 
chapter 10 I discussed the need for consensus guidelines on the reporting of ITS studies. Those that I 
have proposed aim to form a basis for wider agreement on a definitive statement for ITS studies. 
Further work is also needed on sample size calculation for ITS studies and dealing with short data 
series or small expected effect sizes. In chapter 4, I highlighted that ITS studies can be underpowered 
under such circumstances. Only one paper that I am aware of has tried to address the issue of power 
calculation for ITS studies.(4) This was based on running simulations in order to estimate the number 
of time points that provide sufficient power and the distribution of these time points. Nevertheless, 
they do not address the sample size required at each time point. Because the power of an ITS study 
depends on such a broad range of factors it may be difficult to develop a conclusive formula for 
estimating the required sample size. Where researchers predict that effect sizes are likely to be small 
other approaches may be adopted such as using surrogate or intermediate outcomes. Intermediate 
or surrogate outcomes are outcomes that lie along the causal pathway. Examples include antibody 
levels as a surrogate for risk of disease following a vaccination intervention, smoking as an 
intermediate outcome for the effect of a smoking cessation campaign on lung cancer. Larger effects 
may be expected with intermediate outcomes, in particular if the final endpoint is rare or follows a 
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long lag.(5) Nevertheless, there can be problems with using intermediate outcomes in ITS studies, for 
example, data on intermediate outcomes is generally less likely to be available routinely: routine data 
on antibody levels is unlikely to be available in most settings, in particular if repeated measures are 
required as for ITS, routine data on smoking is also less easily and regularly available compared to data 
on rates of disease (such as hospital admissions or mortality). Furthermore, surrogates are not always 
good predictors of the final outcome, therefore care needs to be taken in selecting appropriate 
surrogates and interpreting the results.(6)In addition to the recommendations for ITS, other powerful 
quasi-experimental designs would benefit from more in depth methodological work and guidance. In 
particular, regression discontinuity designs (RDD) have wide applicability in public health in situations 
where thresholds exist, for example age thresholds for vaccination programmes and morbidity 
thresholds in screening programmes. Introductory methodological papers that present RDD to 
researchers and policy makers in an accessible manner may result in wider adoption of this method. 
Furthermore, reporting recommendations on RDD would facilitate their inclusion in systematic 
reviews and other evidence syntheses. 
 
 Conclusions 
Through this thesis I have undertaken an in depth and critical analysis of the ITS design. Within study 
comparisons have clearly demonstrated that ITS, in particular when used in combination with a control 
series, are powerful designs.(18-22) I would therefore like to encourage researchers and especially 
public health practitioners to implement ITS as a robust method of evaluation of interventions and to 
urge a move away from weak before-after or cross-sectional evaluations. Nevertheless, evaluators 
need to be aware of the limitations of ITS in order to ensure that evaluations are as robust as possible. 
The papers presented in this thesis go some way towards increasing understanding of these limitations 
and how to address them, as well as disseminating this knowledge in an accessible way.  
By improving understanding of the ITS design, I am hopeful that there will be an increase in evaluations 
of complex interventions that might otherwise be considered unevaluable. This is important in order 
to address the existing evaluative bias which means that there is a lack of evidence on more complex 
interventions. In addition to increasing the use of ITS, it is equally important that such studies are 
considered and adequately appraised in systematic reviews, guidelines development or directly in the 
generation of policies and public health interventions. 
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The work undertaken through this thesis benefits at least five groups of people: 1. Those who evaluate 
the effectiveness of public health interventions. Greater awareness of the ITS design should lead to 
more robust evaluations, in particular in situations where RCTs are not possible. Beneficiaries in this 
group include academics, health think tanks such as the King's Fund and the Nuffield trust and, given 
that evaluation is a core aspect of developing interventions, public health practitioners and 
policymakers introducing new interventions. 2. Those who review evidence on the effectiveness of 
interventions and make recommendations on which interventions to implement. The guidance 
developed on ITS methodology and reporting will help those who review evidence to appraise 
whether evaluations have been conducted appropriately and the level of evidence they provide 
regarding the effectiveness of an intervention. This will benefit systematic reviewers, such as the 
Cochrane Collaboration, and those who produce guidelines on public health interventions, such as the 
National Institute of Health and Clinical Excellence. 3. Those who implement public health 
interventions. Public health practitioners are frequently frustrated by a lack of evidence on which 
interventions are effective to address a given health problem. Improved evaluations of public health 
interventions will enable public health practitioners, policymakers, health service managers and 
others who implement population level health interventions to make better informed decisions about 
which health policies and programmes to employ. 4. Those who pay for interventions. Improved 
evaluation of interventions will also help to identify those interventions which are ineffective and thus 
help to limit inappropriate resource allocation. More efficient use of resources could benefit 
taxpayers, private organisations or third sector organisations that fund public health interventions. 5. 
Those who stand to benefit from public health interventions. Ultimately, the most important 
beneficiaries are the patients and members of the public. Better informed decisions will result in the 
implementation of more effective health interventions which lead to the greatest improvements in 
population health.  
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 Supplementary appendix 1: Example dataset* 
year month aces time smokban pop stdpop 
2002 1 728 1 0 364277.4 379875.3 
2002 2 659 2 0 364277.4 376495.5 
2002 3 791 3 0 364277.4 377040.8 
2002 4 734 4 0 364277.4 377116.4 
2002 5 757 5 0 364277.4 377383.4 
2002 6 726 6 0 364277.4 374113.1 
2002 7 760 7 0 364277.4 379513.3 
2002 8 740 8 0 364277.4 376295.5 
2002 9 720 9 0 364277.4 374653.2 
2002 10 814 10 0 364277.4 378485.6 
2002 11 795 11 0 364277.4 375955.5 
2002 12 858 12 0 364277.4 378349.7 
2003 1 887 13 0 363350.8 376762.4 
2003 2 766 14 0 363350.8 379032.3 
2003 3 851 15 0 363350.8 379360.4 
2003 4 769 16 0 363350.8 376162 
2003 5 781 17 0 363350.8 377972.4 
2003 6 756 18 0 363350.8 381830.7 
2003 7 766 19 0 363350.8 379888.6 
2003 8 752 20 0 363350.8 380872.2 
2003 9 765 21 0 363350.8 380966.9 
2003 10 831 22 0 363350.8 381240.4 
2003 11 879 23 0 363350.8 382104.9 
2003 12 928 24 0 363350.8 381802.7 
2004 1 914 25 0 364700.4 381656.3 
2004 2 808 26 0 364700.4 383680 
2004 3 937 27 0 364700.4 383504.2 
2004 4 840 28 0 364700.4 386462.9 
2004 5 916 29 0 364700.4 383783.1 
2004 6 828 30 0 364700.4 380836.8 
2004 7 845 31 0 364700.4 383483 
2004 8 818 32 0 364700.4 380906.2 
2004 9 860 33 0 364700.4 382926.8 
2004 10 839 34 0 364700.4 384052.4 
2004 11 887 35 0 364700.4 384449.6 
2004 12 886 36 0 364700.4 383428.4 
2005 1 831 37 1 364420.8 388153.2 
2005 2 796 38 1 364420.8 388373.2 
2005 3 833 39 1 364420.8 386470.1 
2005 4 820 40 1 364420.8 386033.2 
2005 5 877 41 1 364420.8 383686.4 
2005 6 758 42 1 364420.8 385509.3 
2005 7 767 43 1 364420.8 385901.9 
2005 8 738 44 1 364420.8 386516.6 
2005 9 781 45 1 364420.8 388436.5 
2005 10 843 46 1 364420.8 383255.2 
2005 11 850 47 1 364420.8 390148.7 
2005 12 908 48 1 364420.8 385874.9 
2006 1 1021 49 1 363832.6 391613.6 
2006 2 859 50 1 363832.6 391750.4 
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*Barone-Adesi F, Gasparrini A, Vizzini L, Merletti F, Richiardi L. Effects of Italian smoking regulation on 
rates of hospital admission for acute coronary events: a country-wide study. PLoS One 2011;6:e17419. 
  
2006 3 976 51 1 363832.6 394005.6 
2006 4 888 52 1 363832.6 391364.9 
2006 5 962 53 1 363832.6 391664.6 
2006 6 838 54 1 363832.6 389022.3 
2006 7 810 55 1 363832.6 391878.5 
2006 8 876 56 1 363832.6 388575.3 
2006 9 843 57 1 363832.6 392989 
2006 10 936 58 1 363832.6 390018.8 
2006 11 912 59 1 363832.6 390712.3 
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 Supplementary appendix 2: interrupted time series tutorial Stata code 
 
************************************************************************** 
* This file provides the Stata code used for the analysis of the example dataset  
* used in the paper: 
* Interrupted time series regression for the evaluation of public health  
* interventions: a tutorial 
* IJE 2016 
* J. Lopez Bernal, S. Cummins, A. Gasparrini 
************************************************************************** 
 
clear 
set more off 
capture log close 
 
 
**************** 
 
insheet using "sicily.csv", comma 
*or: import delimited "sicily.csv" 
 
/* This dataset includes the following variables  
year 
month 
time = elapsed time since the start of the study 
aces = count of acute coronary episodes in Sicily per month (the outcome) 
smokban = smoking ban (the intervention) coded 0 before the intervention and 1 after 
pop = the population of Sicily (in 10000s) 
stdpop =  age standardised population 
*/ 
 
 
************************************************ 
*Step 3: Descriptive analyses 
************************************************ 
/* Examining the data is an important first step. Looking at the pre-intervention trend can give an  
indication of how stable the trend is over time, whether a linear model is likely to be approproate 
and whether there appears to be a seasonal trend */ 
 
 
*Here we convert the counts into a rate and examine a scatter plot of the pre-intervention data 
gen rate = aces/stdpop*10^5 
twoway (scatter rate time) if smokban==0, title("Sicily, 2002-2006") ytitle(Std rate x 10000) 
yscale(range(0 .)) ylabel(#5, labsize(small) angle(horizontal)) /// 
xtick(0.5(12)60.5) xlabel(6"2002" 18"2003" 30"2004" 42"2005" 54"2006", noticks labsize(small)) 
xtitle(year) 
 
 
*It is also useful to produce summary statistics for before and after the intervention 
summ, detail 
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bysort smokban: summ aces 
bysort smokban: summ rate 
 
 
 
************************************************ 
*Step 4: Poisson regression model 
************************************************ 
/* In step 2 (main paper) we chose a step change model and we also use a Poisson model as we are 
using count data 
In order to do this we model the count data directly (rather than the rate which doesn't follow a 
Poisson distribution) 
We then use the population (log transformed) as an offset variable in order to transform back to rates 
*/ 
 
 
*log transform the standardised population: 
gen logstdpop = log(stdpop) 
 
 
*Poisson with the outcome (aces), intervention (smokban) and time as well as the population offset 
offset 
glm aces smokban time, family(poisson) link(log) offset(logstdpop) eform 
 
 
*We generate predicted values based on the model in order to create a plot of the model: 
predict pred, nooffset 
 
*This can then be plotted along with a scatter graph:
gen rate1 = aces/stdpop /*to put rate in same scale as count in model */ 
twoway (scatter rate1 time) (line pred time, lcolor(red)) , title("Sicily, 2002-2006") /// 
ytitle(Std rate x 10000) yscale(range(0 .)) ylabel(#5, labsize(small) angle(horizontal)) /// 
xtick(0.5(12)60.5) xlabel(6"2002" 18"2003" 30"2004" 42"2005" 54"2006", noticks labsize(small)) 
xtitle(year) /// 
xline(36.5) 
 
 
*Generate the counterfactual by removing the effect of the intervention (_b[smokban]) for the post-
intervention period 
gen pred1 = pred/exp(_b[smokban]) if smokban==1 
 
 
*Add the counterfactual to the plot 
twoway (scatter rate1 time) (line pred time, lcolor(red)) (line pred1 time, lcolor(red) lpattern(dash)), 
title("Sicily, 2002-2006") /// 
ytitle(Std rate x 10000) yscale(range(0 .)) ylabel(#5, labsize(small) angle(horizontal)) /// 
xtick(0.5(12)60.5) xlabel(6"2002" 18"2003" 30"2004" 42"2005" 54"2006", noticks labsize(small)) 
xtitle(year) /// 
xline(36.5) 
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************************************************ 
*Step 5: methodological issues 
************************************************ 
* (a) Allowing for overdispersion 
/*In the model above we have not allowed for overdispersion - in order to do this we can add 
the scale(x2) parameter to the model which allows the variance to be proportional rather than  
equal to the mean */ 
glm aces smokban time, family(poisson) link(log) offset(logstdpop) scale(x2) eform 
 
* (b) Model checking and autocorrelation 
*Check the residuals by plotting against time 
predict res, r 
twoway (scatter res time)(lowess res time),yline(0) 
 
*Further check for autocorrelation by examining the autocorrelation and partial autocorrelation 
functions 
tsset time 
ac res 
pac res, yw 
 
* (c) Adjust for seasonality 
/* installation of the "circular" package. o find packages select Help > SJ and User-written Programs,  
and click on search */ 
 
*we need to create a degrees variable for time divided by the number of time points in a year (i.e. 12 
for months) 
gen degrees=(time/12)*360 
 
*we then select the number of sine/cosine pairs to include: 
fourier degrees, n(2) 
 
*these can then be included in the model 
glm aces smokban cos* sin* time, family(poisson) link(log) offset(logstdpop) scale(x2) eform 
 
*we can again check for autocorrelation 
predict res2, r 
twoway (scatter res2 time)(lowess res2 time),yline(0) 
tsset time 
ac res2 
pac res2, yw 
 
 
*predict and plot of seasonally adjusted model** 
predict pred2, nooffset 
twoway (scatter rate1 time) (line pred2 time, lcolor(red)), title("Sicily, 2002-2006") /// 
ytitle(Std rate x 10000) yscale(range(0 .)) ylabel(#5, labsize(small) angle(horizontal)) /// 
xtick(0.5(12)60.5) xlabel(6"2002" 18"2003" 30"2004" 42"2005" 54"2006", noticks labsize(small)) 
xtitle(year) /// 
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xline(36.5) 
 
 
/*it is sometimes difficult to clearly see the change graphically in the seasonally adjusted model 
therefore it can be useful to plot a straight line as if all months were the average to produce a 
'deseasonalised' trend. */ 
 
egen avg_cos_1 = mean(cos_1) 
egen avg_sin_1 = mean(sin_1) 
egen avg_cos_2 = mean(cos_2) 
egen avg_sin_2 = mean(sin_2) 
 
drop cos* sin* 
 
rename avg_cos_1 cos_1 
rename avg_sin_1 sin_1 
rename avg_cos_2 cos_2 
rename avg_sin_2 sin_2 
 
 
*this can then be added to the plot as a dashed line  
predict pred3, nooffset 
 
twoway (scatter rate1 time) (line pred2 time, lcolor(red)) (line pred3 time, lcolor(red) lpattern(dash)), 
title("Sicily, 2002-2006") /// 
ytitle(Std rate x 10000) yscale(range(0 .)) ylabel(#5, labsize(small) angle(horizontal)) /// 
xtick(0.5(12)60.5) xlabel(6"2002" 18"2003" 30"2004" 42"2005" 54"2006", noticks labsize(small)) 
xtitle(year) /// 
xline(36.5) 
 
 
 
 
********************************************************** 
** additional material 
********************************************************** 
***add a change in slope 
 
*generate interaction term between intervention and time centered at the time of intervention 
gen inter_smokbantime = smokban*(time-36) 
 
 
*restore fourier variables that were previously changed 
drop cos* sin* degrees 
gen degrees=(time/12)*360 
fourier degrees, n(2) 
 
*add the interaction term to the model 
glm aces smokban inter_smokbantime cos* sin* time, family(poisson) link(log) offset(logstdpop) 
scale(x2) eform 
*(the coefficient and CI for the interaction term suggests that there is very little slope change) 
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*plot seasonally adjusted model with deseasonalised trend** 
predict pred4, nooffset 
 
egen avg_cos_1 = mean(cos_1) 
egen avg_sin_1 = mean(sin_1) 
egen avg_cos_2 = mean(cos_2) 
egen avg_sin_2 = mean(sin_2) 
drop cos* sin* 
rename avg_cos_1 cos_1 
rename avg_sin_1 sin_1 
rename avg_cos_2 cos_2 
rename avg_sin_2 sin_2 
 
predict pred5, nooffset 
 
twoway (scatter rate1 time) (line pred4 time, lcolor(red)) (line pred5 time, lcolor(red) lpattern(dash)), 
title("Sicily, 2002-2006") /// 
ytitle(Std rate x 10000) yscale(range(0 .)) ylabel(#5, labsize(small) angle(horizontal)) /// 
xtick(0.5(12)60.5) xlabel(6"2002" 18"2003" 30"2004" 42"2005" 54"2006", noticks labsize(small)) 
xtitle(year) /// 
xline(36.5) 
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 Supplementary appendix 2: interrupted time series tutorial R code 
################################################################################ 
# This file provides the R code used for the analysis of example dataset used  
# used in the paper: 
#   Interrupted time series regression for the evaluation of public health  
#     interventions: a tutorial 
#   IJE 2016 
#   J. Lopez Bernal, S. Cummins, A. Gasparrini 
################################################################################ 
 
 
# Install packages required for the analysis (uncomment if needed) 
#install.packages("lmtest") ; install.packages("Epi") 
#install.packages("tsModel"); install.packages("vcd") 
 
# load the packages 
library(foreign) ; library(tsModel) ; library("lmtest") ; library("Epi") 
library("splines") ; library("vcd") 
 
# read data from csv file 
data <- read.csv("sicily.csv") 
head(data) 
View(data) 
 
# This dataset includes the following variables: 
# year 
# month 
# time = elapsed time since the start of the study 
# aces = count of acute coronary episodes in Sicily per month (the outcome) 
# smokban = smoking ban (the intervention) coded 0 before intervention, 1 after 
# pop = the population of Sicily (in 10000s) 
# stdpop =  age standardised population 
 
 
################################################################################ 
#Step 3: Descriptive analyses 
####################################### 
# Examining the data is an important first step 
# Looking at the pre-intervention trend can give an indication of how stable the 
#   trend is over time, whether a linear model is likely to be appropriate, and 
#   whether there appears to be a seasonal trend 
 
## Scatter plot 
 
# compute the standardized rates 
data$rate <- with(data, aces/stdpop*10^5) 
# start the plot, excluding the points and the x-axis 
plot(data$rate,type="n",ylim=c(00,300),xlab="Year", ylab="Std rate x 10,000", 
  bty="l",xaxt="n") 
# shade the post intervention period grey 
rect(36,0,60,300,col=grey(0.9),border=F) 
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# plot the observed rate for pre-intervention period 
points(data$rate[data$smokban==0],cex=0.7) 
#specify the x-axis (i.e. time units) 
axis(1,at=0:5*12,labels=F) 
axis(1,at=0:4*12+6,tick=F,labels=2002:2006) 
# add a title 
title("Sicily, 2002-2006") 
 
# It is also useful to produce summary statistics 
summary(data) 
 
#tabulate aces before and after the smoking ban 
summary(data$aces[data$smokban==0]) 
summary(data$aces[data$smokban==1]) 
 
summary(data$rate[data$smokban==0]) 
summary(data$rate[data$smokban==1]) 
 
 
################################################################################ 
#Step 4: Poisson regression model 
####################################### 
# In step 2 (main paper) we chose a step change model and we also used a Poisson 
#   model as we are using count data 
# In order to do this we model the count data directly (rather than the rate 
#   which doesn't follow a Poisson distribution), using the population (log 
#   transformed) as an offset variable in order to transform back to rates 
 
#Poisson with the standardised population as an offset 
model1 <- glm(aces ~ offset(log(stdpop)) + smokban + time, family=poisson, data) 
summary(model1) 
summary(model1)$dispersion 
round(ci.lin(model1,Exp=T),3) 
 
# create a new dataframe with 0.1 time units to improve the graph 
datanew <- data.frame(stdpop=mean(data$stdpop),smokban=rep(c(0,1),c(360,240)), 
  time= 1:600/10,month=rep(1:120/10,5)) 
 
# We generate predicted values based on the model in order to create a plot 
pred1 <- predict(model1,type="response",datanew)/mean(data$stdpop)*10^5 
 
#This can then be plotted along with a scatter graph (see above) 
plot(data$rate,type="n",ylim=c(0,300),xlab="Year",ylab="Std rate x 10,000", 
  bty="l",xaxt="n") 
rect(36,0,60,300,col=grey(0.9),border=F) 
points(data$rate,cex=0.7) 
axis(1,at=0:5*12,labels=F) 
axis(1,at=0:4*12+6,tick=F,labels=2002:2006) 
lines((1:600/10),pred1,col=2) 
title("Sicily, 2002-2006") 
 
191 
 
# to plot the counterfactual scenario we create a data frame as if smokban 
#   (the intervention) was never being implemented 
datanew <- data.frame(stdpop=mean(data$stdpop),smokban=0,time=1:600/10, 
  month=rep(1:120/10,5)) 
 
# generate predictions under the counterfactual scenario and add it to the plot 
pred1b <- predict(model1,datanew,type="response")/mean(data$stdpop)*10^5 
lines(datanew$time,pred1b,col=2,lty=2) 
 
# return the data frame to the scenario including the intervention 
datanew <- data.frame(stdpop=mean(data$stdpop),smokban=rep(c(0,1),c(360,240)), 
  time= 1:600/10,month=rep(1:120/10,5)) 
 
 
################################################################################ 
#Step 5: methodological issues 
################################################################## 
 
#a) Overdispersion: Quasi-Poisson model  
# In the model above we have not allowed for overdispersion - in order to do 
#   this we can use a quasipoisson model, which allows the variance to be 
#   proportional rather than equal to the mean 
 
model2 <- glm(aces ~ offset(log(stdpop)) + smokban + time, family=quasipoisson, 
  data) 
summary(model2) 
summary(model2)$dispersion 
round(ci.lin(model2,Exp=T),3) 
 
#b) Model checking and autocorrelation 
 
# Check the residuals by plotting against time 
res2 <- residuals(model2,type="deviance") 
plot(data$time,res2,ylim=c(-5,10),pch=19,cex=0.7,col=grey(0.6), 
  main="Residuals over time",ylab="Deviance residuals",xlab="Date") 
abline(h=0,lty=2,lwd=2) 
 
# Further check for autocorrelation by examining the autocorrelation and 
#   partial autocorrelation functions 
acf(res2) 
pacf(res2) 
 
#c) adjusting for seasonality 
# There are various ways of adjusting for seasonality - here we use harmonic 
#   terms specifying the number of sin and cosine pairs to include (in this 
#   case 2) and the length of the period (12 months) 
model3 <- glm(aces ~ offset(log(stdpop)) + smokban + time +  
  harmonic(month,2,12), family=quasipoisson, data) 
summary(model3) 
summary(model3)$dispersion 
round(ci.lin(model3,Exp=T),3) 
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# EFFECTS 
ci.lin(model3,Exp=T)["smokban",5:7] 
 
# TREND 
exp(coef(model3)["time"]*12) 
 
# We again check the model and autocorrelation functions 
res3 <- residuals(model3,type="deviance") 
plot(res3,ylim=c(-5,10),pch=19,cex=0.7,col=grey(0.6),main="Residuals over time", 
  ylab="Deviance residuals",xlab="Date") 
abline(h=0,lty=2,lwd=2) 
acf(res3) 
pacf(res3) 
 
# predict and plot of the seasonally adjusted model 
pred3 <- predict(model3,type="response",datanew)/mean(data$stdpop)*10^5 
plot(data$rate,type="n",ylim=c(120,300),xlab="Year",ylab="Std rate x 10,000", 
  bty="l",xaxt="n") 
rect(36,120,60,300,col=grey(0.9),border=F) 
points(data$rate,cex=0.7) 
axis(1,at=0:5*12,labels=F) 
axis(1,at=0:4*12+6,tick=F,labels=2002:2006) 
lines(1:600/10,pred3,col=2) 
title("Sicily, 2002-2006") 
 
# it is sometimes difficult to clearly see the change graphically in the 
#   seasonally adjusted model, therefore it can be useful to plot a straight 
#   line representing a 'deseasonalised' trend 
# this can be done by predicting all the observations for the same month, in 
#   this case we use June 
pred3b <- predict(model3,type="response",transform(datanew,month=6))/ 
  mean(data$stdpop)*10^5 
 
#this can then be added to the plot as a dashed line 
lines(1:600/10,pred3b,col=2,lty=2) 
 
 
################################################################################ 
# additional material 
################################################################## 
 
# add a change-in-slope 
# we parameterize it as an interaction between time and the ban indicator 
model4 <- glm(aces ~ offset(log(stdpop)) + smokban*time + harmonic(month,2,12), 
  family=quasipoisson, data) 
summary(model4) 
round(ci.lin(model4,Exp=T),3) 
 
# predict and plot the 'deseasonalised' trend 
# compare it with the step-change only model 
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pred4b <- predict(model4,type="response",transform(datanew,month=6))/ 
  mean(data$stdpop)*10^5 
plot(data$rate,type="n",ylim=c(120,300),xlab="Year",ylab="Std rate x 10,000", 
  bty="l",xaxt="n") 
rect(36,120,60,300,col=grey(0.9),border=F) 
points(data$rate,cex=0.7) 
axis(1,at=0:5*12,labels=F) 
axis(1,at=0:4*12+6,tick=F,labels=2002:2006) 
lines(1:600/10,pred3b,col=2) 
lines(1:600/10,pred4b,col=4) 
title("Sicily, 2002-2006") 
legend("topleft",c("Step-change only","Step-change + change-in-slope"),lty=1, 
  col=c(2,4),inset=0.05,bty="n",cex=0.7) 
 
# test if the change-in-slope improve the fit 
# the selected test here is an F-test, which accounts for the overdispersion, 
#   while in other cases a likelihood ratio or wald test can be applied 
anova(model3,model4,test="F") 
# not surprisingly, the p-value is similar to that of the interaction term 
 
#  
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 Supplementary appendix 4: Further model specifications 
 
Slope change following a lag (figure 2 (d)): 
Here, the start of the intervention can be coded as 1 following the lag (rather than immediately after 
the intervention). For example, in Table 5.1, if we assume a 6 month lag and the intervention was 
introduced in January 2005, we code the intervention as 1 from July 2005. We then use the usual slope 
change regression model: with representing the slope change. 
 
Table 5.1: variable specification for slope change following a lag 
Year Month Time elapsed 
Smoking 
ban 
lagged 
ACEs Std popn 
  (  (    
2004 1 25 0 914 381656.3 
2004 2 26 0 808 383680 
2004 3 27 0 937 383504.2 
2004 4 28 0 840 386462.9 
2004 5 29 0 916 383783.1 
2004 6 30 0 828 380836.8 
2004 7 31 0 845 383483 
2004 8 32 0 818 380906.2 
2004 9 33 0 860 382926.8 
2004 10 34 0 839 384052.4 
2004 11 35 0 887 384449.6 
2004 12 36 0 886 383428.4 
2005 1 37 0 831 388153.2 
2005 2 38 0 796 388373.2 
2005 3 39 0 833 386470.1 
2005 4 40 0 820 386033.2 
2005 5 41 0 877 383686.4 
2005 6 42 0 758 385509.3 
2005 7 43 1 767 385901.9 
2005 8 44 1 738 386516.6 
2005 9 45 1 781 388436.5 
2005 10 46 1 843 383255.2 
2005 11 47 1 850 390148.7 
2005 12 48 1 908 385874.9 
 
 
Temporary level change (figure 2 (e)): 
This model may be used where a reversible intervention is introduced temporarily. For example, if the 
intervention were introduced for six months, then withdrawn, the variables may be specified as per 
Table 5.2. A level change regression model could then be run as follows: 
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 where represents the level change at introduction and represents the remaining level 
change at withdrawal. Under the assumption that the latter is null, and that the level comes back to 
the underlying trend, can be excluded. 
Table 5.2: variable specification for a temporary level change or temporary slope change 
Year Month Time elapsed 
Smoking 
ban 
introduced 
Smoking 
ban 
withdrawn 
ACEs Std popn 
  (  (  (W)   
2004 1 25 0 0 914 381656.3 
2004 2 26 0 0 808 383680 
2004 3 27 0 0 937 383504.2 
2004 4 28 0 0 840 386462.9 
2004 5 29 0 0 916 383783.1 
2004 6 30 0 0 828 380836.8 
2004 7 31 0 0 845 383483 
2004 8 32 0 0 818 380906.2 
2004 9 33 0 0 860 382926.8 
2004 10 34 0 0 839 384052.4 
2004 11 35 0 0 887 384449.6 
2004 12 36 0 0 886 383428.4 
2005 1 37 1 0 831 388153.2 
2005 2 38 1 0 796 388373.2 
2005 3 39 1 0 833 386470.1 
2005 4 40 1 0 820 386033.2 
2005 5 41 1 0 877 383686.4 
2005 6 42 1 0 758 385509.3 
2005 7 43 0 1 767 385901.9 
2005 8 44 0 1 738 386516.6 
2005 9 45 0 1 781 388436.5 
2005 10 46 0 1 843 383255.2 
2005 11 47 0 1 850 390148.7 
2005 12 48 0 1 908 385874.9 
 
Temporary slope change leading to a level change (Figure 2(f)): 
This model could be used to represent a phase during which an intervention was gradually introduced 
in which case we may be interested in the slope change as the intervention was phased in, as well as 
the absolute level change following its introduction. The variable specification in Table 1 (main text) 
can be used with the following regression model: . For this model if we 
assume the temporary slope change over 5 months we can use the variable specification in table 5.3, 
where represents the full change and is modified accordingly to represent partial changes along 
time. 
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Table 5.3: variable specification for a temporary level change or temporary slope change 
Year Month Time elapsed Intervention ACEs Std popn 
  (  (    
2004 1 25 0 914 381656.3 
2004 2 26 0 808 383680 
2004 3 27 0 937 383504.2 
2004 4 28 0 840 386462.9 
2004 5 29 0 916 383783.1 
2004 6 30 0 828 380836.8 
2004 7 31 0 845 383483 
2004 8 32 0 818 380906.2 
2004 9 33 0 860 382926.8 
2004 10 34 0 839 384052.4 
2004 11 35 0 887 384449.6 
2004 12 36 0 886 383428.4 
2005 1 37 0.2 831 388153.2 
2005 2 38 0.4 796 388373.2 
2005 3 39 0.6 833 386470.1 
2005 4 40 0.8 820 386033.2 
2005 5 41 1 877 383686.4 
2005 6 42 1 758 385509.3 
2005 7 43 1 767 385901.9 
2005 8 44 1 738 386516.6 
2005 9 45 1 781 388436.5 
2005 10 46 1 843 383255.2 
2005 11 47 1 850 390148.7 
2005 12 48 1 908 385874.9 
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 Contribution of the candidate to the paper 
 I identified the need for an introduction to segmented regression analysis as a gap in the 
literature. 
 I decided on the structure of the paper as a tutorial with worked example and appropriate 
control. 
 The bulk of the work in this contribution consisted of identifying, cleaning and analysing the 
dataset, including: 
o Identifying a dataset and intervention and within this selecting a suitable 
subpopulation that could be used to illustrate a basic ITS analysis. 
o Identifying a dataset with a seasonal pattern so that I could demonstrate 
approaches to adjusting for seasonality 
o Ensuring that analysis could be undertaken with the dataset that did not deviate too 
far from a basic ITS model as this was intended as an introductory paper. 
 I cleaned the data and reshaped into time series format in order that readers could 
understand the appropriate data layout. 
 I then selected a range of different impact models and presented data layouts and 
regression models for each of these (appendix 11.1.4). 
 Finally, I wrote and appropriately annotated code for the analysis in both R and Stata to 
clearly describe how to undertake each of the steps involved in ITS analysis in an appropriate 
statistical package. 
 I sought feedback from my co-authors throughout this process and presented various drafts 
for comment and revised accordingly. I also checked the R code with AG and adapted this as 
necessary. 
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 Methodological paper 2 appendices 
11.2.1 Contribution of the candidate to the paper 
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 Contribution of the candidate to the paper 
 I initiated the idea for this paper after recognising the range of decisions I was making in 
deciding on the most suitable way to model both the counterfactual and the impact model 
in each of my case studies. 
 This is not an area that had been covered in the existing literature, but it is clearly key to the 
appropriate design and analysis of interrupted time series studies. 
 For this study I went through the various outcomes and sub-populations that I used within 
my case studies to identify examples that would demonstrate different impacts depending 
on how the models were defined. 
 One of the decisions I had made in the second case study was to restrict the specialists visits 
data due to data quality issues. I decided to examine how the counterfactual might have 
been modelled if we had not taken the data quality issues into account and also trialled 
various linear and non-linear models to demonstrate that these can produce different 
results and that such modelling decisions should be made a priori. 
 I also wanted to demonstrate how inappropriate impact models could show effects 
irrespective of the intervention. For this I selected one of my control populations which I 
knew had not received the intervention and analysed the data using various different 
models. Here it was clear that the best fitting model showed an effect but we knew that this 
could not be due to the intervention (as it was non-existent). This nicely demonstrated the 
need to select the impact model according to a clear a priori understanding of the 
intervention and outcome under study, rather than post-hoc model fit. 
 I undertook each of these analyses myself and wrote the paper and produced the 
frameworks that I propose. 
 Again, I sought feedback from my co-authors throughout this process and they made 
suggestions regarding additional modelling aspects to consider and the paper went through 
various revisions. 
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 Methodological paper 3 appendices 
11.3.1 Web appendix 1: Segmented regression interaction model for a controlled interrupted time 
series 
11.3.2 Contribution of the candidate to the paper 
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 Web appendix 1: Segmented regression interaction model for a controlled 
interrupted time series 
 
 
Figure 1: Segmented regression interaction model for a controlled interrupted time series 
Intervention group in blue, control group in red. T = time since the start of the study, X = intervention (pre-intervention period = 0, post-
0, 2, 4   6 1, 3, 5  7 relate 
to slopes. Curved arrows represent differences between the intervention group and control group.  (Adapted from Linden and Adams 2011) 
[1]  
 
Segmented regression equation for slope change with a control series: 
 
 is the outcome variable at time ,  is a variable representing the time since the start of the study 
and  is a dummy variable indicating the pre- or post-intervention period.  now represents the 
intervention group ( ) or control group ( ). Here  represents the difference in intercept 
at =0,  represents the slope difference between the intervention and control group in the pre-
intervention period, represents the difference between the change in level in the control and 
intervention group associated with the intervention,  represents the difference between the change 
in slope in the control and intervention group associated with the intervention (Figure 4). Therefore 
 and  are the parameters of interest for the measures of effect. 
 
Linden, A. and J.L. Adams, Applying a propensity score-based weighting model to interrupted time 
series data: improving causal inference in programme evaluation. J Eval Clin Pract, 2011. 17(6): p. 
1231-8. 
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 Contribution of the candidate to the paper 
 The idea for this paper was initiated by me based on a clear gap in the literature. 
 I recognised the use of controls as one of the most practical and robust ways for dealing with 
history bias, the major threat to the validity of ITS. Nevertheless, there was a lack of 
guidance on how to select controls and design a CITS study. 
 I identified and classified 6 different types of controls that can be used in CITS studies 
(previously only location base controls and control outcomes had been described in the 
methodological literature). 
 I also developed the framework for selecting controls and analysing CITS studies and 
described where covariate imbalance can bias CITS studies. 
 As with the previous methodological studies, much of the work consisted of identifying and 
exploring a suitable dataset and within this a subpopulation that could clearly demonstrate 
the concepts that I wanted to introduce.  
o The LANTERNS dataset was a very large dataset and I chose this because of the large 
number of possible controls and because these included at least three different 
types of controls from my classification. 
o I found a subpopulation in which the intervention had been introduced around the 
same time in multiple roads and in which an effect was visible in the uncontrolled 
ITS. 
o I then used my newly developed framework to select a control and analyse the CITS 
study. 
o Subsequently I repeated this analysis but this time selecting a control based on 
covariate balance. 
o This allowed me to demonstrate the importance of first considering potential 
sources of history bias and whether the control can exclude these. 
 The paper was written by me with comments on drafts from my co-authors and subsequent 
revisions.  
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 Case study 1 appendices 
11.4.1 Gross domestic product growth in Spain 
11.4.2 Unemployment in Spain 
11.4.3 Trend in monthly mortality rate from accidental falls (control) for all of Spain before and since 
the financial crisis 
11.4.4 Trend in monthly suicide rates before and since the financial crisis by area 
11.4.5 Trend in monthly suicide rates before and since the financial crisis by sex 
11.4.6 Trend in monthly suicide rates before and since the financial crisis by age group 
11.4.7 Time series plots of trends in monthly suicide rates for all of Spain based on the alternative 
models used in sensitivity analysis 
11.4.8 Unemployment rates during the first quarter of 2005 and the last quarter of 2010 
11.4.9 Contribution of the candidate to the paper 
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 Web Appendix 1: Gross domestic product growth rate in Spain compared to 
previous quarter, seasonally adjusted, 2002 to 2012 
 
 
 
 
 
 
 
OECD.StatExtracts.  2012  [cited 2012 
04/07/2012]; Available from: http://stats.oecd.org/Index.aspx?QueryName=350. 
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 Web Appendix 2: Unemployment rate in Spain 2005 to 2012 
 
 
 
 
 
 
 
 
Instituto Nacional de Estadística [National Statistics Institute].   [cited 2012 04/07/2012]; 
Available from: http://www.ine.es/. 
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 Web Appendix 3: Trend in monthly mortality rate from accidental falls 
(control) for all of Spain before and since the financial crisis 
 
Seasonally adjusted. Circles = observed rates; red line = modelled rates fitted to the data; blue line = deseasonalised trend. 
Vertical dotted line = onset of the financial crisis 
 
  
Pre- financial crisis Financial crisis period 
Step change: RR: 1.031; 95% CI: 0.939 to 1.132; p=0.525 
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 Web Appendix 4: Trend in monthly suicide rates before and since the 
financial crisis by area 
 
(a) Northern Spain 
 
(b)  Central Spain 
 
 
Pre- financial crisis Financial crisis period 
Pre- financial crisis Financial crisis period 
Step change: RR: 1.090; 95% CI: 0.967 to 1.226; p=0.160 
Step change: RR: 1.043; 95% CI: 0.911 to 1.195; p=0.538 
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(c) Mediterranean and Canary Islands 
 
Seasonally adjusted. Circles = observed rates; red line = modelled rates fitted to the data; blue line = deseasonalised trend. 
Vertical dotted line = onset of the financial crisis. (a) includes Galicia, Asturias, Cantabria, the Basque Country, Navarra, La 
Rioja and Aragon; (b) includes Castilla and Leon, Castilla La Mancha, Extremadura and Madrid; (c) includes Catalonia, 
Valencia, Murcia, Andalucia, the Balearic Islands and the Canary Islands. 
  
Pre- financial crisis Financial crisis period 
Step change: RR: 1.086; 95% CI: 1.005 to 1.172; p=0.037 
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 Web Appendix 5: Trend in monthly suicide rates before and since the 
financial crisis by sex 
 
 
Seasonally adjusted. Circles = observed rates; red line = modelled rates fitted to the data; blue line = deseasonalised trend. 
Vertical dotted line = onset of the financial crisis.  
  
Males 
Females 
Pre- financial crisis Financial crisis period 
Males:  Step change: RR: 1.100; 95% CI: 1.026 to 1.179; p=0.007 
Females: Step change: RR: 1.013; 95% CI: 0.894 to 1.149; p=0.834 
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 Web Appendix 6: Trend in monthly suicide rates before and since the 
financial crisis by age group 
 
(a)  Age 15-39 years 
 
 
(b) Age 40-64 years 
 
 
Pre- financial crisis Financial crisis period 
Pre- financial crisis Financial crisis period 
Step change: RR: 1.104; 95% CI: 0.980 to 1.245; p=0.110 
Step change: RR: 1.082; 95% CI: 0.980 to 1.195; p=0.119 
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(c) Age 65 years and older 
 
Seasonally adjusted. Circles = observed rates; red line = modelled rates fitted to the data; blue line = deseasonalised trend. 
Vertical dotted line = onset of the financial crisis.  
  
Pre- financial crisis Financial crisis period 
Step change: RR: 1.067; 95% CI: 0.957 to 1.191; p=0.243 
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 Web Appendix 7: Time series plots of trends in monthly suicide rates for all 
of Spain based on the alternative models used in sensitivity analysis 
 
(a) Model allowing for both a step and a slope change in the financial crisis period 
 
(b) Model with the crisis period lasting only for the duration of GDP contraction (April 2008 to 
December 2009) 
 
Pre- financial crisis Financial crisis period 
Pre- financial crisis Financial crisis period Post-crisis 
Step change: RR: 1.181; 95% CI: 1.013 to 1.377; p=0.037 
Slope change: RR: 0.998; 95% CI: 0.995 to 1.001; p=0.208 
Step change: RR: 1.063; 95% CI: 1.022 to 1.106; p=0.003 
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(c) Model with the onset of the financial crisis at the time when unemployment began to rise (July 
2007) 
 
All models seasonally adjusted. Circles = observed rates; red line = modelled rates fitted to the data; blue line = 
deseasonalised trend. Vertical dotted line = onset of the financial crisis, second dotted line in (b) = end of recession period. 
  
Pre- financial crisis Financial crisis period 
Step change: RR: 1.076; 95% CI: 1.007 to 1.149; p=0.034 
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 Web Appendix 8: Unemployment rates during the first quarter of 2005 and 
the last quarter of 2010 
 
   2005 Q1 2010 Q4 Difference 
      
  All Spain 10.2% 20.3% 10.1%       
 Area:  
 
 
  Northern Spain 8.9% 14.3% 5.4% 
  Central Spain 9.6% 17.3% 7.7% 
  Mediterranean 10.9% 23.7% 12.9%       
 Sex:  
 
 
  Males 7.8% 20.0% 12.2% 
  Females 13.6% 20.8% 7.1%       
 Age group*:  
 
 
  16-19 39.1% 65.5% 26.4% 
  20-24 23.2% 36.2% 12.9% 
    25-54 12.3% 19.6% 7.4% 
  55+ 8.6% 12.8% 4.2%       
Unemployment rates as a percentage of the economically active population. Q1 = first quarter, Q4 = last quarter. *Age-group 
divisions are different to those used in the study as these were the categories published by the Instituto Natcional de 
Estadistica. Source: Instituto Nacional de Estadística [National Statistics Institute]  
 
 
 
 
 
 
 
Instituto Nacional de Estadística [National Statistics Institute].   [cited 2012 04/07/2012]; 
Available from: http://www.ine.es/. 
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 Contribution of the candidate to the paper 
 The concept of this paper was my own. I found that the majority of previous studies of the 
effects of the financial crisis had used very weak before and after designs and thought that 
the evidence needed to be improved. I was also interested from a methodological 
perspective in applying the ITS design to an unplanned event. 
 I developed the protocol and sought appropriate ethical approval. 
 I identified suitable data sources and extracted the data 
 I was responsible for deciding on the methodological approach  this included deciding on 
the ITS design, defining the timing of the financial crisis, defining the impact model and 
deciding on the stratification variables. 
 I also cleaned and formatted the data and undertook all of the analysis including several 
sensitivity analyses. 
 Finally, I was responsible for writing up the study. 
 I received support and advice on the analysis from AG and all of the co-authors contributed 
to reviewing and providing feedback on the manuscript through several versions. 
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 Case study 2 appendices 
 
11.5.1  S1 Table: Population characteristics: England and Scotland 2007-2014 [1] 
11.5.2  S2 Table: Trend changes in specialist visits and hospitalisations following the intervention  
11.5.3  S1 Figure: Time series of outpatient specialist visits in England and Wales 
11.5.4  S2 Figure: Time series of inpatient hospitalisations in England and Wales 
11.5.5  S3 Figure: NHS reference costs 
11.5.6  S1 Text: Controlled interrupted time series model 
11.5.7  S1 Checklist. REporting of studies Conducted using Observational Routinely-collected health 
Data (RECORD) statement. 
11.5.8  S1 Protocol 
11.5.9  S1 Data: English data 
11.5.10 S2 Data: Scottish data 
11.5.11 S3 Data: Algorithms used for extraction of English data. 
11.5.12 S4 Data: Algorithms used for extraction of Scottish data. 
11.5.13 Contribution of the candidate to the paper 
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  S2 Table: Trend changes in specialist visits and hospitalisations following 
the intervention England vs Wales 
 
  Trend change England  Trend change Wales  Trend change England v Wales 
  Effect 95% CI 
p-
value  Effect 95% CI 
p-
value  Effect 95% CI 
p-
value 
Outpatient specialist visits           
 Total 1.011 [1.007,1.015] <0.001  0.9879 [0.980,0.996] 0.003  1.0233 [1.014,1.033] <0.001 
 GP referred 1.016 [1.012,1.020] <0.001  0.9908 [0.977,1.004] 0.186  1.0254 [1.011,1.040] 0.001 
Inpatient hospitalizations           
 Total 0.9982 [0.995,1.002] 0.332  0.9988 [0.995,1.003] 0.565  1.000 [0.994,1.005] 0.846 
 Elective 0.9977 [0.994,1.001] 0.212  0.9983 [0.991,1.006] 0.672  0.999 [0.991,1.007] 0.808 
 Emergency 1.000 [0.995,1.004] 0.878  0.9987 [0.997,1.001] 0.182  1.000 [0.996,1.005] 0.884 
 
Coefficients for trend change are relative change in the slope gradient following the intervention. Trend change study v control is the slope 
change in England over and above any change in Wales accounting for differences in baseline trends. All segmented regression models used 
log transformed Gaussian distribution. 
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  S1 Figure: Time series of outpatient specialist visits in England and Wales 
Total 
 
 
GP referred 
 
 
Red o = England, blue x = Wales. Lines = deseasonalized linear trend. Vertical lines delineate the intervention phase (between Q2 2014 and 
Q2 2013) 
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   S2 Figure: Time series of inpatient hospitalisations in England and Wales 
Total 
 
Elective 
 
Emergency  
 
 
Red o = England, blue x = Wales. Lines = deseasonalized linear trend. Vertical lines delineate the intervention phase (between Q2 2014 and 
Q2 2013) 
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  S3 Figure: NHS reference costs  
A) Reference costs for outpatient specialist visits(1)  
 
 
 
 
B) Reference costs for inpatient admissions (1) 
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1. Department of Health. Reference costs 2014-15 2015 [Available from: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/477919/2014-
15_Reference_costs_publication.pdf.  
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  S1 Text: Controlled interrupted time series model 
 
 
Intervention group in blue, control group in red. T = time since the start of the study, X = intervention (pre-intervention period = 0, post-
0 3 1-2 4-5 relate to slopes. 
Curved arrows represent differences between the intervention group and control group. (Adapted from Linden and Adams 2011)(1)  
 
Segmented regression equation for slope change with a control series: 
 
  is the outcome variable at time ,  is a variable representing the time since the start of the study 
and  is a dummy variable indicating the pre- (  = 0) or post-intervention period (  = 1).  represents 
the intervention group ( ) or control group ( ). represents the intercept at =0,  is the 
underlying pre-intervention trend (slope), is the slope change following the intervention,  
represents the difference in intercept between the two groups at =0,  represents the slope 
difference between the intervention and control group in the pre-intervention period,  represents 
the difference between the change in slope in the control and intervention group associated with the 
intervention. Therefore  is the parameter of interest for the measure of effect. 
 
References 
1. Linden A, Adams JL. Applying a propensity score-based weighting model to interrupted time 
series data: improving causal inference in programme evaluation. J Eval Clin Pract. 2011;17(6):1231-
8. 
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  S1 Checklist. REporting of studies Conducted using Observational 
Routinely-collected health Data (RECORD) statement. 
The RECORD statement  checklist of items, extended from the STROBE statement, that should be 
reported in observational studies using routinely collected health data. 
 
 Ite
m 
No
. 
STROBE items Location in 
manuscript 
where items 
are reported 
(page) 
RECORD items Location in 
manuscript 
where items 
are 
reported 
(page) 
Title and abstract  
 1 
design with a 
commonly used term in 
the title or the abstract 
(b) Provide in the 
abstract an informative 
and balanced summary 
of what was done and 
what was found 
Title and 
abstract 
RECORD 1.1: The type of 
data used should be specified 
in the title or abstract. When 
possible, the name of the 
databases used should be 
included. 
 
RECORD 1.2: If applicable, 
the geographic region and 
timeframe within which the 
study took place should be 
reported in the title or 
abstract. 
 
RECORD 1.3: If linkage 
between databases was 
conducted for the study, this 
should be clearly stated in 
the title or abstract. 
Abstract 
paragraph 2 
 
 
 
 
Abstract 
paragraph 2 
 
 
 
 
 
n/a 
Introduction 
Background 
rationale 
2 Explain the scientific 
background and 
Introduction   
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rationale for the 
investigation being 
reported 
Objectives 3 State specific 
objectives, including 
any prespecified 
hypotheses 
Introduction 
final 
paragraph 
  
Methods 
Study 
Design 
4 Present key elements of 
study design early in the 
paper 
Methods: 
statistical 
analysis 
  
Setting 5 Describe the setting, 
locations, and relevant 
dates, including periods 
of recruitment, 
exposure, follow-up, 
and data collection 
Methods: data 
and study 
population 
  
Participants 6 (a) Cohort study - Give 
the eligibility criteria, 
and the sources and 
methods of selection of 
participants. Describe 
methods of follow-up 
Case-control study - 
Give the eligibility 
criteria, and the sources 
and methods of case 
ascertainment and 
control selection. Give 
the rationale for the 
choice of cases and 
controls 
Cross-sectional study - 
Give the eligibility 
criteria, and the sources 
n/a RECORD 6.1: The methods 
of study population selection 
(such as codes or algorithms 
used to identify subjects) 
should be listed in detail. If 
this is not possible, an 
explanation should be 
provided.  
 
RECORD 6.2: Any 
validation studies of the 
codes or algorithms used to 
select the population should 
be referenced. If validation 
was conducted for this study 
and not published elsewhere, 
detailed methods and results 
should be provided. 
 
Methods: 
data and 
study 
population 
(NB: data 
for all NHS 
pts was 
included 
other than 
the 
exclusions 
stated on p6) 
 
n/a 
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and methods of 
selection of participants 
 
(b) Cohort study - For 
matched studies, give 
matching criteria and 
number of exposed and 
unexposed 
Case-control study - For 
matched studies, give 
matching criteria and 
the number of controls 
per case 
RECORD 6.3: If the study 
involved linkage of 
databases, consider use of a 
flow diagram or other 
graphical display to 
demonstrate the data linkage 
process, including the 
number of individuals with 
linked data at each stage. 
 
 
 
 
n/a 
Variables 7 Clearly define all 
outcomes, exposures, 
predictors, potential 
confounders, and effect 
modifiers. Give 
diagnostic criteria, if 
applicable. 
Methods: data 
and study 
population; 
statistical 
analysis 
RECORD 7.1: A complete 
list of codes and algorithms 
used to classify exposures, 
outcomes, confounders, and 
effect modifiers should be 
provided. If these cannot be 
reported, an explanation 
should be provided. 
S1-s2 data 
extraction 
Data 
sources/ 
measureme
nt 
8 For each variable of 
interest, give sources of 
data and details of 
methods of assessment 
(measurement). 
Describe comparability 
of assessment methods 
if there is more than one 
group 
Methods: data 
and study 
population 
  
Bias 9 Describe any efforts to 
address potential 
sources of bias 
Methods: 
statistical 
analysis; 
Discussion 
paragraphs 2 
and 3 
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Study size 10 Explain how the study 
size was arrived at 
Methods: data 
and study 
population 
  
Quantitative 
variables 
11 Explain how 
quantitative variables 
were handled in the 
analyses. If applicable, 
describe which 
groupings were chosen, 
and why 
Methods: 
statistical 
analysis 
  
Statistical 
methods 
12 (a) Describe all 
statistical methods, 
including those used to 
control for confounding 
(b) Describe any 
methods used to 
examine subgroups and 
interactions 
(c) Explain how missing 
data were addressed 
(d) Cohort study - If 
applicable, explain how 
loss to follow-up was 
addressed 
Case-control study - If 
applicable, explain how 
matching of cases and 
controls was addressed 
Cross-sectional study - 
If applicable, describe 
analytical methods 
taking account of 
sampling strategy 
(e) Describe any 
sensitivity analyses 
Methods: 
statistical 
analysis  
 
Methods: 
statistical 
analysis  
 
n/a 
 
n/a 
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n/a 
Data access 
and 
cleaning 
methods 
 ..  RECORD 12.1: Authors 
should describe the extent to 
which the investigators had 
access to the database 
population used to create the 
study population. 
 
RECORD 12.2: Authors 
should provide information 
on the data cleaning methods 
used in the study. 
n/a  all of 
the database 
population 
within the 
defined 
study period 
was 
included 
 
 
Methods: 
data and 
study 
population 
Linkage  ..  RECORD 12.3: State 
whether the study included 
person-level, institutional-
level, or other data linkage 
across two or more 
databases. The methods of 
linkage and methods of 
linkage quality evaluation 
should be provided. 
n/a 
Results 
Participants 13 (a) Report the numbers 
of individuals at each 
stage of the study (e.g., 
numbers potentially 
eligible, examined for 
eligibility, confirmed 
eligible, included in the 
study, completing 
follow-up, and 
analysed) 
Table 1 and S1 
Table 
 
 
 
 
 
n/a 
RECORD 13.1: Describe in 
detail the selection of the 
persons included in the study 
(i.e., study population 
selection) including filtering 
based on data quality, data 
availability and linkage. The 
selection of included persons 
can be described in the text 
and/or by means of the study 
flow diagram. 
Methods: 
data and 
study 
population 
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(b) Give reasons for 
non-participation at 
each stage. 
(c) Consider use of a 
flow diagram 
 
n/a 
Descriptive 
data 
14 (a) Give characteristics 
of study participants 
(e.g., demographic, 
clinical, social) and 
information on 
exposures and potential 
confounders 
(b) Indicate the number 
of participants with 
missing data for each 
variable of interest 
(c) Cohort study - 
summarise follow-up 
time (e.g., average and 
total amount) 
Table 1 and S1 
Table 
 
 
 
n/a 
 
 
n/a 
  
Outcome 
data 
15 Cohort study - Report 
numbers of outcome 
events or summary 
measures over time 
Case-control study - 
Report numbers in each 
exposure category, or 
summary measures of 
exposure 
Cross-sectional study - 
Report numbers of 
outcome events or 
summary measures 
n/a 
 
 
n/a 
 
 
 
n/a 
  
Main results 16 (a) Give unadjusted 
estimates and, if 
applicable, confounder-
Results: 
Paragraphs 2-
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adjusted estimates and 
their precision (e.g., 
95% confidence 
interval). Make clear 
which confounders 
were adjusted for and 
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potential bias or 
imprecision. Discuss 
both direction and 
magnitude of any 
potential bias 
Discussion: 
paragraph 3 
RECORD 19.1: Discuss the 
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that were not created or 
collected to answer the 
specific research question(s). 
Include discussion of 
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unmeasured confounding, 
missing data, and changing 
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Discussion: 
paragraph 3 
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reported. 
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of analyses, results from 
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ility 
21 Discuss the 
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study results 
Discussion: 
paragraph 2 
  
Other Information 
Funding 22 Give the source of 
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the funders for the 
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based 
Financial 
disclosure 
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Methods: 
data and 
study 
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*Reference: Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sørensen HT, von 
Elm E, Langan SM, the RECORD Working Committee.  The REporting of studies Conducted using 
Observational Routinely-collected health Data (RECORD) Statement.  PLoS Medicine 2015; in press. 
 
*Checklist is protected under Creative Commons Attribution (CC BY) license. 
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  S1 Protocol 
 
Evaluation of the impact of GP led commissioning on secondary care activity 
 
Background: 
Clinical Commissioning Groups (CCGs) were created following the Health and Social Care Act 2012 
(HSCA),(1) and replaced Primary Care Trusts on 1 April 2013 as the main budget holders and 
commissioners of NHS services in England. CCGs are led by a board, primarily made up of General 
Practitioners (GPs), and represent all GP practices in the local area. Each is responsible for a population 
of 100,000-900,000. The theory behind GP led commissioning is, firstly, that GPs understand their 
that by holding the budgets and being given the freedom to reinvest any savings they are incentivized 
to ration spending. It has been hypothesized that, given the incentive to minimize costs, GP budget 
holding may lead to a shift away from expensive secondary care activity towards a more community 
based approach.(2-4) GP commissioning may also influence patient experience of secondary care 
services as it could incentivize hospitals to reduce waiting times and work to improve patient 
satisfaction given the threat that commissioners may switch contract to providers that provide a 
better patient experience.(4) Nevertheless, unintended consequences are also possible, for example, 
there may be inappropriate reductions in care that should have been in hospital and patient 
satisfaction could suffer if GPs, as budget holders, prioritize cost over patient experience. 
 
Aim: 
To evaluate the impact of GP led commissioning on secondary care activity 
 
Questions 
1. Has the introduction of GP led commissioning been associated with a change in rates of hospital 
admissions? 
2. Has the introduction of GP led commissioni
experience of secondary care in the NHS? 
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Outcomes 
Primary outcomes:  
Secondary care activity, including: 
- GP referrals made 
- GP referrals seen 
- Total admissions 
- elective admissions 
- outpatient appointments 
- emergency admissions 
Secondary outcomes: 
Patient experience, including 
- waiting times 
- patient satisfaction 
 
Analysis 
An interrupted time series (ITS) design with segmented regression analysis will be used to evaluate 
the effect of GP led commissioning on secondary care activity. The intervention was fully implemented 
in April 2013, yet there was a phase in period during which many CCGs were present in shadow form 
prior to April 2013 and after full implementation changes to commissioning are likely to only have 
manifested gradually (existing contracts may have taken some time to expire and CCGs may have 
chosen to simply renew existing contracts in the early stages before they became well established). 
eflected in the chosen impact 
model. Possible impact models are outlined in Figure 1, ultimately one of these will be chosen a priori 
based on further consideration of existing knowledge of the intervention and/or secondary data, other 
impact models will be used in a sensitivity analysis. 
The greatest limitation of the ITS design is the potential for confounding by events concurrent to the 
intervention. In order to strengthen the validity of the design we will incorporate control series to 
exclude effects from possible confounding events. Geographical control groups will include secondary 
care activity in Scotland, Wales and Northern Ireland (where the HSCA was not implemented). Control 
outcomes such as critical care activity (a service that would be unlikely to be substituted by changes 
to community care) will also be included in the analyses. 
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Stratified analyses by different types of secondary care activity (elective, emergency, outpatient) and 
by specialty will be undertaken in order to establish the nature of any effect. 
 
 
Figure 2: possible impact models 
(a) gradual slope change beginning during the phase in of the intervention 
(b)  
(c) step change with exclusion  
(d)  
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Data 
Monthly data will be needed for each of the following variables  ideally from 2007-2015 
Variable Data source Range 
Outcomes   
Elective admissions (England) NHS England (HES) 
 
HSCIC 
Apr08-Aug15 
 
Apr07-Jul15 
Outpatient appointments 
(England) 
NHS England (HES) 
 
HSCIC 
Apr08-Aug15 
 
Apr07-Jul15 
Emergency admissions 
(England) 
NHS England (HES) 
 
HSCIC 
Apr08-Aug15 
 
Apr07-Jul15 
GP referrals made (England) NHS England (HES) 
 
Apr08-Aug15 
GP referrals seen (England) NHS England (HES) 
 
Apr08-Aug15 
   
Denominator data   
Population (England) ONS 07-14 
   
Stratification variables   
Gender   
Age-group   
Diagnosis   
Specialty   
   
Controls   
Elective admissions (Scotland) ISD (NHS Scotland) 04-Jun15 
Outpatient appointments 
(Scotland) 
ISD (NHS Scotland) 04-Jun15 
Emergency admissions 
(Scotland) 
ISD (NHS Scotland) 04-14 
GP referrals made (Scotland)   
GP referrals seen (Scotland)   
Population (Scotland) ONS 07-14 
Elective admissions (Wales)  99-14 
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Outpatient appointments 
(Wales) 
Statswales 89-12 
Emergency admissions (Wales)  99-14 
GP referrals made (Wales) Statswales Jan05-Sep15 
GP referrals seen (Wales)   
Population (Wales) ONS 07-14 
Elective admissions (NI) dhsspsni 05-15 
Outpatient appointments (NI) dhsspsni 09-15 
Emergency admissions (NI) dhsspsni 05-15 
GP referrals made (NI)   
GP referrals seen (NI)   
Population (NI) ONS 07-14 
Critical care admissions 
(England) 
HSCIC Apr08-Mar14 
 
Secondary outcomes  
Waiting times (England + controls)  
Patient satisfaction score (England + controls)  
  
 
 
Data sources 
Secondary care activity: 
Data on each inpatient admission, outpatient appointment and accident and emergency attendance 
in NHS hospitals in England are collected as Hospital Episode Statistics (HES) published by the Health 
and Social Care Information Centre (HSCIC, http://www.hscic.gov.uk/hes). Overall activity in each of 
these categories is made publically available on a monthly basis with a four month delay via the health 
and social care information centre website and dates back to April 2007 (Figure 1). More detailed 
annual data is also available stratified by various covariates including diagnosis, specialty and hospital 
provider. Adult Critical care data is also published on an annual basis. In addition to the data which is 
made publically available HSCIC operate a Data Access Request Service on a cost recovery basis 
whereby data can be requested for additional covariates (such as age, gender and index of multiple 
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deprivation) and in greater detail  such as monthly time series of stratified data and even individual 
patient data. Such requests take between 14 to 60 days to gain access to the data. 
  
Figure 1: Admitted patients finished consultant episodes in England by month 2007-2014 
 
[More data now available via NHS England, including monthly data stratified by other covariates: 
http://www.england.nhs.uk/statistics/statistical-work-areas/hospital-activity/monthly-hospital-
activity/mar-data/] 
Patient experience: 
Monthly waiting time data is published by NHS England including: 
- Referral to Treatment Waiting Times (http://www.england.nhs.uk/statistics/statistical-work-
areas/rtt-waiting-times/) 
- Cancer waiting times  (http://www.england.nhs.uk/statistics/statistical-work-areas/cancer-
waiting-times/) 
- Diagnostic waiting times (http://www.england.nhs.uk/statistics/statistical-work-
areas/diagnostics-waiting-times-and-activity/monthly-diagnostics-waiting-times-and-
activity/) 
The NHS Patient Survey Programme coduct annual surveys of patient experience including the 
Inpatient, Outpatient, Community Mental Health and Accident & Emergency surveys. 
(http://www.england.nhs.uk/statistics/statistical-work-areas/pat-exp/ and 
https://www.gov.uk/government/collections/patient-experience-statistics) 
Patient Reported Outcome Measures (PROMs) assess the quality of care delivered to NHS patients 
from the patient perspective. Currently covering four clinical procedures (hip replacements, knee 
replacements, groin hernia and varicose veins), PROMs calculate the health gains after surgical 
treatment using pre- and post-operative surveys. 
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Control data: 
In Scotland quarterly hospital activity data is published online by the NHS Information Services 
Devision (ISD, http://www.isdscotland.org/Health-Topics/Hospital-Care/) with one quarter delay. 
Welsh hospital activity data in Wales is collected monthly and collated in the Patient Episode Database 
for Wales (PEDW) and annual data is published at the end of each year dating back to 1991 by the NHS 
Wales Informatics Service (http://www.infoandstats.wales.nhs.uk/page.cfm?orgid=869& pid=40977). 
In Northern Ireland annual hospital activity data is published by the Department of Health, Social 
Services and Public Safety Information Office dating back to 2005 
(http://www.dhsspsni.gov.uk/index/statistics/hospital/hospital-activity.htm).  
 
 
Threats and potential solutions 
Threat Solution 
Some CCGs were present in shadow form for several 
months prior to becoming the official commissioning 
body so may have influenced commissioning in the 
months leading up to the intervention. 
Consider modelling the intervention earlier 
Changes to commissioning could have taken some time 
to manifest: existing contracts may have taken some time 
to expire and CCGs may have chosen to simply renew 
existing contracts in the early stages before they became 
well established 
Consider modelling a slope change during the changeover 
period to allow for a gradual change whilst contracts 
expired then a step change once contracts should have all 
expired. Alternatively could exclude the intervention 
period from the model 
The HSCA resulted in other changes to the structure of 
the NHS and public health services (see appendix). 
Therefore it  may be difficult to disentangle whether some 
effects are due to the introduction of CCGs or due to other 
changes 
It is unlikely that the other changes would have had an 
impact on secondary care referrals so this should not be 
an issue for the primary outcome. Some of the other 
could result in changes to secondary outcomes relating to 
patient experience, nevertheless this change was more of 
a gradual progression rather than a sudden new change 
with the implementation of the act.  
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Using a control outcome such as critical care activity, 
could help to exclude some of the other changes that 
could have affected all types of care. 
 
Another option is to treat the intervention as the HSCA as 
a whole rather than focus on a part of the act. 
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Appendix 
2012 Health and Social Care Act key policy areas: 
 
1. Clinically led commissioning: 
  Abolition of Primary Care Trusts (PCTs) and Strategic Health Authorities (SHAs) + 
moving commissioning to GP led Clinical Commissioning Groups (CCGs) 
2. Provider regulation to support innovative services: 
 Monitor (a national regulatory body) given greater role in promoting competition and 
role in licensing providers of NHS services (including private sector and charity 
providers).  
 Emphasis on choice and competition as a driver of improved patient care 
3. Greater voice for patients: 
 Building on previous efforts to increase patient involvement in the NHS 
 Included establishment of Healthwatch (as a committee of the Care Quality 
Commission) to represent patient views in advising NHS organisations 
4. New focus for public health: 
 Establi
at a national level (and abolishment of the Health Protection Agency) 
 Moving public health departments at a local level from PCTs to Local Authorities 
(establishment of PHE as ne body to drive improvements in PH) 
5. Greater accountability locally and nationally:
 Strengthens and clarifies accountability for and within the NHS 
 CCGs accountable to NHS England and assessed against a commissioning outcomes 
framework 
 Statutory health and w
commissioning of local NHS services and social care. 
6. Streamlined arms-length bodies: 
 Several bodies abolished with key functions transferred to other bodies (including: 
General Social Care Council, Office of the Healthcare Professions Adjudicator, Alcohol 
Education and Research Council, National Patient Safety Agency, NHS Institute for 
Innovation and Improvement, National Information Governance Board and the 
Appointments Commission) 
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  S1 Data 
English data 
Available at: 
https://doi.org/10.1371/journal.pmed.1002427.s009 
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 S2 Data 
Scottish data 
Available at: 
https://doi.org/10.1371/journal.pmed.1002427.s010 
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 S3 Data 
Algorithms used for extraction of English data. 
Available at:  
https://doi.org/10.1371/journal.pmed.1002427.s011 
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 S4 Data 
 
Algorithms used for extraction of Scottish data. 
Available at: 
https://doi.org/10.1371/journal.pmed.1002427.s012  
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 Contribution of the candidate to the paper 
 As with the previous case study, the concept of this paper was my own. It was motivated by 
the lack of quantitative outcome evaluations of this large scale policy and by the fact that it 
had been identified as difficult to evaluate Vittal Katikireddi1 et al. I was interested in the 
methodological challenges posed by this evaluation. 
 I developed the proposal for this study, applied for ethical approval and identified and 
applied for the data from the Health and Social Care Information Centre (England). 
 I identified suitable controls and also applied for the data from the NHS Scotland 
Information Services Division, and the NHS Wales Information Service. 
 I spent a significant amount of time investigating the details of the reforms and deciding on 
the most appropriate impact model in consultation with my co-authors. 
 I undertook the data cleaning, formatting and all uncontrolled and controlled analyses for 
each outcome and the sensitivity analyses. 
 I also identified and examined cost data from a separate data source to see if this matched 
our findings with respect to the increase in outpatient specialist visits. 
 I received advice on analytical approaches from SS, JFW, and AG. 
 I wrote the paper and received advice and feedback on the paper from all co-authors 
 
1. Vittal Katikireddi S, McKee M, Craig P, Stuckler D. The NHS reforms in England: four challenges to 
evaluating success and failure. Journal of the Royal Society of Medicine. 2014;107(10):387-92. 
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11.6.1 Data extracted in the literature review 
11.6.2 Eligible studies 
11.6.3 Contribution of the candidate to the paper 
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 Appendix 1: Data extracted in the literature review 
 
Study characteristics: 
 Type of intervention (classified as health promotion interventions, health protection 
interventions, health service intervention, and non-health interventions or events) 
 Primary outcome (classified as health or disease measures, mortality measures, health 
behaviours, service or treatment uptake, treatment outcomes or service quality, and non-
health outcomes) and  
 Type of data source 
 
We extracted the following information on the methodological reporting of the study:  
 Whether the study time period was clearly stated, 
 Whether the time interval was clearly stated,  
 Whether the timing of the intervention was clearly defined,  
 Whether the authors reported checking for changes to data collection or processing, 
 Whether the authors justified their choice of study period,  
 Whether the authors considered possible history bias (due to confounding interventions or 
events around the time of the intervention),  
 Whether any design adaptations were implemented to mitigate the risk of history bias, 
 Type of control series if a control series was used (classified as location based control, 
characteristic based control, behaviour based control, historical control cohort, control 
outcome, control time period and randomised control group). 
 Method of analysis (segmented regression or autoregressive integrated moving average 
model),  
 Impact model selected (including whether they allowed for a level change and/or a slope 
change, whether a transition phase was included, whether they allowed for a lagged effect 
and whether they allowed for a floor or ceiling effect),  
 Whether the selected impact model was justified a priori,  
 Whether linearity was assessed in the outcome data and Whether a linear or non-linear model 
was used,  
 Whether seasonality was considered and adjusted for,  
 Whether time-varying confounders were considered and adjusted for,  
 Whether autocorrelation was considered and adjusted for,  
 Whether the authors undertook any sensitivity analyses and Whether these were justified a 
priori,  
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 Contribution of the candidate to the paper 
 As with the other papers, the concept of this article was my own. 
 There were two components to this paper: 1. Development of a new reporting framework, 
2. A literature review of the reporting of methods in applied ITS studies. 
 I first identified existing reporting frameworks that might be relevant to ITS studies, 
systematically went through these, considering which components might be included within 
an ITS reporting framework and collating these. 
 I built on existing methodological literature as well as the work that I had developed in 
chapters 4,5 and 6 to identify other methodological issues pertinent to ITS that were not 
covered in existing reporting criteria. 
 I drew this together to develop ITS specific reporting criteria that were loosely modelled on 
the TREND (Transparent Reporting of Non-randomised Designs) criteria. 
 While these criteria were developed after undertaking the case studies (and therefore not 
applied to the case studies) I retrospectively checked through the methods reporting of my 
case studies to identify any further components that should be included within the FERITS 
statement. 
 For the literature review, I defined the search criteria to keep this manageable and 
appropriate to the aims of the study (providing an illustrative example of current reporting) 
and decided on what data I wanted to extract from the papers. 
 I undertook the literature review including identifying papers, deduplicating, excluding those 
that were non-eligible and reviewing the methods reporting and extracting the relevant 
data. 
 I then undertook the descriptive analysis of the extracted data and presented the results. 
 Finally, I wrote the paper with input from my co-authors on both the reporting criteria and 
the main body of the manuscript following an initial draft. 
 
